Vital Healthcare Property Trust logo

Focus on Fundamentals: Driving Operational Performance

Full Year Results12 August 2025VHPReal Estate

VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by Northwest Healthcare

Properties Management Limited

Page 1 of 4


MARKET RELEASE

13 August 2025

Focus on Fundamentals: Driving Operational Performance

Northwest Healthcare Properties Management Limited (the Manager), the manager of Vital

Healthcare Property Trust (Vital), has today released its results for the 12 months ended 30 June

2025 (FY25).


Vital is pleased to report that distributions of 9.75 cents per unit (cpu) were paid to Unit Holders

in FY25, consistent with guidance, funded from Adjusted Funds from Operations (AFFO) of

10.41cpu.


Strong progress was made during the year at a portfolio level. New and renewal leasing

successes lifted occupancy to 98.6% (from 98.0%). In addition, the profitability of Vital’s diverse

underlying hospital tenants continued to improve. Vital’s strong balance sheet was further

enhanced as improved terms and pricing from a major debt refinance were secured. Vital’s

next debt maturity is now not until March 2027.


Chris Adams Co Head of the A/NZ Region said: “We continue to drive further enhancement in

the quality of the Vital portfolio; the result of developments having completed, disposal of non-

core assets and asset management initiatives. The major refinancing of debt facilities is also a

testament to the quality of the Vital portfolio, banking relationships and strength of defensive

cashflows from a high quality and diversified tenant base.”

FY25 outcomes:

Financial

Vital’s pre-tax operating earnings were up 4.8% to $77.4 million versus the year ended 30 June

2024 (FY24), driven by strong like-for-like rental growth, additional income from completed

developments and lower management fees. In FY25 Unit Holders received distributions of

9.75cpu, consistent with FY24. Net Tangible Assets (NTA) were $2.47 per unit as at 30 June

2025, impacted by unrealised property valuation changes, the mark-to-market of interest rate

swaps and a weaker Australian Dollar exchange rate.


Key outcomes include:


• Operating earnings (pre-tax) up 4.8% to $77.4 million

• AFFO of 10.41cpu versus 10.90cpu in the prior comparative period (pcp)

• Distributions of 9.75cpu, consistent with guidance, on a 93.6% AFFO pay-out ratio

• NTA per unit of $2.47, down from $2.69 in the pcp



VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz

Managed by Northwest Healthcare

Properties Management Limited

Page 2 of 4


Operational performance

The underlying property portfolio performance was pleasing, with strong leasing outcomes

achieved – an endorsement of Vital’s high quality and well-located properties, accompanied

by a proactive leasing strategy. Occupancy further improved to 98.6% with this momentum

carrying over into positive early leasing outcomes for the year ended 30 June 2026 (FY26).

Together with leasing renewals and extensions, like-for-like Net Property Income

1

(NPI)

increased by 3.7% and Weighted Average Lease Expiry (WALE) was up to 18.5 years.


Key outcomes include:


• Like-for-like NPI up 3.7% versus FY24

• Occupancy further increased to 98.6%, up 0.6% versus pcp, reflecting over 9,400sqm of

new leasing executed

• WALE up from 18.3 years to 18.5 years

• Diversified and high-quality tenant mix maintained,

• Key hospital operator profitability (portfolio basis) further improved versus pcp, to almost

two times rent cover

2


• Weighted average capitalisation rate of the property portfolio softened 23bps to 5.54%,

resulting in an unrealised value reduction of $96.7 million - signs are now emerging that

property valuations have begun to stabilise

Development

Good progress was made in delivering Vital’s committed development pipeline with two

projects totalling $108.8 million being completed, substantially on time and budget. At 30

June 2025 only $36.9m remains to be deployed.


Subject to achieving hurdle earnings and value accretion outcomes for Unit Holders and

available capital, the focus for FY26 and beyond is the activation of the embedded value in

Vital’s robust development pipeline.


Key outcomes include:


• Completed the delivery of the:

o A$16.0 million expansion of Maitland Private Hospital (NSW), on a project yield of

6.0%; and

o $91.5 million Stage 2 of the $141.4m redevelopment of Wakefield Hospital

(WGN), on a project yield of 5.7%

• Initiated a $11.5 million capacity expansion project at Wakefield Hospital in June 2025,

on a project yield of ~7.0%

• Awarded Sector Leader by GRESB for ESG in healthcare for listed entities globally for

developments

Capital management

With strong support from Vital’s banking group in FY25, Vital extended $1.1 billion of debt

facilities (75% of total facility limits) on enhanced terms and pricing. Vital’s defensive,

diversified and long dated cashflows support current gearing at 42.1%, with material

headroom to bank covenants.




1

Determined on a constant currency basis

2

Measured as Rent/EBITDAR (earnings before interest, tax, depreciation, amortisation and rent) for the last twelve months to

31 March



VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz

Managed by Northwest Healthcare

Properties Management Limited

Page 3 of 4


The continued focus on disciplined capital management and deployment resulted in select

non-core asset recycling initiatives totalling $50 million, with the proceeds deployed to fund

Vital’s remaining committed development projects.


Key outcomes include:


• $1.1 billion debt refinance completed, delivering improved terms, pricing and an

extended maturity profile

• Strong balance sheet maintained – Gearing

3

at 42.1%, up from 39.1% in the pcp

• Weighted average debt duration extended to 3.8 years with no debt maturing until

March 2027

• Interest rate hedging cover increased to 82% with a weighted average duration of 3.2

years and weighted average hedged rate of 3.55% for FY26

• $50 million realised from non-core asset sales, with the proceeds reinvested into funding

Vital’s high quality committed development projects.

Outlook and guidance:

Vital is well placed for FY26 and beyond as a number of the headwinds that have impacted

healthcare property and the real estate sector more generally begin to abate, including

higher interest rates, operator challenges in Australia, and a risk off position from investors.


The recovery in New Zealand is further advanced than Australia, with continued strong

operator performance and a stabilisation of property valuations and moderation in

construction costs observed.


The continuation of this trend will allow the fundamentals of the Vital business to again emerge

including strong demand for health services, an attractive income return from a high-quality

diversified tenant base and opportunities to leverage the embedded value within the Vital

portfolio.


The Board and management are confident with Vital’s strategy to deliver attractive risk

adjusted returns over the medium to long term for our Unit Holders.


Distributions totalling 9.75cpu (payable quarterly) are forecast for FY26.

Conference call and webcast:

A conference call and webcast are scheduled for 10:00 am (NZST) on Wednesday, 13 August

2025. Participants are encouraged to pre-register for the event to avoid delays.

Conference call

Participants can register for the conference call by navigating to: https://s1.c-

conf.com/diamondpass/10043436-iyn8gk.html

Please note that registered participants will receive a pin upon registration allowing direct

entry to the call.




3

Trust Deed Gearing Ratio – calculated as total borrowings to gross asset value of the Trust. Bank Loan to Value ratio was

43.6% (covenant: 55.0%) at 30 June 2025.



VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz

Managed by Northwest Healthcare

Properties Management Limited

Page 4 of 4


Webcast

Presentation slides and audio can be viewed by copying the following URL into your internet

browser: https://event.choruscall.com/mediaframe/webcast.html?webcastid=LzAZ47i2

You will be required to input your name, email address and company name to register for the

webcast.

A copy of the webcast will be available on Vital’s website later in the day at: www.vhpt.co.nz


– ENDS –

ENQUIRIES

Chris Adams

Co-Head, A/NZ, Northwest Healthcare Properties Management Limited

Tel +61 408 665 332, Email chris.adams@nwhreit.com

Michael Groth

Chief Financial Officer, Northwest Healthcare Properties Management Limited

Tel +61 409 936 104, Email michael.groth@nwhreit.com

About Vital (NZX code VHP):

Vital Healthcare Property Trust is an NZX-listed fund that invests in high-quality healthcare

properties in New Zealand and Australia including private hospitals (~78%* of portfolio value),

ambulatory care facilities (~18%* of portfolio value) and life science facilities (~4%* of portfolio

value).

Vital is the leading specialist listed landlord of healthcare property in Australasia.

Vital is managed by Northwest Healthcare Properties Management Limited, a subsidiary of

Toronto Stock Exchange listed Northwest Healthcare Properties REIT (TSX: NWH-UN.TO), a global

investor and manager of healthcare infrastructure.

For more information, please visit our website: www.vhpt.co.nz

For more information about Northwest, please visit: www.nwhreit.com

__________________________________

* All figures are as at 30 June 2025, NZD/AUD exchange rate of 0.9275.

---

Annual Report
2025

Driving operational performance

F Y 2 5
OUTCOMES

9. 75cpu

Distributions paid to Unit Holders

3.7%

Like-for-like Net Property Income (NPI) growth

$2.47

Net Tangible Assets (NTA) per unit

98.6%

Occupancy

Contents
AWARDS AND RECOGNITION

As part of its sustainability efforts, hard copy Annual Reports will no

longer be mailed unless specifically requested by Unit Holders. As

with previous results, the full Annual Report will be emailed to Unit

Holders and will be available on the NZX and be posted on Vital’s

website: https://www.vitalhealthcareproperty.co.nz/financial-

results/. This initiative will save approximately 252,000 pages of

printing per annum and reduce our greenhouse gas emissions both

through reducing printing and mailing.

Investors who would like to receive a printed Annual Report can

request one by calling Computershare on +64 9 488 8777,

emailing enquiry@computershare.co.nz or mailing a request

to: Computershare Investor Services Limited, Private Bag 92119,

Auckland 1142.

2025 NEW ZEALAND COMMERCIAL

PROJECT AWARDS – GOLD | ORMISTON

HOSPITAL STAGE 1 EXPANSION

GOLD AWARD FOR VITAL’S

ANNUAL REPORT

About Vital and Northwest 4

Overview of Vital 6

FY25 Key Events 10

Manager’s Report 12

Financial Summary

and Portfolio Metrics 16

Asset Allocation 17

Australian Portfolio Overview 18

New Zealand Portfolio Overview 20

Completed Developments 22

Committed Developments 28

Sustainability 34

Our Board 54

Our Executive Team 56

Corporate Governance 58

Financial Statements 68

Vital’s Structure 11 6

Directory 11 8

CIVIC, HEALTH AND ARTS PROPERTY AWARD

ORMISTON HOSPITAL STAGE 1 EXPANSION

DEVELOPMENT EXCELLENCE AWARDS 2025

– WINNER – HIGHLY COMMENDED HEALTH

SOCIAL INFRASTRUCTURE | MACARTHUR

HEALTH PRECINCT STAGE 1 (GENESISCARE,

CAMPBELLTOWN)

MBA NSW 2024 AWARDS - EXCELLENCE IN

SUSTAINABILITY – COMMERCIAL CATEGORY

| MACARTHUR HEALTH PRECINCT STAGE 1

(GENESISCARE, CAMPBELLTOWN)

GRESB SECTOR LEADER IN DEVELOPMENTS

FOR LISTED HEALTHCARE GLOBALLY

All values in this report are in NZ dollars

unless stated otherwise.

ANNUAL REPORT 2025

|

3

TSX listed owner and manager of
NZ$10.3b of healthcare infrastructure

across four continents.

EXCELLENCE

Delivering exceptional outcomes

INTEGRITY

Doing what’s right

PARTNERSHIP

Succeeding together

Northwest (Australia and New Zealand)

is the manager of Vital, with over 50

professionals in the region. We have offices

in Auckland, Melbourne and Sydney.

Be the leading global diversified healthcare real estate entity.

Vision

Provide best in-class real estate solutions to the healthcare industry

and deliver exceptional shareholder value to investors.

Mission

Values

4

|

VITAL HEALTHCARE PROPERTY TRUST

Vital is an NZX listed
property trust which

owns ~$3.2b of

healthcare property in

New Zealand

and Australia.

To be Australia and New Zealand’s leading listed healthcare property fund.

Deliver stable and growing total Unit Holder returns, including an attractive

risk-adjusted income distribution, sourced from healthcare real estate.

Vision

Mission

ANNUAL REPORT 2025

|

5

WESTERN
AUSTRALIA

NORTHERN


TERRITORY

SOUTH


AUSTRALIA

NEW SOUTH

WALES

TASMANIA

VICTORIA

QUEENSLAND

Overview of Vital

1

1

All numbers quoted on this page relate to income producing properties only and exclude strategic land holdings.

4%

8%

22%

12 %

21 %

6

|

VITAL HEALTHCARE PROPERTY TRUST

18.5 years
WALE

$148.8m

NET PROPERTY

INCOME

Avive Clinic, Melbourne

30%

3%

SOUTH

ISLAND

NORTH

ISLAND

5.5%

$3.2

b

WEIGHTED

AVE CAP RATE

PORTFOLIO

VALUE

ANNUAL REPORT 2025

|

7

Acute Hospitals 58.1%
Ambulatory Care 22.2%

Specialty Hospitals

(mental health and rehabilitation) 19.7%

Sub-sector diversification

% of Value

Key Numbers

Healthe Care 16.4%

Allevia 3.0%

Epworth HealthCare 13.7%

Evolution Healthcare 13.9%

Burnside 3.0%

Southern Cross 4.2%

GenesisCare 2.3%

Endoscopy Auckland

1

1.5%

Boulcott Hospital 1.7%

Other 21.9%

Aurora Healthcare 18.4%

Tenant diversification

% of Rent

18.4%

21 . 9 %

16.4%

2.3%

1.7%

1.5%

4.2%

3.0%

3.0%

13.9%

13.7%

A

M

B

U

L

A

T

O

R

Y

C

A

R

E


2

2

.

2

%

AMBULATORY

CARE

SPECIALTY

HOSPITAL

ACUTE

HOSPITAL

58.1%

H

O

S

P

I

T

A

L


7

7

.

8

%

22.2%

19.7%

1

Joint venture between Evolution Healthcare and Allevia

8

|

VITAL HEALTHCARE PROPERTY TRUST

2.0%
42.1%

BALANCE SHEET GEARING

DISTRIBUTION 10-YEAR CAGR

PER ANNUM FY15 - FY25

$4.9m

LIKE-FOR-LIKE NET PROPERTY

INCOME GROWTH OVER FY25

9. 75cpu

FY26 DISTRIBUTION

GUIDANCE

~$2.2b

COMMITTED AND POTENTIAL

DEVELOPMENT PIPELINE

Maitland Private Hospital, Maitland

ANNUAL REPORT 2025

|

9

AUGUST 2024
• Grace Hospital Oropi Day Unit (Stage 4

of 5) reached practical completion.

SEPTEMBER 2024

• Vital marked 25 years of being listed on

the NZX.

• A$16.0m Maitland Private Hospital

expansion reached practical completion.

• PCNZ Property Conference

delegates tour of Wakefield

Hospital’s redevelopment.

OCTOBER 2024

• A$57.4m Macarthur Health Precinct Stage 1

(GenesisCare Integrated Cancer and Health Centre)

achieved Excellence in Sustainability – Commercial

Category at the Master Builder’s Association NSW

2024 Awards.

• GRESB – Vital was again recognised as a Global

Sector Leader for ESG in Developments for listed

healthcare globally.

• Prime Minister Rt Hon. Christopher Luxon opened

the $38.1m Ormiston Hospital Stage 1 Expansion,

operated by Southern Cross Healthcare.

• Inaugural Climate Related Disclosure was released.

JULY 2024

FY25 Key Events

QUARTER 1

QUARTER 2

Prime Minister Rt Hon. Christopher Luxon opened

the Ormiston Hospital Stage 1 Expansion

South Australia’s Minister for Health and Wellbeing,

Hon. Chris Picton MP officially opened Playford Health Hub Stage 2

10

|

VITAL HEALTHCARE PROPERTY TRUST

JANUARY 2025
• GenesisCare Integrated Cancer and Health Centre awarded

6 Star Green Star Design & As Built v1.3 certified rating.

• $11.5m Level 5 expansion at Wakefield Hospital commenced.*

FEBRUARY 2025

• Health Minister Simeon Brown officially opened Wakefield

Hospital Stage 2 redevelopment, which is operated by

Evolution Healthcare.

• South Australia’s Minister for Health and Wellbeing,

Hon. Chris Picton MP officially opened the A$43.4m Playford

Health Hub Stage 2 tenanted by Calvary, Sonic Healthcare,

GenesisCare, SA Health and Radiology SA.

• Keystone Trust Student awarded the 2025 Vital Healthcare

Property Trust Keystone Scholarship.

MAY 2025

• Ormiston Hospital Stage 1 Expansion achieved

Gold in the Health category at the New Zealand

Commercial Project Awards.

• Playford Health Hub Stage 2 awarded 6 Star Green

Star Design & As Built v1.3 certified rating.

JUNE 2025

• Ormiston Hospital Stage 1 Expansion achieved an

Excellence award in Civic, Health and Arts Category

at the PCNZ Awards.

• $1.1b debt refinancing – Vital extended debt maturity

to 3.83 years with improved terms and no maturities

until March 2027.

JUNE 2025

QUARTER 3

QUARTER 4

*Funding approved in May 2025.

Award-winning Ormiston Hospital Stage 1 Expansion

Health Minister Simeon Brown officially

opened Wakefield Hospital Stage 2

ANNUAL REPORT 2025

|

11

Manager’s Report
Tēnā koutou,

Northwest Healthcare Properties Management Limited (Northwest),

the Manager of Vital Healthcare Property Trust (Vital), is pleased to

report Vital’s results for the year ended 30 June 2025 (FY25).

FY25 highlights included:

• Like-for-like net property income (NPI) up 3.7%

1

.

• Enhanced occupancy of 98.6% with over 9,400sqm of vacancy

leased, primarily space at recently completed developments.

• Distributions of 9.75cpu (consistent with guidance) delivered on

a 93.6% AFFO pay-out ratio.

• Completed $1.1b debt refinance, delivering improved terms and

longer duration.

• Delivered two value enhancing developments:

–A$16.0m expansion of Maitland Private Hospital (NSW),

completed in September 2024. This expansion provided

additional mental health and surgical beds, day oncology

chairs, consulting suites and car parking.

–Stage 2 ($91.5m) of Vital’s $141.4m investment into the

redevelopment of Wakefield Hospital (WGN). This state-

of-the-art facility was officially opened by the Hon. Simeon

Brown, Minster of Health in February 2025.

• Commenced an $11.5m capacity expansion of Wakefield

Hospital in June 2025.

• Awarded Sector Leader (the highest possible achievement)

by GRESB for ESG in healthcare for listed entities globally

for development.

• Profitability of our underlying hospital tenants improved with

key rental affordability metric increasing to 57% from 51%.

2

Our commitment to sustainability

Vital’s approach to sustainability is grounded in understanding

and addressing the ways our operations affect both people and

the environment. We remain committed to actively enhancing our

long term sustainability outcomes, both commercially and for the

communities in which we operate.

In FY25 we released our first climate-related disclosure,

aligned with the Aotearoa New Zealand Climate Standards

developed by the External Reporting Board (XRB). This sets out

our climate governance, strategic priorities, risk approach and

performance measures.

Key highlights this year include:

• Submission to GRESB for the fifth consecutive year,

demonstrating continued transparency and performance

benchmarking. Results are expected in October 2025.

• Commenced climate-resiliency property assessments to better

understand and manage physical climate risks.

• Achieved 6 Star Green Star Design & As Built certifications at

Playford Health Hub Stage 2 and the GenesisCare Integrated

Cancer Centre, seeking to deliver sustainable design,

construction and resilient properties.

• Continued implementation of our Reflect Reconciliation

Action Plan (RAP), tracking against key initiatives that support

reconciliation and cultural awareness.

• Leveraged an industry-leading modern slavery platform,

with suppliers actively participating in risk assessments and

transparency efforts.

Portfolio overview

Active asset management remained a high priority throughout FY25.

Over 51,000sqm of space were leased, extended or renewed

during the year, representing 22% of Vital’s total income and 20%

of the portfolio's lettable area, locking in secure, defensive and

long term cashflows for Unit Holders.

These strong leasing outcomes, including over 9,400sqm of

new leasing activity, lifted portfolio occupancy from 98.0% to

98.6% and increased weighted average lease expiry (WALE)

by 0.2 years to 18.5 years, despite the passage of time.

It is worth noting that Vital’s WALE was 18.1 years in FY20,

increasing despite five years passing reflecting leasing,

developments, divestments, acquisitions and other initiatives

undertaken during this time.

The weighted average valuation capitalisation rate on Vital's

property portfolio softened to 5.54% at 30 June 2025, resulting

in an unrealised value reduction of $96.7m. Signs have emerged

that valuations are stabilising.

1

On a like-for-like, constant currency basis

2

Rent cover ratio = Rent / EBITDAR (Earnings before interest, tax, depreciation, amortisation and rent) for last twelve months to 31 March 2025.

Distributions of 9.75cpu delivered, underpinned by occupancy increasing to 98.6% and

structured rent reviews.

12

|

VITAL HEALTHCARE PROPERTY TRUST

3.7%
INCREASE IN LIKE-FOR-LIKE

NET PROPERTY INCOME

~$3.2b

PROPERTY

PORTFOLIO

2024 GRESB SECTOR

LEADER - DEVELOPMENTS

Developments

Good progress was made during the financial year in completing

Vital’s committed developments.

The projects at Maitland Private Hospital and Wakefield Hospital

totalling $108.8m were successfully operationalised in FY25.

New opportunities are being considered on a selective value

adding basis and include the commencement of a new $11.5m

capacity expansion project at Wakefield Hospital.

At 30 June 2025, Vital had $249.9m of developments under way in

New Zealand and Australia, with approximately $36.9m remaining

to spend (excluding land costs).

Acquisitions

No significant acquisitions were made during FY25.

Divestments

Over FY25, the following assets were divested, realising gross

proceeds of $49.7m:

1. In October 2024, the sale of Hirondelle Private Hospital

(NSW) to a private investor settled for A$24.0m.

2. In December 2024, Epworth Rehabilitation (VIC) was sold

with vacant possession to Arcare for A$19.3m as services

ceased at this facility. This sale included two adjacent

residential houses.

3. In May 2025, a residential house in Sydney no longer

required for expansion of a nearby Vital asset was sold for

A$1.7m.

The above sales were achieved at an average 7.0% discount to

book value.

Playford Health Hub, Adelaide

In conjunction with our highly

supportive banking group, $1.1b of

debt extensions were completed in

the year resulting in:

• Improved terms, multicurrency flexibility and

pricing enhancements

• Weighted average debt duration extended to

3.8 years with no debt maturing until March

2027

• Interest rate hedging cover increased to 82%,

with a weighted average duration of 3.2 years

ANNUAL REPORT 2025

|

13

GenesisCare Integrated Cancer and Health Centre, Sydney
Net property income

Net property income increased by 3.7% over FY25 (on a

like-for-like, constant currency basis), reflecting contributions

from the structured rent reviews from the portfolio, improved

occupancy and leasing outcomes.

In FY25, approximately 83% of Vital's rent was linked to CPI,

with 75% of this having a weighted average annual cap of

~3.6% with the balance being uncapped. This rent review

structure is designed to provide Vital’s Unit Holders with

sustainable income growth opportunities.

Financial results

Cash from operations (measured by AFFO) was $70.4m

(down 3.5%) and 10.41cpu (down 4.5%). This outcome

reflects increased tax expense, following law changes, and

interest expense versus growth in net property income after

taking into account the impact of completed developments and

divested property.

Expenses were $71.4m, 1.1% higher than FY24 reflecting

higher borrowings costs and strategic transaction costs,

offset by lower management fees.

Vital’s NTA per unit decreased by 7.9% to $2.47 primarily

due to $96.7m of unrealised property revaluation losses

attributable to +23bps portfolio capitalisation rate softening,

partially offset by development margin gains, rental growth

and leasing. Additionally there were $28.7m of unrealised fair

value losses on the value of derivatives driven by the declining

interest rate environment.

Capital management

Vital’s strong balance sheet was maintained throughout

FY25, with gearing as at 30 June 2025 of 42.1%, well below

financial covenants.

During FY25, with the strong support from Vital’s banking

partners, over $1.1b of debt facilities were extended on

improved terms and flexibility resulting in a weighted average

duration of 3.8 years at 30 June 2025 and no debt maturing

until March 2027. 82% of Vital’s borrowings were hedged at

an average fixed rate of 3.32% at 30 June 2025.

Vital’s distribution reinvestment plan remained active for FY25

raising $6.2m to fund Vital’s development opportunities. A

2.0% issue price discount applied on and from the third quarter

distribution payment.

FY26 guidance

The Board and management are pleased to provide FY26

distribution guidance of 9.75cpu (payable quarterly),

consistent with FY25 distributions.

Refer to disclaimer on back page of this report for limitations

to this guidance.

14

|

VITAL HEALTHCARE PROPERTY TRUST

New Zealand healthcare sector
New Zealand’s private healthcare sector continues to perform

well, with strong underlying demand for services being

experienced by our key hospital tenants.

Signs have recently emerged of the stabilisation in property

valuations and construction costs, although still high, are

moderating. We expect demand for new private healthcare

infrastructure to emerge over the coming year.

Australian healthcare sector

The broader Australian healthcare sector is showing signs of

emerging from its recent short-term challenges, as pressures

from health inflation, private health insurance funding dynamics

and higher interest rates begin to moderate.

Hospital operator profitability continues to improve as the

impact of recently renegotiated private health insurance rates

takes effect, however this has yet to fully translate into broader

confidence in the sector.

Longer term healthcare sector thematics

Over the long-term, sector thematics for New Zealand and

Australian healthcare services are unchanged and positive.

A strong and viable private healthcare sector remains

fundamental to the delivery of healthcare services across both

countries.

Ageing and growing populations, rising life expectancies and

continued technological advancements in health solutions,

combined with public funding capacity constraints underpin

Vital’s confidence in the sector and its ability to deliver long-

term risk adjusted returns for Unit Holders.

Vital’s strategic positioning

Vital’s property portfolio is characterised by high-quality, well

located healthcare properties with embedded development

opportunities that can be activated over time.

This, combined with high income security afforded by a long

weighted average lease term (WALE) to a high-quality and

diversified tenant mix, provides the expectation for Vital to

deliver long term Unit Holder value.

Graham Stuart

Independent Chair

13 August 2025

Northwest Healthcare Properties Management Limited,

the Manager of Vital Healthcare Property Trust

Chris Adams

Co-Head A/NZ Region

Vital has completed over $272m of capital

recycling initiatives since FY23, including

~$50m in FY25, investing the proceeds from

the sale of these non-core properties into

high-quality developments like the recently

completed Maitland Private Hospital

expansion and the redeveloped

Wakefield Hospital. This focus on actively

curating the property portfolio, offers the

potential for enhanced Unit Holder return

benefits over the medium term, reflecting

enhanced property quality, resilience

and performance.

FY26 outlook

We believe the Vital business is well placed for FY26 and beyond

as we begin to see many of the headwinds that have impacted

healthcare property and the real estate sector more generally

begin to abate, including higher interest rates, operator challenges

in Australia and a risk off position from investors.

The recovery in New Zealand is further advanced than Australia,

with continued strong operator performance and a stabilisation of

property valuations and moderation in construction costs observed.

The continuation of this trend will allow the fundamentals of the

Vital business to again emerge including strong demand for health

services, an attractive income return from a diversified tenant base

and opportunities to leverage the embedded value in the Vital

portfolio.

The Board and management remain confident around Vital’s

strategy for delivering medium-long term returns for our

Unit Holders.

We encourage you to join us and look forward to welcoming you

to our Annual General Meeting being held on 6 November 2025.

Nā māua noa, nā

ANNUAL REPORT 2025

|

15

Financial summary
Portfolio metrics

All figures are in New Zealand dollars (NZD) unless otherwise stated

All figures are in New Zealand dollars (NZD) unless otherwise stated

1

Excludes properties held for development

FY21FY22FY23FY24FY25

Financial Performance

Net property income109,66312 3 , 018145,224144,533148,834

Revaluation gain/(loss) on investment properties235,383244,239(208,553)(165,244)(96,722)

Net interest expense27,68428,9833 7, 7 7 040,60645,169

AFFO and distributions

Adjusted Funds From Operations (AFFO)

1

57,457 6 7, 8 2 473, 33572,89970,369

AFFO (cpu)11 . 5 411 . 9 211 . 1 810.9010.41

Cash distribution to Unit Holders (cpu)8.889.639. 759. 759. 75

Financial Position

Total assets2,662,5603,399,8343,429,7123,304,7593,248,092

Borrowings929,3001,018,7771,239,1561,287,4771,363,639

Total equity1,503,4512,165,8761,957,3831,805,1261,679,515

Debt to total assets ratio (%)35.030.036.33 9 .14 2 .1

Net tangible assets ($ per unit)2.893.342.962.692.47

20212022202320242025

Investment properties ($m)2,634.03,339.03,381.03,240.03,212.0

Number of investment properties

1

4146453634

Occupancy (%)99.298.898.998.098.6

Weighted average lease term to expiry (years)18 . 717. 617. 818.318.5

12 month lease expiry (% of income)1. 71. 71.81.21. 7

Financial Summary

16

|

VITAL HEALTHCARE PROPERTY TRUST

1
Healthcare precinct = area or hub for healthcare delivery typically including at least two of a public hospital, major private hospital, health teaching facility or health research facility

Comprises

Public, private, speciality,

rehabilitation and mental

health hospitals

Targeting

Government supported

or high private health

insurance catchments with

growing populations

Comprises

Residential aged care

facilities (excluding

retirement facilities)

Targeting

High quality operators with

substantial balance sheets

and <45.0% rent/EBITDAR

and high-quality infrastructure

Indicative target portfolio weighting

50 - 70%

(30 June 2025: 78%)

Indicative target portfolio weighting

10 - 20%

(30 June 2025: 0%)

HOSPITALS

AGED CARE

OUT-PATIENT/AMBULATORY

CARE

LIFE SCIENCES/RESEARCH

Comprises

Administration, diagnostic

services and specialist

consulting, primary care

out-patient facilities

Targeting

Facilities located in a

healthcare precinct

1


and/or from where

healthcare is delivered

Comprises

Biotechnology,

pharmaceutical, biomedical,

university, health education

and other research facilities

Targeting

Specialised facilities and/

or facilities located in a

healthcare precinct

1

Indicative target portfolio weighting

10 - 20%

(30 June 2025: 18%)

Indicative target portfolio weighting

5 - 15%

(30 June 2025: 4%)

Asset Allocation

Hospitals are expected to remain

the core of Vital's portfolio.

Ageing population in Australia and New

Zealand presents continued investment

opportunity in aged care. The asset class

remains a growth target for Vital subject to

identification of suitable opportunities of scale.

Ambulatory care is expected to be a key growth

area in Australia and New Zealand reflecting shifts

in healthcare delivery models in both countries.

Expected to increase

on completion of RDX.

The indicative target asset allocations listed below

provide an indication of how we could move the portfolio

over time subject to appropriate acquisition and /

or development opportunities becoming available.

ANNUAL REPORT 2025

|

17

PRIVATE
HOSPITALS

AMBULATORY

CARE

• 14 hospitals (acute and specialty

– mental health, rehabilitation)

•5 hospital operators

• 83.0% of AUS portfolio value;

86.0% of AUS portfolio rent

• WALE: 20.7 years

• 6 assets, multiple tenants

• 17.0% of AUS portfolio value;

14.0% of AUS portfolio rent

• WALE: 9.5 years

WESTERN

AUSTRALIA

SOUTH

AUSTRALIA

NEW SOUTH

WALES

VICTORIA

QUEENSLAND

2

3

6

2

7

Australian Portfolio

Overview

18

|

VITAL HEALTHCARE PROPERTY TRUST

VICTORIA
QUEENSLANDNEW SOUTH WALES

WESTERN AUSTRALIA

SOUTH AUSTRALIA

• Belmont Private Hospital

• Currumbin Clinic

• GenesisCare Integrated

Cancer and Health Centre

• Hurstville Private Hospital

• Kellyville Private Hospital

• Lingard Day Centre

• Lingard Private Hospital

• Maitland Private Hospital

• Toronto Private Hospital

• Abbotsford Private Hospital

• Marian Centre

• Burnside Hospital - Stepney

• Playford Health Hub – MOB,

Retail and Carpark

• Tennyson Centre

• 120 Thames Street

• Avive Clinic Mornington Peninsula

• Ekera Medical Centre

• Epworth Camberwell

• Epworth Eastern Hospital

• South Eastern Private Hospital

~$2.1b

20

1

PROPERTIES (AUS)

1

Income Producing Property (excludes strategic assets)

www.vitalhealthcareproperty.co.nz/portfolio/

Full details of individual

properties are available at:

ANNUAL REPORT 2025

|

19

New Zealand
Portfolio Overview

NORTH

ISLAND

SOUTH

ISLAND

12

2

PRIVATE

HOSPITALS

AMBULATORY

CARE

•9 hospitals (all acute)

•6 hospital operators

• 84.1% of NZ portfolio value;

84.3% of NZ portfolio rent

•WALE: 19.2 years

• 5 assets, multiple tenants

• 15.9% of NZ portfolio value;

15.7% of NZ portfolio rent

• WALE: 10.2 years

• Ascot

• Ascot Carpark (Right of Use)

• Ascot Central

• Boulcott Hospital

• Bowen Hospital

• Endoscopy Auckland

• Grace Hospital

• Hutt Valley Health Hub

• Kensington Hospital

• Ormiston Hospital

• Royston Hospital

• Wakefield Hospital

• 68 Saint Asaph Street

• Kawarau Park Health Hub

NORTH ISLAND

SOUTH ISLAND

20

|

VITAL HEALTHCARE PROPERTY TRUST

Ormiston Hospital Stage 1 Expansion, Auckland
~$1.1b

14 PROPERTIES (NZ)

www.vitalhealthcareproperty.co.nz/portfolio/

Full details of individual

properties are available at:

ANNUAL REPORT 2025

|

21

Completed
Developments

During FY25, Vital completed

two developments with a total

development cost of $108.8m.

Details of the completed

developments follow on pages

24-25 of this report.

Playford Health Hub, Adelaide

22

|

VITAL HEALTHCARE PROPERTY TRUST

ANNUAL REPORT 2025
|

23

Wakefield Hospital has undergone a major
transformation to deliver leading healthcare services

and is the largest private hospital in Wellington. Vital’s

contribution capped at a total of $141.4m all in cost

for Stage 1 and 2, was reached in June 2024 with the

balance funded by operator Evolution Healthcare.

Wakefield Hospital - Stage 2

Spanning 6 storeys across multiple buildings and connected via a spacious

atrium, this redevelopment provides a seismically resilient facility with 7 fully

digital operating theatres, 2 cardiac catheterisation labs, 10 ICU/ HDU beds,

a 37-bed inpatient ward, 3,000sqm specialist medical consulting suite, full

radiology unit and new administration and front of house areas.

NLA STAGE 2 ONLY

~10,000sqm

TO WELLINGTON

PUBLIC HOSPITAL

1km

OPERATIONS

COMMENCED

January 2025

% OF VITAL'S

PORTFOLIO

5.9%

~$141. 4 m

TOTAL DEVELOPMENT COST

(INCLUDING $91.5M FOR STAGE 2)

NEW BEDS INCLUDING

10 HDU/ ICU BEDS

47

SUSTAINABILITY

FEATURES

Passive design,

thermal performance

and energy efficient

systems

24

|

VITAL HEALTHCARE PROPERTY TRUST

Located in NSW, servicing the Maitland and
greater Hunter region, the two stage expansion

increased services capacity for mental health and

oncology for operator Healthe Care.

Maitland Private Hospital

The initial stage of the redevelopment built a new level above the existing

mental health ward supporting an increase in the mental health service

capacity by 24 beds, including high quality consulting suites, communal

areas, group rooms and gymnasium.

The second stage relocated the day oncology unit, providing an increase of

5 chairs to 12, creating an improved space for the provision of services, whilst

leveraging the views of the Hunter region.

An additional 67 car parks and improvements to the hospital entry interface

and roadways were also completed as part of Stage 2.

NLA

1,155sqm

TO MAITLAND

HOSPITAL

1.8km

PRACTICAL COMPLETION

ACHIEVED

September 2024

% OF VITAL'S

PORTFOLIO

4.7%

NEW MENTAL HEALTH

BEDS + 4 SURGICAL

BEDS REFURBISHED

24

~ A$16 .0 m

DEVELOPMENT COST

SUSTAINABILITY

FEATURE

Utilisation of existing

common plant to

minimise additional

infrastructure

ANNUAL REPORT 2025

|

25

Wakefield Hospital, acquired by Vital in 2017, has been transformed to provide high quality healthcare
in a state-of-the-art private hospital and specialist facility, in partnership with Evolution Healthcare.

• Vital has contributed a total of $141.4m to the major

redevelopment of Wakefield Hospital (Stage 1 and 2).

• The asset is strategically located ~1km from the Wellington

Public Hospital.

• A 30-year lease term will commence from Stage 2b

practical completion, forecast for late 2025.

• Level 5 expansion commenced in January 2025 to fitout 34

additional surgical beds, unlocking existing shell space, with

a blended net yield of ~7.0%.

• Future operating theatre expansion planning is already

under way to meet healthcare demand.

Under Vital’s ownership, the

redevelopment has transformed

the facility, delivering improved

sustainability and seismic resilience,

increased rental income, lease

duration and property valuation.

4 MAY 2017

(AT ACQUISITION)

30 JUNE 2025IMPROVEMENT

Rental Income~$1.4m~$11.1m693.0%

Asset Management Case Study

26

|

VITAL HEALTHCARE PROPERTY TRUST

1
Health Precinct = area or hub for healthcare delivery typically including at least two of a public hospital, major private hospital, health teaching facility or health research facility

Leasing Highlights

• Renewed car parking agreement - designed to

optimise operations and increase income

• New Lease to Basis, improving occupancy to 82%,

up from 71.1% in FY24

• Strong interest in remaining unlet space

• Strong tenant retention with all major tenants renewed,

maintaining asset occupancy at 100.0%

• WALE 6 years

• Strong tenant covenants including being anchored by

the South Australian Government (OPERA Clinic and

Lyell McEwin Renal Dialysis unit)

• Occupancy increased to 92% since practical

completion in May 2024

• Vacancies successfully leased

• Asset occupancy 100.0% post balance date, up from

75.7% in FY24

• Ascot Central

- ~4,800sqm GFA

- 100.0% leased, up from 96.9% in FY24

- 15 tenants, anchor tenant Fertility Associates

- WALE ~5.0 years

• Ascot

- ~11,400sqm GFA

- 100.0% leased, up from 98.4% in FY24

- 11 tenants, anchor tenant, Allevia Health

- WALE ~15 years

• Ascot Carpark

- 97.3% leased, up from 91.5% in FY24

68 ST ASAPH STREET

TENNYSON CENTRE

PLAYFORD HEALTH HUB

120 THAMES STREET

ASCOT HEALTH PRECINCT

1

ANNUAL REPORT 2025

|

27

Committed
Developments

Vital has five committed

developments under way at a

total projected cost of $249.9m

with $36.9m remaining to spend.

1

This potential development pipeline is expected to be delivered

over a long period of time (~10 years) and is subject to market

conditions being supportive and a range of other requirements

including minimum tenant precommitments.

Vital’s committed and potential

development pipeline of ~$2.2b

(assuming strategic land is fully

developed)

1

remains extensive with a

focus on asset resilience, quality and

portfolio growth.

RDX, Gold Coast (Artist’s Impression)

28

|

VITAL HEALTHCARE PROPERTY TRUST

SUSTAINABILITY FEATURES
Immediately adjacent to the public Hutt Valley

Hospital and Vital owned Hutt Valley Health Hub,

Boulcott Hospital is undergoing a refurbishment and

expansion to increase theatre capacity and support

services, whilst maintaining operational continuity.

An Importance Level 3

facility (building code

and seismic rating

compliance)

Reduced

embodied

carbon

Passive design and

thermal performance

Energy

efficient

systems

estimated

development cost

$24.8m

WALE

20.0 years

1

yield on cost

~6.0%

1

Estimated on practical completion

This complex refurbishment and expansion includes 2 additional

operating theatres, increased capacity within the day stay and

recovery units, a new kitchen and associated support services.

Master planning has commenced for future expansion at Boulcott

Hospital and Vital’s adjacent site at Hutt Valley Health Hub.

Boulcott Hospital, Wellington

forecast completion

Mid-25

Boulcott Hospital, Wellington (Theatre - under construction)

ANNUAL REPORT 2025

|

29

SUSTAINABILITY FEATURES
An Importance Level 3

facility (building code

and seismic rating

compliance)

Reduced embodied

carbon

Passive design and

thermal performance

5 Star Green Star

design review rating

has been lodged

Energy efficient

systems

Adjacent to the existing Vital owned Endoscopy Auckland

on Gillies Avenue in Epsom, this 1,400sqm new stand alone

endoscopy and day surgery facility at 22 Kipling Avenue

is under construction and will be operated by a joint

venture between Evolution Healthcare and Allevia Health.

1

From practical completion

This 3-storey facility will provide 4 procedure rooms, a sterile services

department, associated support services and basement parking. Construction

works are materially progressed with internal fitout works well under way.

Consent for an on grade car park at 24 Kipling Avenue to support the new

facility has been granted and works are expected to commence in August

2025.

estimated

development cost

$32.2m

WALE

20.0 years

1

forecast completion

Mid-late-25

yield on cost

~5.4%

Endoscopy Auckland, Epsom

Render

30

|

VITAL HEALTHCARE PROPERTY TRUST

SUSTAINABILITY FEATURES
An Importance Level 3 facility (building

code and seismic rating compliance)

with the addition of base isolators and

accelerometers designed to exceed the

latest seismic standards

Wakefield Hospital’s new acute services building

commenced operations in January 2025. Almost

immediately, demand for the future 34-bed ward within

the Level 5 shell space triggered the need for expansion.

1

From practical completion

Fitout works to the ward are under way and will increase the hospital

bed capacity to 81-beds (including 10 existing HUD/ ICU beds).

Expansion works are a reflection of the significant healthcare demands

at Wakefield Hospital and to enable future growth of the facility.

Beds will be commissioned in two phases with first 16-beds operational

in late 2025 and the remaining 18-beds operational in mid 2026.

estimated

development cost

$11 . 5 m

WALE

30.0 years

1

forecast completion

Late-25

fully let blended yield

~ 7.0%

Wakefield Hospital Level 5

Expansion, Wellington

Reduced embodied

carbon

Passive design and

thermal performance

Building services

designed around

stepped isolation

plane and

movement joints

Energy efficient

systems

ANNUAL REPORT 2025

|

31

total cost excl land
(A$7.2m)

A$134 . 2m

forecast completion

Early-26

forecast fully let

blended yield

~5.6%

RDX Lumina is a state-of-the-art health and research

focused facility under construction within the Gold

Coast Health and Knowledge Precinct (GCHKP).

By connecting place and possibility, our aim is to

provide real estate solutions for world-class life science

occupiers and innovators within RDX’s premier facility.

RDX, Gold Coast

Reduced embodied

carbon

Climate scenario

analysis and

adaptation

undertaken

End of trip facilities

and EV charging

All electric building

powered by

renewable energy

RDX spans 9 storeys and features sustainable design, targeting a 6 Star

Green Star rating, a first-in-precinct accomplishment. The building offers

a mix of clinical, research, laboratory and specialist consulting spaces,

with tenancies available for lease now. Construction is well progressed

with practical completion delayed to early 2026 due to inclement

weather (Cyclone Alfred) and to accommodate the rework of the feature

atrium. Located adjacent to the Gold Coast Private Hospital, RDX offers

attractive amenity and convenience for healthcare users and clinicians.

Artist’s Impression

Artist’s Impression

SUSTAINABILITY FEATURES

Targeting 6

Star Green Star

certification

32

|

VITAL HEALTHCARE PROPERTY TRUST

SEISMIC AND
SUSTAINABILITY FEATURES

In partnership with the hospital operator (a joint

venture between Evolution Healthcare and

Southern Cross), Grace Hospital continues to

undergo significant expansion.

estimated

development cost

$36. 7m

WALE

24.5 years

1

yield on cost

~5.5%

1

Estimated on practical completion

A multi staged redevelopment, 4 of 5 works packages are now complete.

Oropi Day Unit endoscopy expansion reached practical completion in

August 2024.

The final works package, a 10-bed inpatient unit expansion is currently

under construction with internal services and lining under way.

As the only private surgical hospital in the Bay of Plenty, this major

refurbishment and expansion of Grace Hospital responds to the healthcare

needs of the community.

Grace Hospital, Tauranga

forecast completion

Mid-26

An Importance Level 3

facility (building code

and seismic rating

compliance)

Reduced embodied

carbon

Passive design and

thermal performance

Energy efficient

systems

ANNUAL REPORT 2025

|

33

Sustainability
Whāia te iti kahurangi ki te

tūohu koe me he maunga teitei.

Seek the treasure you value most

dearly. If you bow your head, let

it be to a lofty mountain.

Whakataukī Māori proverb

Sustainability framework

Northwest acknowledges the Traditional Owners of Country

throughout Australia, especially the lands on which we live

and work, and recognises their continuing connection to lands,

waters and communities.

Northwest also acknowledges the Rangatiratanga of Māori as

Tangata Whenua and Treaty of Waitangi partners in Aotearoa

New Zealand. We pay our respects to all First Nations peoples

and to Elders past, present and emerging.

Ormiston Hospital (Stage 1), Auckland

Acknowledgement

of country

ENABLERS

Advancing our sustainability strategy through strong

governance structures and transparency.

Governance

Reporting and Disclosure

Through the development and revitalisation of healthcare

facilities, Vital and Northwest strive to deliver lasting value

for our tenants, support the wellbeing of our people,

protect the environment and strengthen our communities.

This purpose-driven approach informs how we invest and

act, underpinning our broader sustainability ambitions.

To support progress across each sustainability pillar, Northwest

has established a set of global Key Performance Indicators

(KPIs), which are monitored at the regional level. This report

outlines the A/NZ region’s performance against these KPIs,

with results disclosed under each corresponding pillar.

THRIVING

PARTNERS

Empowering healthcare

providers to deliver

better outcomes.

HEALTHY

PLANET

Contributing to a more

sustainable future.

STRONG

COMMUNITIES

Investing in the health and

vitality of our communities.

INCLUSIVE

COMPANY

Building a strong and

engaged workforce.

34

|

VITAL HEALTHCARE PROPERTY TRUST

Having established a clear sustainability framework and robust set of strategic pillars, the real test lies
in how these principles translate into day-to-day decision-making, investment choices and stakeholder

outcomes. For Vital and Northwest, sustainability is not a peripheral commitment, it is a fundamental

lens through which we manage risk, identify opportunities and seek to deliver long-term value for all

stakeholders, including our investors, tenants, employees and the communities we serve.

In this sustainability section, we demonstrate how our strategy is embedded into the practical realities of

our business operations. From integrating climate resilience into asset management plans, to seeking to

drive measurable reductions in energy use, to working closely with partners across our supply chain to

ensure ethical and responsible practices.

We also recognise that achieving genuine progress requires moving beyond ambition to accountability.

That means disclosing transparently against global reporting standards and holding ourselves to a higher

bar year over year. Whilst challenges remain, we continue to integrate sustainability considerations into

our business operations to improve risk management, operational performance and long-term planning.

The practicalities of ESG – from framework to action

Kapa Haka Group from South Wellington Intermediate School

performing during the Wakefield Hospital

Stage 2 redevelopment official opening

ANNUAL REPORT 2025

|

35

Targets and
Achievements

FY25 key ESG highlights

6 61

hours of staff volunteering

489.4 Mwh

solar generation across

Vital assets

98.1%

improvement in air quality

at Tennyson Centre

100%

100%

of landlord controlled

sites have emergency

preparedness plans in place

27

assets have a Green Star*

Performance rating

7

developments are

targeting a minimum of 5

Star Green Star* ratings

* Refer to page 49 for details on Green Star ratings

of landlord controlled base building

electricity contracts use renewable energy

36

|

VITAL HEALTHCARE PROPERTY TRUST

Playford Health Hub, Adelaide
GenesisCare Integrated Cancer and Health Centre, Sydney

Playford Health Hub - Stage 2

South Australia’s first 6 Star Green Star

certified medical office building

GenesisCare Integrated Cancer

and Health Centre, Sydney

6 Star Green Star

ANNUAL REPORT 2025

|

37

Materiality
Materiality process

In 2024, Northwest, as manager of the Vital

portfolio, undertook a comprehensive update of

its materiality assessment to ensure we remain

focused on the sustainability topics that are most

significant, both in terms of their impact on the

environment, people and communities, and their

financial relevance to our long-term performance.

This updated assessment adopts double materiality principles, recognising that

sustainability is multifaceted and requires consideration of:

1. Impact materiality – how our activities affect the environment and broader

society, and

2. Financial materiality – how sustainability-related risks and opportunities

may influence business performance and value creation.

The evaluation spanned actual and potential impacts—both positive and

negative—across Vital’s operations and value chain, including business

relationships and asset lifecycle activities.

This materiality assessment will

continue to guide Vital’s ESG

reporting and decision-making,

ensuring that our approach remains

evidence-based, stakeholder-

informed and strategically aligned

with global best practices and

long-term value creation.

TOPIC IDENTIFICATION

Priority topics were identified through alignment

with internationally recognised sustainability

frameworks and standards, including:

• Global Reporting Initiative (GRI)

• Sustainability Accounting Standards Board (SASB)

• European Sustainability Reporting

Standards (ESRS)

In addition, Northwest considered investor

expectations, emerging ESG themes and

priority issues identified in the previous

2021 materiality assessment.

STAKEHOLDER ENGAGEMENT

Engagement with stakeholders was a core part of

the process. Through a combination of interviews

and surveys, Northwest gathered input from:

• Management and employees across

both Northwest and Vital

• Tenants and healthcare operators

• Suppliers and service providers

• Investors and ESG analysts

This process helped ensure that our sustainability

priorities are reflective of the expectations

and insights of those most connected

to and impacted by our business.

2

1

Healthy Planet

Thriving Partners

Inclusive Company

Strong Communities

Enablers

Playford Health Hub, Adelaide

38

|

VITAL HEALTHCARE PROPERTY TRUST

PRIORITISATION OF TOPICS
Each of the 27 sustainability topics evaluated

were assessed for both impact and financial

significance, and scored using a structured rubric.

The topics were then plotted on a materiality

matrix to clearly map their relative priority.

Key outcomes

Nine topics emerged as Tier 1 priorities,

representing the highest significance due to their

potential for material impact on the environment,

society and financial performance.

Tier 2 topics were also recognised for their importance,

particularly where they ranked highly from either an impact

or financial materiality perspective, such as Climate

Adaptation and Corporate Philanthropy and Volunteerism.

INTEGRATION OF FINDINGS

Following completion of the assessment, the findings

were reviewed and validated by Northwest’s

Corporate Sustainability Team and Executive

Leadership Team. These insights were directly used to:

• Refresh our sustainability strategy

• Update our key performance indicators (KPIs)

• Inform new and evolving sustainability-

related commitments

• Restructure our sustainability reporting

framework based on the themes and

pillars that emerged as top priorities

3

4

Healthy PlanetThriving PartnersInclusive CompanyEnablers

TIER 1 PRIORITY TOPICS

Building certifications

Corporate ethics and governance

Diversity, equity and inclusion

Employee health and safety

Energy management

Regulatory compliance

Tenant safety, wellbeing and inclusivity

Tenant satisfaction and experience

Waste management

The nine Tier 1 topics identified represent our priority focus, providing clear

direction for targeted action and resource allocation. These priorities are subject

to review as stakeholder expectations and operating conditions evolve and are

supported by other important themes also embedded in our broader strategy.

ANNUAL REPORT 2025

|

39

Enablers
Governance of ESG

Vital operates under a robust governance framework that

integrates climate and sustainability considerations into decision-

making at all levels. The Board holds ultimate responsibility

for overseeing climate-related risks and opportunities,

ensuring that environmental objectives are embedded in

Vital's strategic direction. The Board reviews climate-related

disclosures and metrics, including progress toward Vital’s net

zero 2050 target and maintains visibility through structured

quarterly reports, updates from management and dedicated

climate-focused sessions held throughout the year. These

sessions included targeted training on climate disclosure

frameworks and evolving legal obligations for directors.

Supporting this oversight, the Operational Risk Committee

(ORC) and Climate Working Group (CWG) play central

roles in identifying, assessing and managing material climate

risks and opportunities. These bodies report into the Board

via Vital’s leadership team, which includes the Heads of the

A/NZ Region, CFO and Regional General Counsel. The

CWG also collaborates closely with Northwest’s Global

Sustainability Team to ensure that emerging issues are escalated

appropriately. The CWG meets quarterly to assess emerging

climate risks, including asset-level vulnerabilities and transition

risks, and escalates material issues to the ORC. These insights

are incorporated into key business processes, including

acquisitions, divestments and developments, where climate

considerations are embedded in due diligence checklists

and capital planning. Vital’s Audit Committee is tasked with

reviewing the integrity of climate-related disclosures, verifying

compliance with regulatory standards and ensuring that

appropriate internal controls and external assurances are in

place for climate reporting. This layered structure ensures that

sustainability remains a core focus of governance at Vital.

ESG working groups

In addition to the Climate Working

Group and Operational Risk Committee,

Vital has established dedicated working

groups focused on key ESG priorities,

including Modern Slavery, Sustainable

Development, Operations and Facilities

Management, and Reconciliation and

Māori Culture. These groups provide subject

matter expertise, support implementation

of initiatives and ensure cross-functional

alignment on sustainability-related matters.

Integrating sustainability

into investments

By embedding sustainability into our investment

processes, we seek to create long-term value and

mitigate risks related to environmental and social factors.

Leases

We have updated our leasing practices to ensure that new

leases and renewals involving negotiated terms now include

clauses in leases which govern the collaboration with tenants

on energy efficiency, data sharing and sustainability initiatives.

Given the long weighted average lease expiry across our

portfolio, the adoption of these clauses is expected to grow

progressively over time as leases come up for renewal.

40

|

VITAL HEALTHCARE PROPERTY TRUST

Quarterly agenda plus
at least 2 climate specific

sessions per annum

• Heads of A/NZ

• CFO

• Financial Controller

• Regional General Council

• Director of Operations

and Sustainability

• Sustainability Manager

• Development Managers

VITAL

BOARD

OVERSEE

INFORM

MANAGE

IDENTIFY

OPERATIONAL

RISK COMMITTEE

SUSTAINABILITY

WORKING GROUPS

A/NZ


SUSTAINABILITY

STEERING

COMMITTEE

CLIMATE


WORKING

GROUP

Governance structure

Ormiston Hospital Stage 1 Expansion, Auckland

ANNUAL REPORT 2025

|

41

Reporting and disclosure
CLIMATE CHANGE AND RISK MANAGEMENT

Vital is a Climate Reporting Entity (CRE) and is required to

provide Climate-Related Disclosure (CRD). Vital released

its inaugural CRD in October 2024, in alignment with the

Aotearoa New Zealand Climate Standards (CS1, CS2,

and CS3). This disclosure included detailed reporting

across governance, strategy, risk management and

emissions metrics. Vital is preparing to release its second

CRD before 31 October 2025, with an enhanced focus on

the transition plan aspects of our strategy.

To support transparent and credible reporting, limited

assurance has been achieved over Vital’s GHG inventories

since CY22, covering full Scope 1, Scope 2, and Scope

3 categories. For FY25, we are targeting reasonable

assurance for Scope 1 and 2, and limited assurance for

Scope 3. Inventories have been developed using the GHG

Protocol, with material Scope 3 categories determined

via a scoping boundary assessment aligned with a 1%

materiality threshold. The outcomes of our FY25 inventory

and related scenario analysis will be reflected in our

next disclosure.

Vital's Climate Related Disclosures can be found on

our website.

GRESB

Vital submitted to the Global Real Estate Sustainability

Benchmark (GRESB) for the fifth consecutive year in 2025,

reinforcing our ongoing commitment to transparency,

accountability and continuous improvement. GRESB

remains a key global standard for real estate sustainability

benchmarking, enabling Vital to evaluate and compare

our performance across key environmental, social and

governance indicators. Participation also helps identify

opportunities for enhancement across the portfolio.

2024 results saw Vital maintain Sector Leader status for

Developments against listed healthcare peers globally.

• 2024 Standing Investment Score: 82/100

(75 global average)

• 2024 Development Score: 99/100 (85

global average)

Results of the 2025 submission are expected to be released

in October 2025.

Sector Leader

GRESB

B

CDP

BBB

MSCI

Forsyth Barr

B

Sustainalytics

14 . 9

ISS ESG

C-

4 .1

Craigs Investment Partners

42

|

VITAL HEALTHCARE PROPERTY TRUST

Human rights and modern slaveryData privacy and cybersecurity
Industry engagement

Human rights represent the fundamental freedoms,

protections and standards of treatment that every individual

is entitled to. Vital and Northwest are committed to

respecting the human rights of all people and upholding

internationally recognised standards, including those

set out in the Universal Declaration of Human Rights, the

International Bill of Human Rights, and the International

Labour Organization’s Declaration on Fundamental

Principles and Rights at Work. These frameworks guide

our approach to ethical business conduct and responsible

engagement across our operations and supply chains.

In line with this commitment, we assess and manage

modern slavery and human rights-related risks, particularly

in high-risk areas such as construction. This includes

annual modern slavery training for all Australian and

New Zealand employees, with specialised training for

key staff and the Modern Slavery Working Group.

To support responsible sourcing, we have a Supplier

Code of Conduct which is issued at the commencement

of supplier engagement and use the Informed 365

platform to distribute supplier questionnaires, track

responses and assess modern slavery risk. Contracts

are regularly reviewed to ensure alignment with

modern slavery legislation. These efforts are part of a

broader approach to embed sustainable procurement

approaches, reinforce our governance practices and

uphold internationally recognised human rights standards.

Northwest’s Modern Slavery Statement

can be found on our website.

Northwest remains committed to protecting sensitive

information and strengthening our cybersecurity. In

FY25, Northwest enhanced system security through

improved identity verification, access controls, cloud-

based infrastructure and upgraded network protections.

Threat detection, data loss prevention and server security

were also strengthened, alongside the introduction

of new data retention and backup protocols.

To support ongoing readiness, Northwest expanded

its cybersecurity team, launched mandatory

employee training and conducted regular phishing

simulations. A new device tracking system and disaster

recovery framework have been implemented.

Vital continues memberships across relevant industry

bodies to ensure we are abreast of evolving regulatory

standards, sustainability frameworks and industry

best practices. In FY25, our team again actively

participated in working groups, roundtables and

committees facilitated by the Property Councils of New

Zealand and Australia, as well as the Green Building

Councils in both countries. These engagements support

collaboration on topics such as sustainable development,

climate disclosure and legislative preparedness.

We are also members of Sustainable Healthcare Aotearoa

(SHA), a national network of healthcare professionals

focused on advancing low-emission, environmentally

sustainable healthcare in Aotearoa New Zealand through

collaboration, knowledge sharing and advocacy.

ANNUAL REPORT 2025

|

43

Thriving Partners
Places for quality care program

AIR QUALITY TESTING

100% of landlord-controlled assets within

the Vital portfolio have completed air

quality testing, reinforcing our commitment

to maintaining healthy indoor environments

across our healthcare facilities. Air quality

testing is conducted every two years.

DISASTER AND RECOVERY

PLANNING

Vital maintains comprehensive emergency

preparedness plans across all landlord-

properties, tailored to the specific risks

and operational requirements of each

site. These plans address a broad range

of potential scenarios, including natural

disasters, utility outages and critical

incident responses. Each plan is monitored,

reviewed and updated to reflect new

information, operational changes or

emerging risks, ensuring they remain current

and effective. This proactive approach

supports business continuity, safeguards

tenant wellbeing and reinforces the

resilience of our healthcare infrastructure.

TENANT PORTAL

Northwest is currently exploring the

adoption of Prism, a digital tenant

engagement and building performance

portal, across the A/NZ portfolio,

following its successful implementation

across Northwest’s assets in Europe.

The platform streamlines maintenance

workflows, enhances tenant communication

and supports data-driven sustainability

management. Prism enables real-time

tracking of building performance,

document management and preventative

maintenance, whilst also helping to identify

opportunities for improved efficiency and

reduced environmental impact.

Formalise “Places for Quality Care” programMaterial topic(s)

Complete air quality testing at 100% of landlord-controlled portfolio.

Energy Pollution and Air Quality

Tenant Safety, Wellbeing,

and Inclusivity

Business Continuity

Tenant Satisfaction

and Experience

Update disaster and recovery planning at properties and business units.

Deploy online tenant engagement portal to one additional region.

Enhance tenant satisfaction

Deploy annual tenant satisfaction survey.

Complete property-specific action plans to address

survey results for 75% of properties.

In progressSubstantially completeOn trackComplete

Ormiston Hospital Stage 1 Expansion, Auckland

44

|

VITAL HEALTHCARE PROPERTY TRUST

Tenant satisfaction
Project revitalise -

Ascot lobby upgrade

Tenant advisory committees

TENANT ENGAGEMENT SURVEY

In 2024, Vital tenants participated in a refreshed tenant

satisfaction survey to better understand their perspectives on

property management, communication and sustainability

priorities. The survey uses a standardised metric to track

satisfaction year over year and provides valuable insights to

guide service improvements.

Informed by the results, we are working to develop targeted

action plans. The goal is to complete these plans across 75% of

properties by the end of 2025. Going forward, the survey will

be conducted annually towards the end of the year, supporting

our commitment to continuous improvement and an enhanced

tenant experience.

As part of our commitment to proactive tenant engagement, we

have introduced tenant engagement meetings across our medical

office buildings in Australia and New Zealand. These meetings,

held annually and often aligned with site visits, offer a structured

forum to address a range of operational and strategic matters

including cleaning, maintenance, security, leasing requirements

and capital works planning.

By inviting a representative cross-section of tenants, we ensure

a robust and inclusive dialogue. These meetings also present

an opportunity to go beyond traditional satisfaction surveys by

fostering deeper, recurring engagement that builds trust over time.

We will continue to adapt the format based on tenant feedback,

including rotating committee members periodically to maintain

fresh perspectives and high participation.

In Q3 and Q4 in collaboration with Allevia Hospital

Ascot and other valued tenants, Vital undertook a major

refurbishment of the main ground floor lobby at Ascot as

part of its ongoing commitment to elevating healthcare

environments. Branded as Project Revitalise, the initiative

aimed to enhance the comfort, functionality and aesthetics

of the shared space. The project was guided by core

priorities including minimising disruption, maintaining

cost certainty and delivering an inviting, sustainable and

well-connected environment for patients, visitors and staff.

The completed upgrade includes:

• repositioned admissions area for Allevia Hospital Ascot

• improved wayfinding and security services with

a new concierge desk near the main entry

• comprehensive interior refresh including new flooring,

ceiling features, acoustic treatments and feature lighting

• digital signage, in-built planting and

expanded soft seating areas

• new café operator, providing convenient, nutritious

and high-quality food and drink options

These improvements streamline the patient journey

whilst also creating a more welcoming and

efficient environment for tenants and staff.

ASCOT LOBBY UPGRADE PHOTOS

Ascot, Auckland

Ascot, Auckland

ANNUAL REPORT 2025

|

45

Healthy Planet
Building utility

performance metrics

Our new third-party data collection platform

streamlines data capture by extracting consumption

information directly from utility invoices, receiving

data from retail providers and integrating building

management systems into a centralised portal. This

transition builds on the data collection methods

developed in previous years; however, collecting

tenant utility data continues to present challenges. We

are actively engaging with tenants to reinforce the

importance of this data in supporting our sustainability

goals and regulatory reporting obligations.

Establish building utility performance metricsMaterial topic(s)

Efficiently collect, track, analyse and report energy

and utility data to meet and refine targets.

Energy Management

Waste Management

Water Management

Building Certifications

and Performance

Formalise energy management plan

Create regional specific 3-year capital budget roadmaps to implement energy

conservation measures identified from energy audits in line with reduction targets.

Establish environmental building certifications program

Evaluate development of global plan for pursuing certifications,

including for tenant-controlled properties.

In progressSubstantially completeOn trackComplete

Maitland Private Hospital, Maitland

46

|

VITAL HEALTHCARE PROPERTY TRUST

GREEN STAR
Vital is committed to delivering high-performing, sustainable

healthcare assets by pursuing Green Star certification through

both the New Zealand Green Building Council (NZGBC) and

the Green Building Council of Australia (GBCA). Green Star is a

leading internationally recognised rating system that evaluates the

environmental design, construction and operations of buildings.

GREEN STAR – PERFORMANCE RATINGS

In 2024, 31 assets within the Vital portfolio were eligible for

a Green Star Performance rating, a framework that evaluates

the operational sustainability of buildings on a scale from 1

Star (Minimum Practice) to 6 Star (World Leadership).

Of the assets assessed, 27 assets achieved the following ratings:

Green Star Performance certification renewals

are scheduled for Q1 of FY26.

GREEN STAR – DEVELOPMENTS

In alignment with our sustainability strategy and Board-approved

environmental targets, Vital is committed to a minimum 5

Star Green Star rating for all new developments and major

refurbishments, as defined by GRESB, reflecting our ambition to

deliver sustainable outcomes across energy, water, materials,

indoor environment quality and emissions. Some earlier projects

proceeded prior to this commitment and are therefore not rated.

All applicable future projects will target at least 5 Stars.

Vital has achieved 6 Star Green Star certification for:

• Playford Health Hub – Stage 2, Adelaide; and

• GensisCare Integrated Cancer Centre, Sydney.

• RDX Centre of Excellence, Gold Coast has

achieved a 6 Star Design certification.

Vital is targeting 5 Star Green Star deign and as built ratings for:

• Kipling Avenue, Auckland

• Coomera Health Precinct - Stage 1, Gold Coast

• Logan Private Hospital, Meadowbrook

• Buranda Health Hub, Woolloongabba

• St Asaph St, Christchurch

• 61-71 Park Road, Auckland

Environmental building

certifications program

After-hours operational

performance review

Decarbonisation

roadmap

14

assets

11

assets

2

assets

Our optimisation strategy is centred on reducing

energy consumption and carbon emissions by

targeting inefficiencies in building operations

during low-occupancy periods. One core

initiative is the implementation of after-hours

operational performance reviews to assess real-

time system behaviour against expected low-

load performance benchmarks. These reviews

are instrumental in uncovering unnecessary

overnight energy use such as excessive lighting,

non-scheduled air conditioning operation and

misconfigured BMS logic, contributing greater

insight into both avoidable costs and emissions.

Each finding is translated into practical

interventions such as lighting automation,

smarter ventilation schedules and BMS

reprogramming. This approach is designed

not only to seek measurable reductions

in electricity usage but also to contribute

to our decarbonisation roadmap.

As part of our commitment to reducing operational

emissions, we have undertaken a detailed analysis

of energy efficiency upgrade opportunities

across the portfolio. These upgrades have been

prioritised using a structured approach that

considers asset end-of-life timelines, emissions

reduction potential and alignment with key capital

projects. This ensures that decarbonisation efforts

are strategically sequenced and supported

by appropriate capital allocation, enabling

us to maximise environmental impact whilst

maintaining operational and financial efficiency.

1 S TA R -

MINIMUM

PRACTICE

2 S TA R -

AVERAGE

PRACTICE

2 S TA R -

GOOD

PRACTICE

ANNUAL REPORT 2025

|

47

Tennyson Centre Plasma
Shield Project – results

In 2024, a plasma air purification project was implemented at the

Tennyson Centre in Adelaide, South Australia. The initiative aimed to

enhance indoor air quality through advanced filtration technology.

As part of the project, the site permanently adopted the ASHRAE 241

Infection Risk Management Mode, a standard designed to minimise airborne

infection risks in shared spaces. Following implementation, testing confirmed

a 98.1% improvement in air quality, marking a significant outcome in terms of

environmental health and safety. The project has contributed to a cleaner indoor

environment for building occupants, including staff, tenants and visitors.

98.1%

Improvement in air quality

at Tennyson Centre

Tennyson Centre,

Adelaide

48

|

VITAL HEALTHCARE PROPERTY TRUST

Sustainable Development
Guidelines

In FY25, we undertook a comprehensive review and update

of our Sustainable Development Guidelines, which provide

a consistent framework for embedding environmentally

sustainable design (ESD) principles across all new

developments and major refurbishments. The revision aligns

the guidelines with the latest commitments in Northwest’s

Sustainability Policy, updated Green Star requirements

and GRESB definitions, ensuring our approach remains

both current and practical. The review process involved

extensive consultation across regional development,

asset management and facilities management teams.

GenesisCare Integrated Cancer and Health Centre, Sydney

Enhanced guidance

on climate resilience

Reaffirmation of our target to

achieve a minimum 5 Star Green

Star rating on all major projects

Revised project classification

system aligned with

GRESB standards

Key updates include enhanced guidance on climate

resilience, reaffirmation of our target to achieve a minimum

5 Star Green Star rating on all major projects, and a revised

project classification system aligned with GRESB standards.

The guidelines also reflect practical adjustments, such as

replacing the previously required NABERS certification—

currently not applicable to private healthcare facilities—with

alternative pathways through Green Star Performance

tools. Other changes clarify expectations around low-

emission technologies and consolidate ESG reporting

obligations into a single reference point for project teams.

A summary of our Sustainable Development

Guidelines can be found on our website.

ANNUAL REPORT 2025

|

49

Strong Communities
Keystone Trust

Vital is proud to continue its partnership with Keystone Trust, an

organisation dedicated to supporting young people pursuing

careers in property and construction. In FY25, we strengthened

this relationship through a range of initiatives aimed at fostering

industry talent and increasing access to professional opportunities.

This year, two internship placements were offered to Keystone

students across the Vital and Northwest teams, providing

valuable on-the-job experience and exposure to real-world

property management and development projects. We also

continued our annual scholarship support, helping alleviate

financial barriers for students pursuing tertiary education. In

addition, our team remains actively involved in mentoring

programmes, offering guidance and industry insight to help

students build confidence and prepare for successful careers.

Vital also hosted 22 Keystone students for a site visit to Endoscopy

Auckland, offering a unique behind-the-scenes look at both an

operational hospital and a major new development under way.

The students toured the existing facility and gained exposure

to the construction of a new 1,400 sqm endoscopy suite, a

$32.0m project scheduled for completion in late 2025.

Our engagement with Keystone Trust reflects Vital’s ongoing

commitment to investing in the next generation of property

professionals and promoting greater equity within the sector.

2024 Keystone Trust GalaKeystone Trust students visit Endoscopy Auckland

2025 Vital Keystone Scholarship

recipient Hannah (Chau) Nguyen

Strengthen community engagementMaterial topic(s)

Increase employee participation in community volunteering

programs to foster local engagement and support.

Corporate Philanthropy

and Volunteerism

Community Engagement

Human Rights

Urban Design and Impact

on Public Spaces

Biodiversity and Environmental

Rehabilitation

Develop and implement a Reconciliation Action Plan (RAP) in Australia to

promote partnerships, respect and opportunities with Indigenous communities.

Launch initiatives aimed at improving local biodiversity at existing assets.

In progressSubstantially completeOn trackComplete

50

|

VITAL HEALTHCARE PROPERTY TRUST

Biodiversity
Volunteering

Reconciliation and cultural awareness

In support of local biodiversity, Vital initiated

a beekeeping project at Ascot in Auckland.

The project was launched in 2023 to enhance

urban pollination and support New Zealand’s

bee population and involves the installation and

management of beehives on site. Following a

successful natural hive expansion during the 2024

swarming season, the site now hosts two active

beehives. In addition to fostering biodiversity, the hives

produce honey, which is shared with on-site tenants.

Following the success of this initiative, discussions

are under way to expand beehive installations

across additional Vital assets in New Zealand.

Throughout FY25, Northwest team members across Australia and

New Zealand actively participated in a range of volunteering

initiatives, supporting local communities and organisations aligned

with social wellbeing and equity. In Auckland, staff contributed to

the Middlemore Hospital Mental Health Unit, beginning the day

with a mihimihi in the marae before revitalising overgrown gardens

to help create a more calming outdoor space for patients.

In Australia, our Melbourne employees supported Foodbank

Australia, helping to combat food insecurity through food relief

programs that support over 2,800 frontline charities and more

than 3,300 school breakfast programs nationwide. Volunteers

also lent their time at the Magpie Nest Café in Melbourne, which

provides free meals and a welcoming space for individuals facing

homelessness, mental health challenges and social exclusion.

The Sydney team also joined forces with ReLove, a not-for-

profit that furnishes homes for people transitioning out of crisis.

Volunteers took on a variety of hands-on roles from assembling

and cleaning donated furniture, to walking alongside clients

as they selected household items and helping move and

set up furnishings in new homes. These full-day volunteering

sessions not only provided practical support but also offered

dignity and choice to people rebuilding their lives.

Northwest remains committed to reconciliation and has been progressing

commitments within our Reflect Reconciliation Action Plan (RAP) and

making a meaningful contribution. Throughout the year, our focus has

been on supporting First Nations peoples/ businesses' participation

on our construction projects and providing services to support our

standing investments. We have worked with our development team

to review our construction contract documentation and updated them

to incorporate minimum participation rate requirements across our

projects. We have also been working with our asset management and

facilities management team to identify opportunities to engage First

Nations suppliers across our standing asset portfolio. In addition, we

have explored ways and provided opportunities for our staff to engage

in cultural and knowledge sharing activities throughout the year.

The Reconciliation Working Group continues to work and deliver

on the goals we have set for ourselves within our RAP.

Bees Up Top rehomed a swarm with Sophie Benfell-Brinsden -

Asset Manager and Liz Ingram - Sustainability Manager

Melbourne employees volunteering at Foodbank Australia

Sydney team volunteering at ReLove

Bracelet weaving for National Reconciliation week

ANNUAL REPORT 2025

|

51

Employee engagement
pulse check

Throughout 2024, Northwest experienced significant organisational

changes, reinforcing the importance of employee engagement.

As part of an ongoing commitment towards an engaging

and responsive workplace, an employee pulse survey was

conducted in Q3 of FY25 in partnership with TalentMap, an

employee engagement and benchmarking specialist. The

survey provided valuable insights across five key dimensions:

Organisational Engagement, Leadership, Growth and

Development, Organisational Culture, and Change and

Transformation. Whilst Organizational Culture scored highest

(66), followed by Leadership (61), Engagement (54) and

Change and Transformation (55) showed room for improvement,

particularly when benchmarked against external comparators.

Encouragingly, the A/NZ team expressed strong confidence

in leadership visibility, recent change initiatives and career

development opportunities. Positive views were also shared

about the increased representation of women in leadership,

diverse project work and optimism tied to recent transitions.

The survey also highlighted communication from leadership as

the most significant opportunity for improvement, alongside

challenges in workload distribution and office environment.

These insights are helping shape targeted actions to strengthen

internal communications, support wellbeing and enhance

the employee experience across the organisation.

Inclusive Company

Enhance employee satisfaction and performanceMaterial topic(s)

Deploy employee satisfaction survey.

Employee Satisfaction

and Retention

Employee Training

and Development

Deploy sustainability education

Have a sustainability-engaged and educated workforce.

Enhance social connections and culture

Enhance employee engagement through actively connecting

people globally through both formal and informal programs.

In progressSubstantially completeOn trackComplete

Auckland team volunteering at Ambury Park Farm for Riding Therapy

52

|

VITAL HEALTHCARE PROPERTY TRUST

Training
Global mobility

and career growth

We are committed to fostering a culture of continuous

learning and professional growth across all levels of the

business. Our training framework includes both role-

specific development and organisation-wide programs,

ensuring employees are equipped with the knowledge

and tools needed to succeed in their roles whilst upholding

the company’s values and compliance obligations.

In 2024, we introduced mandatory onboarding training for

all new hires covering essential topics such as diversity and

inclusion, mental health and wellbeing and sustainability.

Through our partnership with LinkedIn Learning, employees

gained access to over 20,000 courses, enabling both

microlearning and formal certification on topics ranging

from technical skills to ESG fundamentals. A dedicated

sustainability module was required for all new employees,

focusing on the strategic importance of sustainability

and how individuals can contribute to our goals.

We also deliver region-wide training in critical areas such

as cybersecurity, modern slavery and privacy, alongside

ongoing access to industry webinars and events, particularly

for employees engaged in ESG-related reporting.

We are committed to creating a rewarding employee

experience that supports both personal and professional

growth. Our inclusive culture and global platform provide

opportunities for staff to thrive across regions and explore

diverse career pathways. In FY25, we were proud to

see two team members from the A/NZ region transfer

to Northwest offices abroad, reflecting our focus on

internal mobility and cross-regional development.

WORKFORCE BREAKDOWN

FY24FY25

Australia and New Zealand5653

Turnover rate (voluntary)11 . 1 %16.0%

Turnover rate (involuntary)4.7%12.5%

GENDER

FY24FY25

MFMF

Gender (workforce)43.0%57.0%47.0%53.0%

Middle management

1

47.0%53.0%72.0%29.0%

Senior leadership

2

67.0%33.0%60.0%40.0%

A G E

FY24FY25

>200.0%0.0%

21-3013.0%11.0%

31-4043.0%49.0%

41-5021.0%13.0%

51-6021.0%25.0%

61-642.0%2.0%

65+0.0%0.0%

HEALTH AND SAFETY

FY24FY25

Absentee Rate

3

0.7% 0.9%

Injury Rate 00

Fatalities 00

TRAINING

FY24FY25

ESG training completion rate100.0%100.0%

VOLUNTEERING

FY24FY25

Total hours of volunteer

time by employees

2586 61

1

People leader, VP and below

2

C-Suite, Regional Heads, SVP

3

The absentee rate is the ratio of

employees with absences to total

salaried employment

Auckland team volunteering at Tiaho Mai

- Adult Mental Health (Te Whatu Ora)

ANNUAL REPORT 2025

|

53

Our Board
Graham Stuart

Independent Chair and

Member of the Audit Committee

(68, Auckland)

Graham Stuart is an experienced

corporate director with an established

track record of performance in

governance and in prior executive

roles. He is currently a Director of

Ravensdown Limited and Director of

Dairy Goat Co-operative (N.Z.) Limited.

He was previously the CEO of Sealord

Group from 2007 to 2014 and Director,

Strategy and Growth and CFO of

Fonterra Co-operative Group from 2001

to 2007, Independent Chair of EROAD

Limited and an Independent Director

and Chair of the Audit Committee at

Tower Limited.

Graham is a Fellow of Chartered

Accountants Australia & New Zealand

(CAANZ) and has a Master of Science

degree from Massachusetts Institute

of Technology and a Bachelor of

Commerce with first class honours from

the University of Otago.

Mike Brady

Non-Independent Director

(58, Toronto)

Mike Brady was appointed global

President of Northwest Healthcare

Properties REIT (TSX: NWH.UN) in

2023 after serving as global Executive

Vice President, General Counsel and

Board Secretary since joining the REIT

in 2006. He has extensive experience

in real estate investments and finance,

transaction management, global

leadership, governance and legal

matters.

Mike has played a significant commercial

and legal role in the strategic direction

and growth of the REIT, most recently

leading the team to complete a €2.0

billion pan-European joint venture fund,

a $435 million UK hospital portfolio,

and a $2 billion joint venture fund and

acquisition of a $1.25 billion hospital

portfolio in Australia.

Prior to joining the corporate real estate

world, Mike was a corporate law

partner at two Toronto-based law firms,

where he developed his real estate

practice. He has a Bachelor of Arts

(Economics) and a joint LL.B./Masters of

Business Administration from Dalhousie

University, Halifax.

Angela Bull

Independent Director and

Member of the Audit Committee

(50, Auckland)

Angela Bull is an independent director

of Channel Infrastructure Ltd (NZX:

CHI), Property For Industry Limited

(NZX:PFI), Foodstuffs South Island Ltd

and Foodstuffs NZ Ltd. She is also on

the Trust Board of St Cuthbert’s College

and an independent director of Bayleys

Corporation Board (NZ) and recently

joined the Board of Fulton Hogan as an

independent director.

Angela is a former Chief Executive of

Tramco Group, a large New Zealand

owned property investment company

which specialises in large scale land

holdings, notably the Viaduct Harbour

precinct in Auckland and Wairakei Estate

in the Waikato; a former Board member

of the Property Council of New Zealand;

and a former independent director of the

Real Estate Institute of New Zealand and

realestate.co.nz.

She holds a Bachelor of Laws and a

Bachelor of Arts (Political Science) and

practised property and environmental law

prior to her executive career. Previously,

Angela held a number of senior positions

over a 10-year period with Foodstuffs

Auckland and Foodstuffs North Island Ltd,

most recently being General Manager

Property Development for Foodstuffs

North Island.

The Board comprises five highly qualified directors based in Auckland,

Toronto, Sydney

*

and Melbourne, three of whom are independent.

Their executive experience includes healthcare, property and finance.

54

|

VITAL HEALTHCARE PROPERTY TRUST

Craig Mitchell
Non-Executive Director and

Member of the Audit Committee

(57, Sydney)

(Zachary Vaughan replaced Craig

Mitchell on the Board effective 12

August 2025)

Craig Mitchell is a professional manager

with an inclusive leadership style, Craig

has more than 20 years of experience

specialising in the property industry. His

previous roles include Northwest CEO

(ceased 30 June 2025) and Executive

Director and Chief Operating Officer of

Dexus, an ASX top 50 listed REIT.

Craig has a Master of Business

Administration (Executive) from the

Australian Graduate School of

Management, a Bachelor of Commerce

and a Fellow of CPA Australia. He

has also completed the Advanced

Management Program at Harvard

University, Boston.

Zachary Vaughan

Non-Independent Director

(Appointed 12 August 2025)

(48, Toronto)

Zachary Vaughan was appointed

Chief Executive Officer of Northwest

Healthcare Properties REIT in July 2025.

He brings over 20 years of experience

in real estate investment and asset

management, with a strong track record

of leadership across global markets.

Prior to joining Northwest, Zachary

served as Global Head and Chief

Investment Officer of Real Estate at Arrow

Global, where he led the firm’s real estate

strategy. He remains a Non-Executive

Director at Arrow. Before Arrow, he held

several senior roles at Brookfield Asset

Management, including Managing

Partner and Head of European Real

Estate, Head of Multifamily Investments,

and CEO of Brookfield REIT.

Earlier in his career, Zachary was a

Director in the Real Estate Investment

team at the Canada Pension Plan

Investment Board (CPPIB), and Director

of Acquisitions at International Property

Corporation/Reichmann International.

Zachary holds an Honours Bachelor of

Economics from Western University. He

is now based in Toronto, where he leads

Northwest’s global healthcare real estate

platform spanning North America, Brazil,

Europe, and Australasia.

Zachary was appointed as a Non-

Independent Director to the board of the

Manager on 12 August 2025.

Dr Michael Stanford AM

Independent Director and Chair 

of the Audit Committee

(66, Melbourne)

Dr Michael Stanford has more than 30

years’ experience in the health sector

in either Group CEO or Board roles.

Michael’s current Board roles include

Chair of Nexus Hospitals, a leading

provider of specialist day and short stay

private hospital based care; and Board

member of the Royal Australian College

of General Practitioners as well as Board

member of Healius (ASX:HLS).

Michael was the Group CEO of St

John of God Healthcare, Australasia’s

third largest private hospital provider,

for 16 years during which time the

company increased revenue fivefold

through organic and M&A growth plus

more than A$1 billion greenfield and

brownfield developments. Michael’s other

Managing Director roles included the

ASX listed Australian Hospital Care and

two public hospital networks in Victoria.

Michael holds an MBA from Macquarie

University and Bachelor of Medicine and

Bachelor of Surgery from UNSW. He

is a Fellow of the Australian Institute of

Company Directors.

In 2018 Michael was awarded a

Member of the Order of Australia for

significant service to the health sector

through executive roles, to tertiary

education and the WA community, in

2010 he received the WA Citizen of the

Year Award – Industry and Commerce

category.

Directors are based in

Auckland (x2), Toronto,

Sydney

*

and Melbourne.

Their current and prior

executive experience

includes healthcare,

property and finance.

Playford Health Hub,

Adelaide

* As of 12 August 2025, with the replacement of Craig Mitchell by Zachary Vaughan,

two directors are based in Toronto and no directors are based in Sydney

ANNUAL REPORT 2025

|

55

Chris Adams
Co-Head A/NZ Region

(55, Melbourne)

Chris Adams jointly leads the Northwest

business in Australia and New

Zealand, and manages Northwest’s

NZX-listed Vital Healthcare Property

Trust, which he has been part of

the leadership team since 2017.

He has extensive experience in the

property industry in Australia, New

Zealand and the United Kingdom,

including over 25 years’ direct

experience in health property.

Chris was one of the founding Executives

at ASX-listed Generation Healthcare

REIT which was acquired by Northwest

in 2017. Prior to that he established Vital

Healthcare Property Trust’s presence

in Australia in 1999 following various

roles with the group in New Zealand.

Chris holds a Bachelor of Property

from the University of Auckland.

Alex Belcastro

Senior Vice President,

Developments and Precincts

(37, Sydney)

Alex Belcastro, formerly the Chief

Business Development Officer at Ramsay

Health Care managing a multi-billion-

dollar hospital asset portfolio, joined our

team in 2021.

Alex leads precinct transactions, leasing

and developments. She also provides

strategic leadership to the development

and leasing divisions and heads our

Strategy and Research function.

With over 18 years of specialised

experience in social infrastructure, she

has facilitated large-scale transactions

and developments across public and

private sectors.

Her diverse background spans advisory,

operational and ownership roles,

adding valuable real estate expertise

to our platform.

Holding a Master of Construction

Management and a Bachelor of Planning

and Design from the University of

Melbourne, Alex has also honed her skills

through executive education at Harvard

Business School.

Kirsty Bowyer

Vice President, Development

(40, Auckland)

Kirsty Bowyer joined the team in New

Zealand in 2023 and is responsible

for overseeing the planning, design

and construction of Vital’s development

projects across New Zealand. With

more than 15 years of experience

in the construction and property

industry including major healthcare

infrastructure projects, Kirsty brings a

deep and practical understanding of the

complexities of healthcare development,

combining technical expertise with

strategic leadership.

Before joining Northwest, Kirsty spent

13 years at Johnstaff, one of Australia’s

leading property and construction

consultancies. During her time there, she

held various senior roles, leading the

end to end delivery of capital works

programmes across both Australia and

New Zealand.

Over the course of her career, Kirsty has

delivered more than $2.5 billion worth

of healthcare real estate. Her leadership

is characterised by a strong commitment

to clinical user engagement, operational

efficiency and design excellence.

Kirsty is also a committee member of the

New Zealand Health Design Council,

where she contributes to national discourse

on health infrastructure innovation.

Our Executive Team

Northwest has over 240 employees globally, including more than 50 real

estate professionals in New Zealand and Australia. The Vital Executive

Team is made up of property professionals with extensive experience in

New Zealand, Australia and beyond.

56

|

VITAL HEALTHCARE PROPERTY TRUST

Vanessa Flax
Vice President, Regional General

Counsel and Company Secretary

(54, Melbourne)

Vanessa Flax joined the team in 2019,

prior to which she was a special counsel

at Ashurst Australia.

Vanessa has 25 years of deep and

broad ranging property law experience

in Australia and New Zealand, including

acting as primary legal adviser (for

approximately 15 years) for Vital

and Northwest.

Vanessa’s legal experience covers

all aspects of real estate property

transactions, including acquisitions,

divestments and sales, leasing and

Crown leasing, development transactions

and due diligence.

Vanessa has a Bachelor of Arts and

Bachelor of Laws from the University

of Witwatersrand, South Africa.

Kawarau Park Health Hub, Queenstown

Michael Groth

Chief Financial Officer

(51, Melbourne)

Michael Groth has over 18 years’

experience as a senior finance executive

in the listed and unlisted property funds

and funds management industry. Prior

to joining the team in 2019, Michael’s

most recent position was as Group Chief

Financial Officer of the Melbourne based

and ASX-listed real estate fund manager,

APN Property Group Limited.

Michael has extensive experience in

financial management and reporting,

taxation, treasury and capital

management, corporate structuring,

acquisitions, disposals and equity raisings

in the listed and unlisted property and

funds management industry.

Michael holds a Bachelor of Commerce

and Bachelor of Science and has been

a member of the Chartered Accountants

Australia and New Zealand since 2000.

Richard Roos

Co-Head A/NZ Region

(60, Melbourne)

Richard Roos jointly leads the Northwest

business in Australia and New Zealand.

He has over 25 years’ experience

in commercial real estate financing,

acquisitions and property management,

of which the last 17 years have been in

healthcare real estate in senior roles for

Northwest in Canada and Australia.

Richard is responsible for asset

management, transactions, people

and culture, and ESG. He is also

focused on building and expanding

strong relationships with Northwest’s

operator partners.

Kawarau Park, Queenstown

ANNUAL REPORT 2025

|

57

Corporate Governance
Vital Healthcare Property Trust and Northwest Healthcare Properties Management

Limited. All information as at 30 June 2025, unless otherwise stated.

The Board of Directors

The role of the Board of Directors is to set the strategic direction

of Vital and to support management in monitoring the delivery

of this against specific performance objectives. The Board

also ensures all business risks are appropriately identified and

managed and compliance with all applicable regulatory,

statutory, financial, health and safety and social responsibilities

of the Manager. The Board also plays an important role of

overseeing risks and opportunities associated with environmental

(including climate), social and governance (ESG) factors, the

preparation of climate statements and compliance with any other

applicable ESG reporting or broader regulatory requirements.

Board composition

The Manager is committed to having an effective Board providing

a balance of independent skills, knowledge, experience and

perspectives.

All Directors bring a significant breadth and depth of expertise and

have the composite skills to optimise the financial and portfolio

performance of Vital and returns to Unit Holders.

Attendance at

Board meetings

Attended /

Eligible to attend

Date of appointment

Graham Stuart8/812 November 2018

(Appointed Chair

17 November 2020)

Michael Stanford8/819 November 2019

Craig Mitchell8/829 June 2021

Angela Bull8/826 April 2022

Mike Brady**7/89 August 2023

The Board does not impose any specific restriction on the tenure

of any Director as it considers such a restriction may lead to the

loss of experience and expertise. However, as noted below, the

Board does have regard for best practice around tenure when

assessing the independence of directors. In addition, there has been

on-going renewal of the Board and the longest serving director

has served for less than 7 years (as at the date of this report).

The table below shows all relevant interests of Directors

and Officers in units, which include legal and beneficial

interests in Vital units as at 30 June 2025.

DirectorsHoldings (number of

units) non-beneficial

Holdings (number

of units) beneficial

Graham Stuart-87,561

Angela Bull5,571

Officers

Aaron Hockly

1

-87,561

1

Aaron Hockly, former Fund Manager, has previously made a voluntary disclosure

that, in addition to his personal holdings, members of his immediate family own an

additional 114,461 units in Vital although he does not control or impact any investment

decisions in relation to such holdings.

Independent Directors

Further information about the Board’s assessment of the

independence of Directors is contained in Recommendation 2.4 of

the NZX Corporate Governance Code on page 64 of this report.

Audit Committee

The Audit Committee is responsible for overseeing

the financial and reporting practices of Vital.

At financial year end and at the date of this report,

the Audit Committee assists the Board in fulfilling its

corporate governance and disclosure responsibilities with

particular reference to financial matters, and internal and

external audit, and is specifically responsible for:

• Reviewing proposed climate, sustainability and ESG

disclosures and advising the Board whether in the Committee’s

view that disclosure complies with applicable standards

and legislative requirements and ensuring that appropriate

controls and assurance processes are undertaken for the

preparation, review, verification and approval of climate,

sustainability and ESG related disclosure reporting;

• Recommending to the Board the appointment /

removal of Vital’s external auditor; and

• Reviewing the performance of the external auditor.

Attendance at Audit

Committee meetings

Attended /

Eligible to attend

Date of

appointment

Graham Stuart4/412 November 2018

Michael Stanford4/419 November 2019

Craig Mitchell4/429 June 2021

Angela Bull4/426 April 2022

**Mike Brady does not sit on the Audit Committee

58

|

VITAL HEALTHCARE PROPERTY TRUST

Australian Subsidiary of Vital
Northwest Healthcare Australian Property Limited (NWHAPL) is

an Australian company which acts as trustee of the two Australian

wholly owned subsidiaries of Vital Healthcare Property Trust, namely

Vital Healthcare Investment Trust and Vital Healthcare Australian

Property Trust. The directors of NWHAPL as at 30 June 2025 are

Mike Brady, Chris Adams, Richard Roos and Miles Wentworth.

Chris Adams replaced Craig Mitchell on and from 30 June 2025.

Management contract

Northwest manages Vital in accordance with Vital’s Trust Deed

in return for which Northwest receives management fees. From

these management fees, Northwest pays salaries and other

related costs (including taxes, rent, IT, travel and training) to

or for its employees, approximately 30 of whom are solely or

majority engaged with managing Vital, as well as the Directors

not appointed by all Unit Holders (two at the date of this report).

As a result, the details in this section relate to Northwest’s

employees rather than Vital’s employees (as there are none).

Remuneration

As noted above, Vital does not have any direct employees.

Instead, Northwest receives management fees to manage

Vital from which it provides remuneration to employees. As

a result, there is no reporting on individual employee salaries.

Notwithstanding the above, the following is

provided to enhance transparency:

1. Details of the holdings in Vital by Directors and officers as

at 30 June 2025 is provided on the previous page.

2. As at the date of this report, the Independent Chair of

the Manager and


Angela Bull (a New Zealand resident

Independent Director) own units. Currently the tax

regime for Vital makes it uneconomic for the offshore

based Directors and officers to hold units in Vital.

3. Details of the costs of Independent Directors appointed

by Unit Holders and, as a result, paid by Vital are

included in note 22 to the accounts in this report.

4. All Northwest’s executive bonuses globally are linked to

Northwest’s unit price as the long-term component of these

bonuses is paid in Northwest units or calculated with reference

to the value of Northwest units. In addition to being Vital’s

Manager, Northwest is Vital’s largest investor, holding an

aggregate shareholding of >28% as at 30 June 2025.

5. The following clawback / malus provisions are

included in the bonus plans for all Northwest executives

globally (including key Vital personnel):

• Where the Participant (i) has been terminated for cause, or

(ii) voluntarily resigns from his or her position with the Trust then

any Deferred Units granted on a discretionary basis pursuant

to Section 7.04 of the Northwest Healthcare Properties Real

Estate Investment Trust Omnibus Equity Incentive Plan (2022)

which have not yet vested at the time of the termination for

cause or voluntary resignation, shall be immediately forfeited

by such Participant.

Directors’ remuneration

DirectorBase

Audit

Committee

Member

ChairTotal

Graham Stuart

Independent Director,

Board Chair and Audit

Committee member

$90K$10K$80K

(Board)

$180K

Angela Bull

1


Independent Director and

Audit Committee member

$90K$10K-$100K

Craig Mitchell

2


Director and Audit

Committee member

N/A---

Michael Stanford

Independent Director and

Audit Committee Chair

A$90K-A$20K

(Audit

Committee)

A$110K

Mike Brady

2


Non-Independent Director

N/A---

($280K paid by Unit Holders, and A$110K paid by the Manager)

1

Paid by the Manager from management fees.

2

Executive of Northwest and, in the case of Craig Mitchell, a Non-Executive Director from

30 June 2025. No separate director’s fees are payable. Mr Mitchell resigned as a Non-

Executive Director on 12 August 2025.

Manager's fees

For the fees paid to the Manager by Vital, please see note 22 to the

accounts in this report.

Joint Investment Policy

Under the terms of the Joint Investment Policy, which applies

to Northwest Healthcare Properties REIT (NWH REIT) and its

owned and controlled entities (including the Manager), an

Investment Committee has been established to avoid, manage

and resolve actual or perceived conflicts of interests between

members of the NWH REIT group in a manner which complies

with any relevant legal obligations and is equitable to each party.

The Joint Investment Policy can be found on Vital’s website.

Modern slavery

In 2024, the Australian manager of the Vital trusts, Northwest

Healthcare Australian Property Limited again published a

statement under the Australian Modern Slavery Act 2018,

which underpinned Vital’s philosophical approach and

commitment to ensuring our operations have sufficient risk

mitigation strategies to address supply-chain risks. Vital

committed to training employees to identify these risks.

Our entire organisation has engaged with tenants and suppliers

to conduct further and ongoing due diligence to identify possible

modern slavery supply chain risks. Vital will continue to assess

the potential modern slavery risks in our operations and develop

and review company policies on these possible impacts.

As part of our ongoing commitment to ethical business practices

and sustainability, we continue to implement a Supplier Code of

Conduct for all new suppliers. The purpose of this code is to

ANNUAL REPORT 2025

|

59

ensure that our suppliers align with our values and principles
and to promote responsible business conduct throughout our

supply chain. By implementing this code we aim to mitigate

risks, uphold our reputation and contribute to positive social

and environmental impacts.

We have also committed to reviewing supplier contracts to ensure

they contain terms consistent with the principles underlying the Act.

Skills and ExperienceGraham

Stuart

Angela

Bull

Craig

Mitchell

Michael

Stanford

Mike

Brady

Accounting/Finance/Economics••

Commercial Real Estate/Asset

Management/Valuation

•••

Corporate Governance•••••

Legal/Regulatory

••

Healthcare Operator•

Sustainability/ESG including

Climate Related Matters

Highly skilled / experienced Moderate skills / experience

Board diversity and relevant skills

At a Board level, diversity of experience is critical to ensure a

healthy exchange of ideas and opinions to deliver higher quality

decision making and outcomes. All Board appointments are always

based on merit and diversity (including gender and ethnicity).

A majority of the Directors are members of professional

organisations such as the Institute of Directors (or equivalent) or

other industry specific and relevant organisations which support

the ongoing education and training of professional directors.

Healthcare real estate is a specialised sector and the Board

believes it is important to have members with a diverse range

of backgrounds, skills and experience to ensure robust

discussion. It is also important to balance skills and knowledge

gained through length of tenure and the value of fresh ideas

in decision making. The table below summarises the skills,

experience and length of service of the current Board.

60

|

VITAL HEALTHCARE PROPERTY TRUST

ReferenceRecommendationApproach
Principle 1 – Code of ethical standards

1.1The board should document minimum

standards of ethical behaviour to which

the issuer’s directors and employees are

expected to adhere (a code of ethics).

The code of ethics and where to find it should

be communicated to the issuer’s employees.

Training should be provided regularly. The

standards may be contained in a single

policy document or more than one policy.

The code of ethics should outline internal

reporting procedures for any breach of ethics,

and describe the issuer’s expectations about

behaviour, namely that every director and

employee:

a. acts honestly and with personal integrity

in all actions;

b. declares conflicts of interest and

proactively advises of any potential

conflicts;

c. undertakes proper receipt and use

of corporate information, assets and

property;

d. in the case of directors, gives proper

attention to the matters before them;

e. acts honestly and in the best interests of

the issuer, shareholders and stakeholders

and as required by law;

f. adheres to any procedures around

giving and receiving gifts (for example,

where gifts are given that are of value

in order to influence employees and

directors, such gifts should not be

accepted);

g. adheres to any procedures about whistle

blowing (for example, where actions

of a whistle blower have complied with

the issuer’s procedures, an issuer should

protect and support them, whether or not

action is taken); and

h. manages breaches of the code

In recognition of Vital’s role in the communities in which we operate, and where our investors live, we

continue to implement and refine policies and practices which encourage responsible investment

practices and compliance with all legal and regulatory requirements.

All of Vital’s Directors and employees must abide by Vital’s Code of Conduct and Business Ethics

(refreshed in May 2024), which documents policies on conflicts of interest, fair dealing, compliance with

applicable laws and regulations, maintaining confidentiality of information, dealing with Vital’s assets and

use of Vital’s information.

The Code recognises the importance of a work environment which actively promotes best practice and

does not compromise business ethics or principles and the Code’s purpose is to uphold the highest ethical

standards, acting in good faith and in the best interests of Unit Holders at all times.

Following the review of the Code, employees will be provided with training in relation to the Code and

Vital has committed to refreshing that training at least once every 3 years.

The Code is on Vital’s website https://www.vitalhealthcareproperty.co.nz/ governance/ and a copy

was provided to staff following the review in May 2024. All new starters are provided with a link to the

Code and are required to confirm their acceptance of its terms.

The Code is supplemented by a number of other policies including the Joint Investment Policy and

Whistleblower Policy which are available on the website at https://www.vitalhealthcareproperty.co.nz/

governance/.

1.2An issuer should have a financial product

dealing policy which applies to employees

and directors

Vital’s Directors, officers and employees, their families and related parties must comply with the Security

Trading Policy. A copy of the Security Trading Policy is on Vital’s website

https://www.vitalhealthcareproperty.co.nz/governance/

The Manager is committed to ensuring compliance with legal and regulatory requirements with respect

to insider trading and restricted persons trading. To assist with such compliance, the Manager’s Security

Trading Policy identifies circumstances where Directors, officers and other restricted persons are permitted

to trade or are prohibited from trading units in Vital. Compliance with these policies is monitored by

the Board. In addition, all trading by Directors and senior managers of the Manager is required to be

reported to NZX in accordance with the Financial Markets Conduct Act 2013. The holdings of Directors

of the Manager are disclosed on page 60.

Before trading in Vital units, a restricted person must get consent in writing from the Chief Financial Officer

of the Manager. Vital has set black-out periods for Directors and staff throughout the year. Also, blackout

periods can be invoked when specific events occur.

Emails are periodically sent to Directors and employees providing information as to the status of the

trading window in relation to the black-out periods.

NZX Corporate Governance Code

The NZX Corporate Governance Code (NZX Code) applies to all issuers of Equity Securities listed on the NZX Main Board.

The NZX Code does not apply to Vital Healthcare Properties Trust (Vital), as it is an issuer of Fund Securities under the NZX Listing Rules.

Notwithstanding the foregoing, the Board of Northwest Healthcare Properties Management Limited (Manager) considers it important from

a governance perspective to identify how, as at 30 June 2025, Vital and the Manager comply with the NZX Code dated January 2025.

The NZX Code is structured around eight principles. The table sets out each principle and an explanation as to if, and how, Vital and the

Manager comply with the recommendations in the NZX Code.

ANNUAL REPORT 2025

|

61

ReferenceRecommendationApproach
Principle 2 – Board composition and performance

2 .1The board of an issuer should operate under

a written charter which sets out the roles

and responsibilities of the board. The board

charter should clearly distinguish and disclose

the respective roles and responsibilities of the

board and management.

The Board has adopted a formal Board Charter which is available on Vital’s website at

https://www.vitalhealthcareproperty.co.nz/governance/.

The Charter sets out the roles and responsibilities of the Board, including in relation to distinguishing

between the respective roles and responsibilities of the Board and management.

The terms of a Director’s appointment are contained in the Board Charter. The Charter reaffirms that

Directors must comply with their duties as set out in the Manager’s Constitution (which is also available on

Vital’s website https://www.vitalhealthcareproperty.co.nz/governance/) and the Companies Act 1993,

including to act in good faith, together with other duties which include (but are not limited to) conducting

themselves in an honest, ethical and responsible manner.

The Board’s specific responsibilities include approving the Manager’s strategic objectives, including those

applicable to Vital and ensuring that effective risk management procedures for the Manager and Vital

are in place and are being observed.

2.2Every issuer should have a procedure for the

nomination and appointment of directors to

the board.

Vital partially complies with this recommendation as the process for appointment of directors is different

for a listed managed investment scheme. Vital is a trust and does not have directors. Its supervisor is

Trustees Executors Limited, which is also the trustee of the Vital Healthcare Property Trust.

The Manager has a Board of Directors, which, subject to the below, is appointed by its sole shareholder,

NWI Healthcare Properties LP.

Two Independent Directors are appointed to the Manager’s Board by Unit Holders in the manner

described in the Trust Deed. A copy of the Trust Deed is available on Vital’s website

(https://www.vitalhealthcareproperty.co.nz/governance/) and also on the Disclose Register through

the Companies Office https://companies-register.companiesoffice.govt.nz/.

Unit Holders have the opportunity to appoint two of the Independent Directors of the Manager. Unit

Holders may nominate and vote on one Independent Director of the Manager each year. The nominee

receiving the most votes will be approved as a Director of the Manager by the Manager’s shareholders.

2.3An issuer should enter into written agreements

with each newly appointed director

establishing the terms of their appointment.

The Manager enters into a written agreement with each newly appointed director setting out the terms of

their appointment, including expectations of the director in his or her role, remuneration entitlements and

indemnity and insurance arrangements.

2.4Every issuer should disclose information about

each director in its annual report or on its

website, including:

a. a profile of experience, length of service

and ownership interests;

b. the director’s attendance at board

meetings; and

c. the board’s assessment of the director’s

independence, including a description

as to why the board has determined

the director to be independent if one of

the factors listed in table 2.4 applies to

the director, along with a description of

the interest, relationship or position that

triggers the application of the relevant

factor

Vital’s Annual Report includes a profile of experience, length of service, and ownership interest of each

Director. The Annual Report also sets out the attendance of each Director at Board meetings and Audit

Committee meetings.

A profile of each director is also included on Vital’s website

https:// www.vitalhealthcareproperty.co.nz/board-management/

The Board considers that at the date of this Annual Report, the Independent Directors are independent,

including by virtue of the following factors listed in table 2.4:

None of the Independent Directors:

• is currently, or was within the last three years, employed in an executive role by the Manager;

• is currently deriving, or within the last 12 months, derived a substantial portion of his or her revenue

from the Manager or the Trust;

• is currently, or was within the last 12 months, in a senior role in a provider of material professional

services to the Manager or the Trust or any of their subsidiaries;

• is currently, or was within the last three years, employed by the external auditor to the Manager or the

Trust or any of their subsidiaries;

• currently has, or did have within the last three years, a material business relationship (e.g. as a supplier

or customer) with the Manager or the Trust or any of their subsidiaries;

• is a substantial product holder of the Trust, or a senior manager of, or person otherwise associated

with, a substantial product holder of the Trust;

• is currently, or was within the last three years, in a material contractual relationship with the Manager

or the Trust or their subsidiaries, other than as a director;

• has close family ties or personal relationships (including close social or business connections) with

anyone in the categories listed above; and

• has been a director of the Manager for a period of 12 years or more.

2.5An issuer should have a written diversity

policy which includes requirements for the

board or a relevant committee of the board

to set measurable objectives for achieving

diversity (which, at a minimum, should address

gender diversity) and to assess annually

both the objectives and the entity’s progress

in achieving them. An issuer within the S&P/

NZX20 Index at the commencement of its

reporting period should have a measurable

objective for achieving gender diversity in

relation to the composition of its board, that

is to have not less than 30% of its directors

being male, and not less than 30% of its

directors being female, within a specified

period. An issuer should disclose its diversity

policy or a summary of it.

This recommendation has not been adopted due to our structure.

We continue to improve diversity on the Board and in Management, in line with the REIT’s diversity policy

introduced in April 2022. The number of women in the organisation is almost 50% of the total number

employed and our focus on gender diversity at a Board level continues.

62

|

VITAL HEALTHCARE PROPERTY TRUST

ReferenceRecommendationApproach
2.6Directors should undertake appropriate

training to remain current on how to best

perform their duties as directors of an issuer.

The Manager provides formal training to Directors during the year and Directors undertake additional

training through professional bodies.

2.7The board should have a procedure

to regularly assess director, board and

committee performance.

Assessment of the Board and each director’s performance is determined by the Chair and takes into

account overall attendance, contribution, training and experience of each member concerned.

2.8A majority of the board should be

independent directors.

The Board of the Manager is comprised of a majority of Independent Directors.

2.9An issuer should have an independent chair

of the board.

The Board of the Manager is chaired by an Independent Director.

2 .10The chair and the CEO should be different

people.

The functions of chair of the Board of the Manager and CEO are fulfilled by different people.

Principle 3 – Board committees

3 .1An issuer’s audit committee should operate

under a written charter. An audit committee

should only comprise non-executive

directors of the issuer. One member of the

committee should be both independent and

have an adequate accounting or financial

background. The chair of the audit committee

should be an independent director and not

the chair of the board.

The Board has adopted a formal written Audit Committee Charter which is available on Vital’s website at

https://www.vitalhealthcareproperty.co.nz/governance/.

The minimum number of members on the Audit Committee is three Directors with a majority being

Independent Directors and at least one member with an adequate accounting or financial background.

The audit committee of the Manager is comprised of four members of which three are independent.

The fourth member is an executive director and, as a result, the composition does not comply with the

recommendation that the audit committee is only comprised of non-executive directors. The Chair of the

audit committee is an independent Director and is not the same person as the Chair of the Board.

3.2Employees should only attend audit

committee meetings at the invitation of the

audit committee.

Directors and officers have a standing invitation to attend audit committee meetings. Other employees

may attend on invitation only.

3.3An issuer should have a remuneration

committee which operates under a written

charter (unless this is carried out by the whole

board). At least a majority of the remuneration

committee should be independent

directors. Management should only attend

remuneration committee meetings at the

invitation of the remuneration committee.

This recommendation has not been adopted due to Vital’s structure.

A key feature of the external management structure under which Vital operates is that remuneration of

management is the responsibility of the Manager, not Vital. As Vital Unit Holders are not economically

exposed to employment remuneration costs, a remuneration committee is not considered necessary by

the Board at this time.

3.4An issuer should establish a nomination

committee to recommend director

appointments to the board (unless this is

carried out by the whole board), which

should operate under a written charter. At

least a majority of the nomination committee

should be independent directors.

This recommendation has not been adopted due to Vital’s structure.

Given its structure and the terms of the Trust Deed, the process for nomination of directors to the Board of

the Manager is not the same as for a listed company.

3.5An issuer should consider whether it is

appropriate to have any other board

committees as standing board committees.

All committees should operate under written

charters. An issuer should identify the members

of each of its committees, and periodically

report member attendance.

From time to time the Board establishes Due Diligence Committees (DDC) under a formal process

memorandum to report on the due diligence process in relation to any potential transaction for Vital of

material size or complexity. An example would be the capital raisings undertaken by

Vital in recent years. A DDC would normally be comprised of an Independent Director, executive

director, relevant management staff and external consultants appropriate for the transaction.

3.6The board should establish appropriate

protocols that set out the procedure to be

followed if there is a “control transaction”

for the issuer including the procedure for

any communication between the issuer’s

board and management and the bidder.

The board should disclose the scope of

independent advisory reports to shareholders.

These protocols should include the option

of establishing an independent control

transaction committee, and the likely

composition and implementation of an

independent control transaction committee.

This recommendation has not been fully adopted due to Vital’s structure and the composition of its unit

register.

The Takeovers Code does not apply to Vital, as a listed managed investment scheme. Vital’s Trust Deed

does include some provisions which would regulate takeover-like transactions relating to units in Vital.

Given the REIT’s ownership of the Manager and cornerstone holding of Vital units, a “control transaction”

is considered unlikely.

As a result of the above, the Board of the Manager has not established protocols that set out the

procedure to be followed if there is a “control transaction” for Vital units.

Principle 4 – Reporting and disclosure

4 .1An issuer’s board should have a written

continuous disclosure policy.

It is important that the market and investors feel confident in the timing or manner of any buying or selling

of Vital units. As a NZX issuer, the Manager is acutely aware of the need to ensure the market, investors

and regulators remain fully informed of any material or price sensitive information relevant to Vital. The

Board, management and employees are aware of the NZX Continuous Disclosure requirements and

Vital has internal procedures in place to ensure compliance.

The Continuous Disclosure Policy can be found on Vital’s website at

https://www.vitalhealthcareproperty.co.nz/governance/.

ANNUAL REPORT 2025

|

63

ReferenceRecommendationApproach
4.2An issuer should make its code of ethics,

board and committee charters and the

policies recommended in the NZX Code,

together with any other key governance

documents, available on its website.

A copy of all relevant policies noted in this document can be viewed on Vital’s website

https://www.vitalhealthcareproperty.co.nz/governance/.

In addition, the website includes the Privacy Policy, the Whistleblower Policy and the Modern Slavery

Statement, all of which are endorsed by the Board.

4.3Financial reporting should be balanced, clear

and objective.

We provide disclosures of financial matters in our Annual Report. In addition, disclosures are provided quarterly

to keep the market updated as to the financial matters impacting Vital.

The Manager maintains and regularly reviews a risk management framework as part of its compliance

assurance programme. Reports are provided to both the Audit Committee and Board along with an annual risk

assessment.

4.4An issuer should provide non-financial

disclosure at least annually, including

considering environmental, social

sustainability factors and practices. It should

explain how operational or non-financial

targets are measured. Non- financial

reporting should be informative, include

forward looking assessments, and align with

key strategies and metrics monitored by the

board.

Vital’s Annual Report includes non-financial disclosures, including environmental, economic and social

sustainability factors and practices. In this regard see page 38 onwards in the sustainability section

for an outlay of ESG related achievements and forward-looking targets, and page 52 onwards in

the sustainability section for references to regulatory non-financial ESG disclosures to which Vital is

committed.

Principle 5 – Remuneration

5 .1An issuer should have a remuneration policy

for the remuneration of directors. An issuer

should recommend director remuneration to

shareholders for approval in a transparent

manner. Actual director remuneration should

be clearly disclosed in the issuer’s annual

report.

This recommendation has not been adopted due to Vital’s structure.

Vital is a trust and does not have directors. Subject to the below, the remuneration costs of the Manager’s

directors are borne by the Manager. As a result, Vital Unit Holders are not economically exposed to

those costs.

Vital’s Trust Deed provides that the costs associated with the two Independent Directors appointed to the

Board of the Manager by Unit Holders are reimbursed out of the trust fund.

Directors are paid a flat fee for each service provided (currently a base director fee and additional

fees for being the Chair, Audit Committee Chair and / or Audit Committee Member). Such fees are

market based by reference to other NZX listed entities; this is assessed annually. Accordingly, the Board

considers that it is unnecessary for Vital to maintain a remuneration policy.

Refer to page 61 of this Annual Report for details of Director remuneration.

5.2An issuer should have a remuneration policy

for remuneration of executives which outlines

the relative weightings of remuneration

components and relevant performance

criteria.

This recommendation has not been adopted due to Vital’s structure.

As noted above, all officers’ remuneration is paid by the Manager not Vital. Accordingly, the Board

considers that it is unnecessary for Vital to maintain a remuneration policy.

5.3An issuer should disclose the remuneration

arrangements in place for the CEO in its

annual report. This should include disclosure

of the base salary, short term incentives and

long term incentives and the performance

criteria used to determine performance based

payments.

This recommendation has not been adopted due to Vital’s structure.

Vital does not have any employees as it is externally managed by the Manager. The remuneration of

executives is not paid by Vital but by the Manager or its related parties.

Principle 6 – Risk management

6 .1An issuer should have a risk management

framework for its business and the issuer’s

board should receive and review regular

reports. An issuer should report the material

risks facing the business and how these are

being managed

The Board of Directors maintains a sound understanding of key risks faced by Vital. Effective management

of all financial and non-financial risks is fundamental to the delivery of the Board’s strategy. In addition, the

Manager will engage other external advisers as appropriate to deal with specific risks.

The Manager has a risk management framework that is integrated into day-to-day operations. As part of

this framework, the Board and Audit Committee work closely with management and external auditors to

support the identification, management and reporting of risks.

This risk management framework is part of Vital’s compliance assurance requirements under the FMCA.

Higher risk groups are reviewed yearly with lower risk groups reviewed biennially. The risk management

framework/Compliance Assurance Programme is reviewed on an annual basis and approved by the

Board.

The Manager has currently identified the following key risk categories:

• Fund manager risk

• Development risk;

• Acquisition of Investment risk

• Asset and facilities management risk

• Information, data security/cybersecurity risk

• Energy/carbon efficiency of assets and operations risk;

• Talent recruitment, retention and succession planning;

• Reputation (social responsibility, brand and stakeholder relationships)

• Access to capital risk

• Compliance risk

• Governance risk

• Fraud/Misconduct risk

• Climate-related risk

64

|

VITAL HEALTHCARE PROPERTY TRUST

ReferenceRecommendationApproach
6.2An issuer should disclose how it manages

its health and safety risks and should

report on their health and safety risks,

performance and management

The Directors and Manager are committed to ensuring that as far as practical, a safe and healthy working

environment is provided for all employees, tenants, contractors and others who may visit our properties.

The Trust’s Health and Safety Policy aims to reflect this commitment.

We have a Risk Management Framework meaning we employ a systematic approach to identifying,

evaluating and managing safety risks.

We have regular training to ensure employees are knowledgeable about our safety practices. A register

is maintained to track participation and ensure compliance.

The Operational Risk Committee oversees our safety protocols and implements strategies to address

operational risks.

Safety expectations are integrated into our supplier contracts and tender/ RFI procedures to ensure

consistency across all external arrangements.

Principle 7 – Auditors

7.1The board should establish a framework

for the issuer’s relationship with its external

auditors. This should include procedures:

a. for sustaining communication with the

issuer’s external auditors;

b. to ensure that the ability of the external

auditors to carry out their statutory audit

role is not impaired, or could reasonably

be perceived to be impaired;

c. to address what, if any, services (whether

by type or level) other than their statutory

audit roles may be provided by the

auditors to the issuer; and

d. to provide for the monitoring and

approval by the issuer’s audit committee

of any service provided by the external

auditors to the issuer other than in their

statutory audit role.

The Board has established an Audit Committee with a majority of Independent Directors.

A copy of the Audit Committee Charter can be found on Vital’s website

https://www.vitalhealthcareproperty.co.nz/governance/.

The Audit Committee Charter sets out the procedures to be followed to ensure the independence of the

Trust’s external auditor. The Audit Committee is responsible for recommending the appointment of the

external auditor and maintaining procedures for the rotation of the external audit engagement partner.

Under the Audit Committee Charter, the external audit engagement partner must be rotated at least every

five years.

The Committee will only recommend to the Board the approval of an external auditor if that external

auditor would be regarded, by a reasonable investor, with full knowledge of all the relevant facts and

circumstances, as capable of exercising objective and impartial judgement on all issues encompassed

within the auditor’s engagement. The continued appointment of Vital’s external auditors is confirmed

annually by the Committee following its review of the external auditor’s performance. One of the duties

of the Committee is ensuring that the external auditor or lead audit partner is changed at least every five

years in accordance with relevant audit independence guidelines and the Audit Committee Charter.

Vital’s auditors annually confirm their compliance with professional standards and ethical guidelines of

Chartered Accountants Australia and New Zealand to evidence their competencies, as well as attend

Vital’s annual meeting to answer question from investors in relation to the audit. Deloitte, Vital’s current

auditor, was first appointed in 2008 and the current engagement partner, Andrew Boivin was appointed

in 2023.

The Audit Committee Charter covers provision of non-audit services with the general principle being

that the external auditor should not have any involvement in the production of financial information or

preparation of financial statements such that they might be perceived to be auditing their own work.

The Board facilitates regular and full interface between its Audit Committee, the external auditors and

management as reflected in the Audit Committee charter.

7. 2The external auditor should attend the

issuer’s Annual Meeting to answer

questions from shareholders in relation to

the audit.

To maximise the effectiveness of communication at the Annual Meeting, the Manager also requires its

external auditors to attend the meeting and be prepared to answer Unit Holders’ questions about the

conduct of the audit, as well as the preparation and content of the independent auditor’s report.

Vital undertakes an annual audit engagement with its external auditor. As part of the process the Audit

Committee identifies any key areas of focus and reporting required of the auditors. Management

is required to attend the meeting to discuss the findings of the report and respond to queries. Any

recommendations for improvement are discussed and management is required to agree a timetable for

the implementation of the changes.

7. 3Internal audit functions should be

disclosed.

The Manager’s ultimate parent has an internal audit programme that includes an annual global internal

control review. The scope of this programme encompasses both the Manager and Vital.

In addition, Vital has a Supervisor who undertakes oversight functions on behalf of Unit Holders, including

in relation to conduct and the payment of management fees / expenses.

Principle 8 – Shareholder rights and relations

8 .1An issuer should have a website where

investors and interested stakeholders

can access financial and operational

information and key corporate governance

information about the issuer.

Vital’s website www.vitalhealthcareproperty.co.nz enables Unit Holders to access financial and

operational information and key corporate governance information about Vital. The website allows key

stakeholders to access and navigate important information with ease.

ANNUAL REPORT 2025

|

65

ReferenceRecommendationApproach
8.2An issuer should allow investors the ability

to easily communicate with the issuer,

including by designing its shareholder

meeting arrangements to encourage

shareholder participation and by

providing shareholders the option to

receive communications from the issuer

electronically.

A key focus of investor relations is to ensure the market and investors are informed of all details necessary

to assess their investment and Vital’s performance as specified by NZX Listing Rules. The Board aims to

foster constructive communications and encourages all stakeholders to engage with Vital.

A key element of corporate communication is the Trust’s website at

www.vitalhealthcareproperty.co.nz. Vital’s website is designed to make it easier for Unit Holders to

locate and understand key information. The website enables all existing and potential Unit Holder to

view information including: an overview of the business and corporate structure, a history of financial

and investment performance, key calendar dates and the ability to access and download all NZX

announcements, presentations and investor forms.

The website also includes key corporate governance documents including the Board Charter, Statement

of Investment Policies and Objectives (SIPO) and other key policy documentation.

The Manager also actively encourages engagement through a communication strategy which includes:

• The Annual Meeting for the Unit Holders to meet with and ask questions of the Board, the Supervisor,

management and external auditors;

• Any other meetings called to obtain approval for the Manager’s action as appropriate;

• Results webcasting providing all investors with the ability to listen and ask questions of Management;

and

• Various investor communications including Annual Reports and Interim Reports.

Through Vital’s external registrar investors have the ability to easily communicate with the issuer, including

providing the option to receive communications from the issuer electronically.

There is a NZ toll free number 0800 225 264 and email address enquiry@vhpt.co.nz to which general

enquiries can be directed.

To further enhance Unit Holder engagement, the format of Vital’s annual meetings is a ‘hybrid’ meeting,

allowing investors to attend in-person or virtually by attending the meeting online. Where one format of

meeting may be more appropriate in the circumstances, the Directors will take into account the competing

interests, cognisant of the importance of Unit Holder participation. The Directors have at the forefront, when

making this decision, the importance of ensuring that all Unit Holders are adequately informed about the

format of these meetings as well as the rules applicable to voting and participation generally.

8.3Quoted equity security holders should

have the right to vote on any major

decisions which may change the nature of

the issuer in which they are invested.

The Manager respects the views of Unit Holders and seeks to foster constructive relationships that

encourages engagement.

Our Unit Holders are entitled to vote to replace the supervisor or the Manager, which would be the two

key decisions which would change the nature of Vital, given its structure as a listed managed investment

scheme. In addition, Unit Holders have the right to appoint two independent directors to the board of the

Manager at each annual meeting.

As a managed investment scheme regulated by the FMCA, investment objectives, investment philosophy,

investment strategy and categories of authorised investments are required to be set out in the SIPO. A

copy of Vital’s SIPO is available here:

https://www.vitalhealthcareproperty.co.nz/app/ uploads/2021/02/SIPO_Vital_New.pdf

Changes to the SIPO may only be made in accordance with section 165 of the FMCA after having given

written notice to Vital’s supervisor, Trustees Executors Limited. Depending on the nature of the changes,

prior notice to Unit Holders or Unit Holder approval may be required.

8.4If seeking additional equity capital,

issuers of quoted equity securities should

offer further equity securities to existing

equity security holder of the same class

on a pro rata basis, and on no less

favourable terms, before further equity

securities are offered to other investors.

Vital’s most recent equity capital raising was implemented in April and May 2022 as an accelerated

entitlement offer. Eligible Unit Holders were entitled to subscribe for 1 new unit for every 8.54 units held at

the record date. This structure allowed existing Unit Holders to participate on a pro rata basis, on no less

favourable terms (subject to certain exceptions, like for Unit Holders outside New Zealand).

Vital has an active dividend reinvestment plan (DRP) under which all eligible Unit Holders are able to

participate. The terms of the DRP remained unchanged during the current accounting period save that a

2% discount applied from the third quarter.

8.5The board should ensure that the notices

of annual or special meetings of quoted

equity security holders is posted on the

issuer’s website as soon as possible and

at least 20 days prior to the meeting.

Under Vital’s Trust Deed at least 14 days’ notice is required for notices of meeting to be sent by post. Vital

will continue to follow the Trust Deed when determining the period of notice to be given. Having said

that, the Notices of Meeting for Vital’s annual meeting since 2020 were provided at least 20 days prior

to the meeting, as was the Notice of Meeting for the special meeting of Unit Holders held in 2021.

The notice of meeting is released on the NZX and included on Vital’s website.

66

|

VITAL HEALTHCARE PROPERTY TRUST

Maitland Private Hospital, Maitland
ANNUAL REPORT 2025

|

67

Financial Statements
Avive Clinic, Melbourne

68

|

VITAL HEALTHCARE PROPERTY TRUST

ANNUAL REPORT 2025|69
Contents

Consolidated Statement of Comprehensive Income70

Consolidated Statement of Financial Position71

Consolidated Statement of Changes in Equity72

Consolidated Statement of Cash Flows73

Notes to the Consolidated Financial Statements74

ABOUT THIS REPORT74

1. Reporting Entity 74

2. Basis of Preparation74

3. Material Accounting Policies76

PERFORMANCE77

4. Segment Information 77

5. Taxation79

6. Investment Properties 82

7. Other Expenses90

CAPITAL STRUCTURE, FINANCING AND RISK MANAGEMENT91

8. Units on Issue91

9. Earnings per Unit92

10. Distributable Income 93

11. Borrowings94

12. Lease Liabilities 96

13. Derivative Financial Instruments96

14. Financial and Risk Management 98

15. Commitments and Contingencies 103

EFFICIENCY OF OPERATIONS104

16. Statement of Cash Flows Reconciliation from Operating Activities104

17. Trade and Other Receivables105

18. Other Assets106

19. Trade and Other Payables106

OTHER NOTES107

20. Investment in Subsidiaries 107

21. Subsequent Events 107

22. Related Party Transactions107

70|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of

Comprehensive Income

For the year ended 30 June 2025

Note

2025

$000s

2024

$000s

Gross property income from rentals154,908150,978

Gross property income from expense recoveries22,19317,810

Property expenses(28,267)(24,255)

Net property income4148,834144,533

Other expenses7(23,355)(30,003)

Strategic transaction expenses(2,872)-

Finance income1,7382,645

Finance expense11.b(46,907)(43,251)

Operating profit77,43873,924

Other gains/(losses)

Valuation (loss)/gain on investment property6.a(96,722)(165,244)

Net (loss)/gain on disposal of investment property(2,376)(5,702)

Fair value (loss)/gain on foreign exchange derivatives487(284)

Fair value (loss)/gain on interest rate derivatives(28,681)(10,540)

Realised (loss)/gain on foreign exchange(11)(87)

Unrealised (loss)/gain on foreign exchange2,072(270)

(125,231)(182,127)

(Loss)/Profit before income tax(47,793)(108,203)

Taxation benefit/(expense)5(3,427)592

(Loss)/Profit for the year attributable to Unit Holders of the Trust(51,220)(107,611)

Other comprehensive income

Items that may be reclassified subsequently to profit and loss:

Movement in foreign currency translation reserve(14,391)6,076

Total other comprehensive (loss)/income after tax(14,391)6,076

Total comprehensive (loss)/income after tax(65,611)(101,535)

Earnings per unit

Basic and diluted earnings per unit (cents)9(7.58)(16.09)

The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.

ANNUAL REPORT 2025|71
Consolidated Statement of

Financial Position

As at 30 June 2025

Note

2025

$000s

2024

$000s

Non-current assets

Investment properties63,170,5663,213,689

Derivative financial instruments1329417,720

Other non-current assets188,09713,980

Total non-current assets3,178,9573,245,389

Current assets

Investment properties held for sale641,29426,284

Cash and cash equivalents1615,64218,934

Trade and other receivables173,31810,081

Other current assets187,4223,888

Derivative financial instruments131,459183

Total current assets69,13559,370

Total assets3,248,0923,304,759

Unit Holders' funds

Units on issue81,217,6841,204,977

Reserves(25)20,966

Retained earnings461,856579,183

Total Unit Holders' funds1,679,5151,805,126

Non-current liabilities

Borrowings111,363,6391,287,477

Lease liability - ground lease9,2689,982

Derivative financial instruments139,0661,856

Deferred tax5144,591158,762

Total non-current liabilities1,526,5641,458,077

Current liabilities

Trade and other payables1929,55332,171

Income in advance1,7881,653

Derivative financial instruments134,87094

Lease liability - ground lease620123

Taxation payable5,1827,515

Total current liabilities42,01341,556

Total liabilities1,568,5771,499,633

Total Unit Holders' funds and liabilities3,248,0923,304,759

For and on behalf of the Manager, Northwest Healthcare Properties Management Limited

G Stuart, Independent Chair

13 August 2025

M Stanford,

Independent Director

The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.

72|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of

Changes in Equity

For the year ended 30 June 2025

Units on

issue

$000s

Retained

earnings

$000s

Translation

of foreign

operations

$000s

Foreign

exchange

hedges

$000s

Share

based

payments

$000s

Total

Unit

Holders'

funds

$000s

For the year ended 30 June 2024

Balance at the start of the period1,180,922753,220(55,121)63,41114,9511,957,383

Changes in Unit Holders' funds24,055---(14,951)9,104

Manager's incentive fee----6,6006,600

Profit/(loss) for the period-(107,611)---(107,611)

Distributions to Unit Holders-(66,426)---(66,426)

Other comprehensive income for the period

Movement in foreign currency translation reserve--6,076--6,076

Balance at the end of the year1,204,977579,183(49,045)63,4116,6001,805,126

For the year ended 30 June 2025

Balance at the start of the period1,204,977579,183(49,045)63,4116,6001,805,126

Changes in Unit Holders' funds12,707---(6,600)6,107

Profit/(loss) for the period-(51,220)---(51,220)

Distributions to Unit Holders-(66,107)---(66,107)

Other comprehensive income for the period

Movement in foreign currency translation reserve--(14,391)--(14,391)

Balance at the end of the year1,217,684461,856(63,436)63,411-1,679,515

The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.

ANNUAL REPORT 2025|73
Consolidated Statement of

Cash Flows

For the year ended 30 June 2025

Note

2025

$000s

2024

$000s

Cash flows from operating activities

Property income155,291151,043

Recovery of property expenses21,97917,711

Interest received9111,289

Property expenses(23,874)(23,637)

Management and trustee fees(19,500)(19,994)

Interest paid(44,759)(41,080)

Tax paid(17,793)(20,006)

Other trust expenses(3,847)(3,881)

Net cash provided by/(used in) operating activities68,40861,445

Cash flows from investing activities

Receipts from foreign exchange derivatives20212,255

Payments for foreign exchange derivatives(260)(12,479)

Capital additions on investment properties(155,685)(250,760)

Purchase of properties(1,436)(10,679)

Proceeds from disposal of properties51,034239,403

Fitout loans to tenants4,028(11,374)

Strategic transaction expenses(1,977)(455)

Net cash provided by/(used in) investing activities(104,094)(34,089)

Cash flows from financing activities

Debt drawdown358,056316,327

Repayment of debt(264,022)(277,227)

Issue of units(57)-

Loan issue costs(1,640)(1,084)

Costs associated with new equity raised(83)(100)

Distributions paid to Unit Holders(59,860)(57,223)

Net cash from/(used in) financing activities32,394(19,307)

Net increase/(decrease) in cash and cash equivalents(3,292)8,049

Cash and cash equivalents at the beginning of the period18,93410,885

Cash and cash equivalents at the end of the year15,64218,934

The notes on pages 74 to 110 form part of and are to be read in conjunction with these financial statements.

74|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

About this Report

1. Reporting Entity


Vital Healthcare Property Trust (“VHP” or the “Trust”) is a unit trust established under the Unit Trusts Act 1960 by a Trust Deed dated

11 February 1994 (as subsequently amended and replaced), domiciled in New Zealand. The Trust is managed by Northwest Healthcare

Properties Management Limited (the “Manager”), with its registered office at Level 17, HSBC Tower, 188 Quay Street, Auckland

Central 1010.

The consolidated financial statements of VHP for the year ended 30 June 2025 comprise VHP and its subsidiaries (together referred to as

the “Group”). VHP is listed on the New Zealand Stock Exchange (NZX) and is a FMC reporting entity for the purpose of the Financial

Markets Conduct Act 2013. The Group's principal activity is the direct and/or indirect investment in, and management of, high quality real

estate in good locations primarily used by healthcare operators or used for healthcare, life sciences and related purposes.

These consolidated financial statements were approved by the Board of Directors of the Manager on 13 August 2025.

2.

 Basis of Preparation

(a) Statement of compliance

These financial statements have been prepared in accordance with New Zealand Generally Accepted Accounting Practice ("NZ GAAP")

and comply with New Zealand equivalents to IFRS Accounting Standards ("NZ IFRS") and other applicable Financial Reporting Standards,

as appropriate toprofit-oriented entities. These financial statements comply with NZ IFRS and IFRS Accounting Standards ("IFRS").

(b)

 Basis of consolidation

The Group’s financial statements incorporate the financial statements of the Trust and entities controlled by the Trust (its subsidiaries) as

set out in Note 20. Control is achieved where the Trust has power over the investees; is exposed, or has rights to variable returns from

its involvement with the investees; and has the ability to use its power to affect its returns. The results of subsidiaries are included in the

consolidated financial statements from the date of acquisition to the date of disposal. All intra-group transactions, balances, cashflows,

income and expenses are eliminated on consolidation.

(c)

 Basis of measurement

The Group uses the historical cost basis except for derivative financial instruments and investment properties which are measured at fair

value. Historical cost is based on the fair value of the consideration given or received in exchange for assets or liabilities. Fair value is

the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the

measurement date, regardless of whether that price is directly observable or estimated using another valuation technique.

(d)

 Functional and presentation currency

These financial statements are presented in New Zealand Dollars ($), which is the Trust's functional and presentation currency. All

information has been rounded to the nearest thousand dollars ($000), unless stated otherwise.

In preparing the financial statements, transactions in currencies other than the Trust’s functional currency (i.e. a foreign currency transaction)

are recorded at the rates of exchange prevailing at the dates of the transactions. At the end of each reporting period, foreign currency

denominated monetary items are retranslated at the rate of exchange prevailing at that time. Exchange differences are recognised in profit

or loss in the period in which they arise, except for exchange differences on transactions entered into to hedge foreign currency exposure.

The assets and liabilities of the Group’s foreign operations are translated to New Zealand Dollars using exchange rates prevailing at the

end of the reporting period. Income and expense items are translated at the average exchange rates for the period. Exchange differences

arising on translation are recognised in other comprehensive income and the foreign currency translation reserve.

ANNUAL REPORT 2025|75
(e) Changes in accounting policy and presentation

All accounting policies have been applied on a basis consistent with the prior year's financial statements.

(f) Standards and Interpretations in issue not yet effective

At the date of authorisation of these financial statements, the Group has not applied new and revised NZ IFRS standards and amendments

that have been issued but are not yet effective. It is not expected that the adoption of these standards and amendments will have a material

impact on the financial statements of the Group except as outlined below.

In May 2024, NZ IFRS 18 Presentation and Disclosure in Financial Statements (effective for reporting periods beginning on or after

1 January 2027) was issued. This standard replaces NZ IAS 1 Presentation of Financial Statements. Management are still assessing the

impact and note this may change the presentation of primary statements.

(g) Climate-related disclosures

Vital is a Climate Reporting Entity (CRE) and is required to comply with the Financial Sector Amendment Act 2021 to provide climate-related

disclosures. In accordance with the External Reporting Board (XRB) Aotearoa New Zealand Climate Standards, Vital expects to release its

second report in October 2025.

(h)

 Material accounting policy information

Material accounting policies that summarise the measurement basis used and are relevant to an understanding of the consolidated financial

statements are provided throughout the notes to the consolidated financial statements. Where necessary, comparative information has been

reclassified to achieve consistency in disclosure with the current period.

(i)

 Fair value hierarchy

The valuation technique inputs used to determine the value of an asset or liability are classified into Levels 1 to 3 based on the degree to

which the fair value inputs are observable. A description of the levels of fair value hierarchy are as follows:

Level 1 fair value measurements are those derived from quoted prices in active markets for identical assets or liabilities.

Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the

asset or liability, either directly (as prices) or indirectly (derived from prices).

Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on

observable market data (unobservable inputs).

(j)

 The notes to the consolidated financial statements

The following notes include information required to understand these financial statements that is relevant and material to the operations,

financial position and performance of the Group. The notes have been collated into sections to help users find and understand inter-related

information. Information is considered material and relevant if, for example:

•the amount is significant by virtue of its size or nature;

•it is important to understand the results of the Group;

•it helps explain the impact of significant changes in the Group's business; or

•it relates to an aspect of the Group's operations that is important to its future performance.

76|VITAL HEALTHCARE PROPERTY TRUST
3. Material Accounting Policies

Critical accounting estimates and judgements


In the application of NZ IFRS, the Board and management are required to make judgements, estimates and assumptions about carrying

values of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on

experience and other factors that are believed to be reasonable under the circumstances, however actual results may differ from these

estimates and assumptions.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in

which the estimate is revised and in any future periods affected.

The critical judgements, estimates and assumptions made in the current period are contained in the following notes:

NoteDescription

Note 5Current and deferred taxation

Note 6Valuation of investment properties

Note 22Related party transactions

ANNUAL REPORT 2025|77
Performance

This section shows the results and performance of the Group and its reporting segments and includes detailed information in respect to its

revenues, expenses and profitability. It also provides information on the investment properties that underpin the Group's performance.

4. Segment Information


The Group's principal activity is the investment in, and management of, high quality real estate in good locations primarily used by

healthcare operators or used for healthcare, life sciences and related purposes. Segment profit represents the profit earned by each

segment including an allocation of

identifiable administration costs, finance costs and gains/(losses) on disposal of investment properties.

This is the measure reported to the Board, who are the chief operating decision makers for the purposes of resource allocation and

assessment of segment performance. The Group operates in both Australia and New Zealand.

The following is an analysis of the Group’s results by reportable segment.

Australia

$000s

New Zealand

$000s

Total

$000s

Segment profit/(loss) for the year ended 30 June 2025:

Gross property income from rentals101,68853,220154,908

Gross property income from expense recoveries8,43813,75522,193

Property expenses(12,893)(15,374)(28,267)

Net property income97,23351,601148,834

Other expenses(14,789)(8,566)(23,355)

Strategic transaction expenses-(2,872)(2,872)

Net finance expense(38,309)(6,860)(45,169)

Operating profit44,13533,30377,438

Fair value (losses) on interest rate derivatives(25,002)(3,679)(28,681)

Valuation gains/(losses) on investment properties(106,338)9,616(96,722)

Net losses on disposal of investment property(2,244)(132)(2,376)

Other foreign exchange gains/(losses)2112,3372,548

Total segment profit/(loss) before income tax(89,238)41,445(47,793)

Taxation expense / (benefit)(3,427)

Profit/(loss) for the year(51,220)

Segment profit/(loss) for the year ended 30 June 2024:

Gross property income from rentals101,46349,515150,978

Gross property income from expense recoveries7,28010,53017,810

Property expenses(11,966)(12,289)(24,255)

Net property income96,77747,756144,533

Other expenses(15,636)(14,367)(30,003)

Net finance expense(38,341)(2,265)(40,606)

Operating profit42,80031,12473,924

Fair value (losses) on interest rate derivatives(7,643)(2,897)(10,540)

Revaluation (losses) on investment properties(133,505)(31,739)(165,244)

Net losses on disposal of investment property(4,523)(1,179)(5,702)

Other foreign exchange gains/(losses)(210)(431)(641)

Total segment profit/(loss) before income tax(103,081)(5,122)(108,203)

Taxation expense / (benefit)592

Profit/(loss) for the year(107,611)

78|VITAL HEALTHCARE PROPERTY TRUST
Net property income comprises rental income and expense recoveries from tenants less property expenses. The Group has three Australian

tenants and one New Zealand tenant that in aggregate contributed $100.2m of gross property income (2024: three Australian tenants and

one New Zealand tenant that contributed $100.5m).

There were no inter-segment sales during the year (2024: nil).

Australia

$000s

New Zealand

$000s

Total

$000s

Segment assets at 30 June 2025:

Investment properties2,106,3601,064,2063,170,566

Other non-current assets3,1985,1938,391

Current assets59,2879,84869,135

Consolidated assets2,168,8451,079,2473,248,092

Segment assets at 30 June 2024:

Investment properties2,213,762999,9273,213,689

Other non-current assets25,0306,67031,700

Current assets47,26112,10959,370

Consolidated assets2,286,0531,018,7063,304,759

Segment liabilities at 30 June 2025:

Borrowings1,095,540268,0991,363,639

Other liabilities172,28832,650204,938

Consolidated liabilities1,267,828300,7491,568,577

Segment liabilities at 30 June 2024:

Borrowings1,107,629179,8481,287,477

Other liabilities178,63233,524212,156

Consolidated liabilities1,286,261213,3721,499,633

All assets and liabilities have been allocated to reportable segments.

Net finance expense and borrowings are allocated against the borrowers segment. In accordance with the Group’s finance facilities,

comprising a common terms deed and bi-lateral facility agreements (refer note 11.a), financing arrangements are cross collateralised across

the Group’s investment properties and other assets and are managed on an aggregate basis.

ANNUAL REPORT 2025|79
5. Taxation

Income tax recognised in the consolidated statement of comprehensive income

2025

$000s

2024

$000s

Profit/(loss) before tax for the period(47,793)(108,203)

Taxation (charge)/credit - 28% on profit before income tax13,38230,297

Effect of different tax rates in foreign jurisdictions(11,601)(13,431)

Tax exempt income / (Non-deductible expense)4,054(1,339)

Foreign tax credits3,0241,559

Tax charges on overseas investments(12,559)(13,058)

Over/(under) provided in prior periods(1,403)1,228

Other adjustments1,676(4,664)

Taxation benefit/(expense)(3,427)592

The taxation (charge)/credit is made up as follows:

Current taxation(15,546)(19,046)

Deferred taxation12,11919,638

Taxation benefit/(expense)(3,427)592

The key assumptions used in the preparation of the Group’s tax calculation are as follows:

Tax rate:

The Group is subject to New Zealand tax on assessable income, including assessable Foreign Investment Fund ("FIF") income attributed

from its Australian subsidiaries (applying either the Fair Dividend Rate ("FDR") method or the attributable FIF method), at a rate of 28%. Its

Australian subsidiaries are subject to Australian withholding tax on assessable income at a rate of 10% for interest income or 15% for 'fund

payment' amounts as they are Australian Managed Investment Trusts (MIT). A New Zealand tax credit is generally available for Australian

withholding tax.

80|VITAL HEALTHCARE PROPERTY TRUST
Deferred Tax balances

Interest rate

swaps

$000s

Revaluation

of investment

properties

$000s

Borrowings

$000s

Other

$000s

Total

$000s

At 1 July 2024(292)(158,383)(223)136(158,762)

Charge to profit and loss for the year3,2277,70485533312,119

Change in exchange rate(53)2,139(27)(7)2,052

At 30 June 20252,882(148,540)605462(144,591)

At 1 July 2023(7,359)(170,190)(174)197(177,527)

Charge to profit and loss for the year7,07112,718(49)(102)19,638

Change in exchange rate(4)(911)-41(874)

At 30 June 2024(292)(158,383)(223)136(158,762)

Imputation credits

2025

$000s

2024

$000s

Imputation (deficit)/credits at end of year(4,295)(4,306)

Recognition and measurement


Income tax comprises current and deferred tax. It is recognised in the consolidated profit or loss unless it relates to items recognised in other

comprehensive income, in which case the current or deferred tax is recognised in other comprehensive income.

Current tax

Current tax is the expected tax payable on the taxable income for the financial year, determined using tax rates enacted or substantively

enacted at the reporting date in the countries where the Group operates, and any adjustments to tax payable in respect of previous

financial years. Management periodically evaluates positions taken in tax returns where the applicable tax regulation is subject to

interpretation and establishes appropriate provisions on the basis of amounts expected to be paid to the tax authorities.

Deferred tax

Deferred tax is provided using the balance sheet liability method, recognising temporary differences between the carrying amounts of assets

and liabilities for financial reporting purposes and their amounts for taxation purposes.

Deferred tax liabilities are recognised for all taxable temporary differences. Deferred tax assets are recognised for all deductible temporary

differences and carried forward tax losses, to the extent that it is probable that taxable profit will be available to utilise them.

The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer

probable that sufficient taxable profits will be available to utilise them.

Deferred tax assets and liabilities are measured using the tax rates that are expected to apply to the forecast circumstances and the

period(s) when the asset or liability giving rise to them are realised or settled, based on the tax rates and laws enacted or substantively

enacted at balance date.

Deferred tax assets and liabilities are offset where there is a legally enforceable right to set off, they relate to the same taxation authority,

and the Group intends to settle its obligations on a net basis.

ANNUAL REPORT 2025|81
Unrecognised deferred tax assets

Deferred tax assets totalling $10.3m (2024: $0.7m) relating to debt deductions in Australia that have not been recognised. These tax losses

can be carried forward 15 years and utilised in future periods subject to specific conditions.

Uncertain tax positions

The Group is in the process of revising tax depreciation claims in relation to the financial years ended 30 June 2021 to 2024 in relation to

Australian and New Zealand investment properties (currently estimated at $1.9m). This tax depreciation and therefore current tax benefit

has not been recorded as the required tax return amendments / positions are subject to the Commissioner of Inland Revenue’s discretion or

determination, which has currently been assessed as not probable.

Significant estimates and judgements


Significant estimates and judgements made in the determination of deferred tax include:

•Deferred tax on fixtures and fittings: It is assumed that all fixtures and fittings will be sold at their tax book value.

•Deferred tax on depreciation: Deferred tax is provided for in respect of New Zealand properties for the depreciation expected to be

recovered on the sale of investment property, using an estimated split between land and buildings as determined by registered valuers.

•Deferred tax on changes in fair value of investment properties: Deferred tax for Australian properties is provided on the capital gain that

is expected from the sale of investment properties based on their fair value. The tax rate used when measuring the deferrred tax position

is either15% (FDR method which applies the Australian 'fund payment' withholding tax rate) or 28% (Attributed FIF method which applies

the New Zealand tax rate) based on the Group's actual FIF income attribution method election and/or its intention to 'opt-in' to the

FDR method.

82|VITAL HEALTHCARE PROPERTY TRUST
6. Investment Properties


Investment properties comprise real estate predominately leased, or targeted to be leased, to health, life sciences and related sector

tenants that is held for either deriving rental income, for capital appreciation or both. The following information excludes Investment Property

reclassified to Investment Properties held for sale.

(6.a) Reconciliation of Carrying Amounts

2025

$000s

2024

$000s

Carrying value of investment property at the beginning of the year3,213,6893,288,356

Acquisition of properties1,18713,183

Capitalised costs127,060212,949

Capitalised interest costs24,87026,480

Net capitalised incentives(2,130)7,159

Disposal of properties(23,275)(161,317)

Classified as held for sale(41,294)(26,284)

Foreign exchange translation difference(32,819)12,174

Revaluation gain/(loss) on investment property(76,602)(165,244)

Carrying value gain/(loss) on investment property under construction(20,120)-

Right of use asset recognised-6,233

Carrying value of investment property at the end of the year3,170,5663,213,689

The Group owns the freehold title to all properties except the car parks at the rear of Ascot Hospital and Ascot Central ("Ascot") and the

GenesisCare Integrated Cancer and Health Centre ("GenesisCare") which are the subject of ground leases ("right-of-use" asset). These

ground leases have a weighted average term remaining of 13.8 and 53.7 years respectively (2024: 14.8 and 54.7 years). As at reporting

date the fair value of the right-of-use assets are $3.5m and $6.3m respectively (2024: 3.7 and $6.4). The ground lease at the Ascot

carpark has a 20 year option to extend the term commencing 8 April 2039. The ground lease at the GenesisCare property has two 15

year options to extend the term commencing 28 February 2079 and 28 February 2094.

(6.b)

 Acquisition of Property

During the period the Group:

•acquired Beck Court Road, Noble Park, VIC for A$1.0m. The road is located adjacent to South Eastern Hospital and other strategic land

holdings, and improves the overall development of the proposed brownfield expansion of the South Eastern Hospital.

(6.c)

 Disposal of Property

During the year the Group:

•divested Hirondelle Private Hospital in Chatswood, NSW Australia for A$24.0m (excluding transaction costs) on 23 October 2024.

•divested Epworth Rehabilitation and the land at 10-14 Alverna Grove in Brighton, VIC Australia for A$19.3m (excluding transaction

costs) on 3 December 2024.

•divested 6a Millet Street, Hurstville, NSW Australia for A$1.7m (excluding transaction costs) on 2 May 2025.

ANNUAL REPORT 2025|83
(6.d) Leasing Arrangements

Investment properties are leased to tenants predominately under long term operating leases. Rent is receivable from tenants monthly.

Minimum lease payments to be received under non-cancellable operating leases not recognised in the consolidated financial statements as

receivable are as follows:

2025

$000s

2024

$000s

Not later than one year163,106148,990

Later than one year and not later than five years608,496568,910

Later than five years1,535,1731,474,202

2,306,7752,192,102

(6.e) Contractual arrangements

The Group is a party to contracts to purchase and construct property, provide incentives and amortising fitout loans to tenants which are not

recognised in the financial statements, unless otherwise noted, for the following amounts:

2025

$000s

2024

$000s

Capital expenditure commitments39,030140,422

The Group has committed to:

•providing up to A$2.0m for air conditioning replacement works at Sportsmed Hospital, Clinic and Consulting suites (incorporated into

the valuation of this property).

•capital expenditure and property acquisition committments relating to development projects' cost to complete.

•reimbursing 50% of a tenants costs (up to A$0.6m) should the agreement for lease be terminated by the Group at any time before

commencement of the developments construction.

•acquire and rentalise additional development works previosuly undertaken by Avive at the Mt Eliza Clinic, totalling A$1.74 million,

contingent on the tenant achieving a defined performance hurdle before the sunset date of 31 December 2027.

(6.f)

 Individual Valuations and Carrying Amounts

The details of the New Zealand and Australian investment property portfolio, including its location, sub sector, fair value, market

capitalisation rate, occupancy and weighted average lease expiry term are as follows:

84|VITAL HEALTHCARE PROPERTY TRUST
Latest independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-25

$M

Jun-24

%

Jun-25

%

Jun-24

%

Jun-25

%

Jun-24

Years

Jun-25

Years

Jun-24

Australia

New South Wales

Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-25191.9205.45.34.9100.0100.025.721.7

Maitland Private HospitalEast Maitland, New South Wales

Hospital (Acute/Mental

Health/Rehab)Healthe CareJun-25149.9146.55.65.5100.0100.022.018.1

Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2491.191.46.06.0100.0100.021.817.8

Kellyville Private HospitalKellyville, New South WalesHosptial (Mental Health)AuroraDec-2450.455.35.65.0100.0100.022.023.0

GenesisCare Integrated Cancer & Health CentreCampbelltown, New South WalesHosptial (Ambulatory Care)GenesisCareJun-2547.650.75.44.9100.0100.013.714.7

Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2540.244.95.34.9100.0100.025.718.1

Toronto Private Hospital

1

Toronto, New South WalesHospital (Mental Health/Rehab)AuroraJun-24-42.9-6.5-100.0-21.7

Victoria

Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationJun-25414.0428.25.04.698.697.222.723.5

South Eastern Private HospitalNoble Park, VictoriaHospital (Mental Health/Rehab)AuroraDec-2489.586.75.55.5100.0100.015.716.7

Epworth CamberwellCamberwell, VictoriaHospital (Mental Health/Rehab)Epworth FoundationJun-2577.883.25.45.0100.0100.019.020.0

Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesJun-2536.037.26.35.897.897.84.14.1

Avive Clinic - Mornington PeninsulaMount Eliza, VictoriaHospital (Mental Health)AviveDec-2430.731.25.55.3100.0100.023.324.3

120 Thames StreetBox Hill, VictoriaAmbulatory CareNewlife IVFJun-2512.012.66.86.375.775.73.94.6

Epworth Rehabilitation

2

Brighton, VictoriaHospital (Rehab)Epworth Foundationn.a-16.4-n.a.-100.0-0.1

Queensland

Belmont Private HospitalCarina Heights, QueenslandHospital (Mental Health)AuroraDec-24145.6164.35.44.8100.0100.020.221.2

Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Mental Health)AuroraJun-2562.574.55.65.0100.0100.010.211.2

Western Australia

Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Mental Health)AuroraDec-2459.061.95.35.0100.0100.016.617.6

Marian CentreWembley, Western AustraliaHospital (Mental Health)AuroraDec-2458.862.45.45.0100.0100.019.110.1

South Australia

Playford Health Hub – MOB, Retail and CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2590.988.25.45.392.273.69.36.8

Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-2588.994.85.65.3100.0100.06.06.0

Burnside Hospital Stepney, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Burnside Hospital FoundatonJun-2577.189.07.16.1100.0100.021.322.3

Total Australia1,813.91,967.85.55.299.099.119.018.1

1Classified as investment property held for sale at 30th June 2025

2This property was divested in Dec24

ANNUAL REPORT 2025|85
Latest independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-25

$M

Jun-24

%

Jun-25

%

Jun-24

%

Jun-25

%

Jun-24

Years

Jun-25

Years

Jun-24

Australia

New South Wales

Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-25191.9205.45.34.9100.0100.025.721.7

Maitland Private HospitalEast Maitland, New South Wales

Hospital (Acute/Mental

Health/Rehab)Healthe CareJun-25149.9146.55.65.5100.0100.022.018.1

Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2491.191.46.06.0100.0100.021.817.8

Kellyville Private HospitalKellyville, New South WalesHosptial (Mental Health)AuroraDec-2450.455.35.65.0100.0100.022.023.0

GenesisCare Integrated Cancer & Health CentreCampbelltown, New South WalesHosptial (Ambulatory Care)GenesisCareJun-2547.650.75.44.9100.0100.013.714.7

Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2540.244.95.34.9100.0100.025.718.1

Toronto Private Hospital

1

Toronto, New South WalesHospital (Mental Health/Rehab)AuroraJun-24-42.9-6.5-100.0-21.7

Victoria

Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationJun-25414.0428.25.04.698.697.222.723.5

South Eastern Private HospitalNoble Park, VictoriaHospital (Mental Health/Rehab)AuroraDec-2489.586.75.55.5100.0100.015.716.7

Epworth CamberwellCamberwell, VictoriaHospital (Mental Health/Rehab)Epworth FoundationJun-2577.883.25.45.0100.0100.019.020.0

Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesJun-2536.037.26.35.897.897.84.14.1

Avive Clinic - Mornington PeninsulaMount Eliza, VictoriaHospital (Mental Health)AviveDec-2430.731.25.55.3100.0100.023.324.3

120 Thames StreetBox Hill, VictoriaAmbulatory CareNewlife IVFJun-2512.012.66.86.375.775.73.94.6

Epworth Rehabilitation

2

Brighton, VictoriaHospital (Rehab)Epworth Foundationn.a-16.4-n.a.-100.0-0.1

Queensland

Belmont Private HospitalCarina Heights, QueenslandHospital (Mental Health)AuroraDec-24145.6164.35.44.8100.0100.020.221.2

Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Mental Health)AuroraJun-2562.574.55.65.0100.0100.010.211.2

Western Australia

Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Mental Health)AuroraDec-2459.061.95.35.0100.0100.016.617.6

Marian CentreWembley, Western AustraliaHospital (Mental Health)AuroraDec-2458.862.45.45.0100.0100.019.110.1

South Australia

Playford Health Hub – MOB, Retail and CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2590.988.25.45.392.273.69.36.8

Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-2588.994.85.65.3100.0100.06.06.0

Burnside Hospital Stepney, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Burnside Hospital FoundatonJun-2577.189.07.16.1100.0100.021.322.3

Total Australia1,813.91,967.85.55.299.099.119.018.1

1Classified as investment property held for sale at 30th June 2025

2This property was divested in Dec24

86|VITAL HEALTHCARE PROPERTY TRUST
Latest independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-25

$M

Jun-24

%

Jun-25

%

Jun-24

%

Jun-25

%

Jun-24

Years

Jun-25

Years

Jun-24

New Zealand

Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareJun-25188.7183.35.55.5100.0100.022.423.4

AscotGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-24125.0125.05.45.4100.098.414.414.2

Grace HospitalTauranga, Bay of PlentyHospital (Acute)Evolution Southern Cross LimitedDec-24122.2109.45.55.4100.0100.025.526.5

Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2495.086.35.85.5100.0100.024.425.4

Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedJun-2586.183.45.45.492.3100.015.614.9

Kawarau ParkLake Hayes, QueenstownHospital (Acute)Southern Cross CLT LimitedJun-2572.069.55.85.6100.094.16.27.1

Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2467.959.45.95.9100.0100.013.014.0

Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareJun-2567.766.05.55.5100.0100.024.425.4

Endoscopy AucklandEpsom, AucklandHospital (Acute)Evolution HealthcareJun-2548.631.75.55.5100.0100.016.917.9

Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedJun-2539.838.55.96.096.996.94.65.5

68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareHealth New Zealand - CanterburyJun-2539.539.45.85.882.271.18.38.8

Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedDec-2434.034.05.55.5100.0100.011.011.8

Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2424.723.66.16.3100.0100.021.022.0

Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-248.48.411.411.797.391.511.511.9

Total New Zealand1,019.6957.75.65.697.997.017.818.6

Properties held for development337.1288.2

Investment properties - non current3,170.63,213.7

Investment properties held for sale41.326.3

TOTAL FAIR VALUE OF

INVESTMENT PROPERTIES3,211.93,240.05.55.398.698.018.518.3

ANNUAL REPORT 2025|87
Latest independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-25

$M

Jun-24

%

Jun-25

%

Jun-24

%

Jun-25

%

Jun-24

Years

Jun-25

Years

Jun-24

New Zealand

Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareJun-25188.7183.35.55.5100.0100.022.423.4

AscotGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-24125.0125.05.45.4100.098.414.414.2

Grace HospitalTauranga, Bay of PlentyHospital (Acute)Evolution Southern Cross LimitedDec-24122.2109.45.55.4100.0100.025.526.5

Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2495.086.35.85.5100.0100.024.425.4

Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedJun-2586.183.45.45.492.3100.015.614.9

Kawarau ParkLake Hayes, QueenstownHospital (Acute)Southern Cross CLT LimitedJun-2572.069.55.85.6100.094.16.27.1

Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2467.959.45.95.9100.0100.013.014.0

Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareJun-2567.766.05.55.5100.0100.024.425.4

Endoscopy AucklandEpsom, AucklandHospital (Acute)Evolution HealthcareJun-2548.631.75.55.5100.0100.016.917.9

Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedJun-2539.838.55.96.096.996.94.65.5

68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareHealth New Zealand - CanterburyJun-2539.539.45.85.882.271.18.38.8

Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedDec-2434.034.05.55.5100.0100.011.011.8

Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2424.723.66.16.3100.0100.021.022.0

Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-248.48.411.411.797.391.511.511.9

Total New Zealand1,019.6957.75.65.697.997.017.818.6

Properties held for development337.1288.2

Investment properties - non current3,170.63,213.7

Investment properties held for sale41.326.3

TOTAL FAIR VALUE OF

INVESTMENT PROPERTIES3,211.93,240.05.55.398.698.018.518.3

88|VITAL HEALTHCARE PROPERTY TRUST
(6.g) Recognition and Measurement

Recognition and measurement

Investment Property

Investment properties are initially measured at cost, including any related transaction costs. Expenditure is capitalised to a property's

carrying value only when its cost can be measured reliably and it is probable that future economic benefits will flow to the Group. All other

repairs and maintenance expenditure is charged to the statement of comprehensive income.

Subsequent to initial recognition, investment properties, including investment properties held for sale, are measured at fair value (inclusive

of adjustments for straight line rental revenue recognition, unamortised lease incentives and costs, and capital expenditure obligations) with

any gains or losses arising on re-measurement recognised in

profit or loss.

Lessee arrangements and Right-of-Use assets

On inception of a lease arrangement (where the Group is a lessee), the lease liability is initially measured as the aggregate of fixed lease

payments due (net of incentives receivable), expected residual value guarantees and the exercise price of purchase options (if reasonably

certain to be exercised) and expected lease termination payments, discounted using the interest rate implicit in the lease, or if this cannot be

determined, the Group's incremental cost of borrowing.

Subsequent to initial recognition, lease payments are allocated between finance costs (which is expensed to the consolidated statement

of comprehensive income over the term of the lease using the effective interest rate method) and a reduction of the initial lease liability

recognised. Refer to Note

12 for the lease liabilities recognised by the Group.

Right-of-Use assets are initially measured at cost, comprising the aggregate of the initial measurement of the lease liability (net of

incentives received), lease payments made before commencement date, initial direct costs and restoration costs and are classified as

Investment Property.

Subsequent to initial recognition right-of-use assets are measured at fair value.

Development of investment property

Investment property that is being developed is measured at cost until either its fair value becomes reliably measurable or the development

reaches practical completion. Borrowing costs are capitalised from when activities to prepare the property for development commence, until

the property is ready for use.

As at 30 June 2025, the carrying value of RDX, QLD (a property currently under construction and expected to achieve practical completion

in early 2026 - therefore held at cost) was reassessed, resulting in a reduction of $20.1m. This primarily reflects required carrying value

adjustments due to actual and forecast costs to complete, updated market observations and broader trends affecting healthcare properties

(and commercial real estate more generally) since construction commenced in late 2022. The adjustment relied on assumptions and

estimates as at 30 June 2025, informed by independent advice, forecast costs to complete estimates, and leasing considerations. The actual

fair value of RDX on completion may differ from the current carrying amount. 

Rental income

Rental income from investment properties is comprised of lease components (including base rent, recovery of property taxes and insurance)

and non-lease components (including property outgoing recoveries). Rental income is recognised at the fair value of consideration

receivable (excluding GST).

Rental income relating to lease components is recognised on a straight-line basis over the term of the lease for the period where the rental

income is fixed and determinable. For leases where the rental income is determined based on unknown future variables such as inflation,

market reviews or other factors, rental income is recognised on an accruals basis in accordance with the terms of the lease.

Rental income from property outgoing recoveries is recognised as the costs are incurred, which is typically when the services are provided.

ANNUAL REPORT 2025|89
Rental income not received at reporting date is reflected in the consolidated statement of financial position as a receivable or, if paid in

advance, as income in advance.

Lease incentives, commissions and other costs

Lease incentives provided to tenants, such as fit-outs or rent free periods, and leasing commissions and other costs incurred when entering

into a lease are recognised as a reduction of net property income on a straight-line basis over the non-cancellable term of the lease.

Derecognition

An investment property is derecognised upon disposal or when no future economic benefits are expected from use. The gain or loss arising

on derecognition of the property is measured as the difference between the net proceeds from disposal and the carrying amount at disposal

date and is recognised in the consolidated statement of comprehensive income in the period in which the property is derecognised.

Valuation process

The purpose of the valuation process is to ensure that investment properties are held at fair value. In accordance with the Group's valuation

policy, external valuations are performed by independent professionally qualified valuers who hold a recognised and relevant professional

qualification and have specialised expertise in the type of investment property being valued. The valuation policy requires that a valuer

may not value the same property for more than two consecutive valuations. All valuations are reviewed by the Manager and approved by

the Board.

The fair value of investment property as at 30 June 2025 was determined through independent professional valuers for approximately 64%

of the portfolio with the balance of the investment property portfolio subject to independent valuation at 31 December 2024. Manager's

valuations are used to determine the balance of the porfolio at each reporting date and are informed by market data and valuation advice

provided by independent valuers, comparable transactional evidence and current period leasing activities. The valuers of properties which

have been independently valued at

30 June 2025 included: Ernst & Young, Colliers International, Cushman & Wakefield, Jones Lang

LaSalle Australia, Savills, CBRE, Urbis, Valued Care, and Absolute Value. The properties which have been independently valued at 30 June

2025 are disclosed above in Note 6.f.

The methods used for assessing the fair value of investment property are the Direct Comparison, Discounted Cash Flow (using a risk adjusted

discount rate), Capitalisation of Contract and Market Income approaches and are unchanged from the prior year. The principal factors

that influence a valuation include the market capitalisation / discount rates, occupancy, market rent assessments and the weighted average

lease term to expiry (WALE).

Climate change

The Group continues to assess the impact of climate change on its business and its real estate assets. While valuers have made no explicit

adjustments to the fair value of investment property in respect of climate change matters, it is anticipated that climate change may have a

greater influence on valuations in the future as investment markets place a greater emphasis on climate change and a property's / tenants

environmental resilience and credentials.

Fair Value Hierarchy

Investment properties are classified as Level 3 under the fair value valuation hierarchy.

Estimates and judgements

The key inputs used in the valuation of investment property are tenant quality, occupancy, rental growth rates, weighted average lease

duration, capitalisation rates, discount rates and terminal yields.

Generally, as:

•tenant quality, occupancy, rental growth rates and/or weighted average lease durations increase, yields firm, resulting in increased fair

values for investment properties, and vice versa;

•capitalisation, discount rates and/or terminal yields used in the valuation approaches decrease (firm), the fair values for investment

properties increase, and vice versa.

90|VITAL HEALTHCARE PROPERTY TRUST
7. Other Expenses

(7.a) Other Expenses

2025

$000s

2024

$000s

Other Expenses

Manager's fees17,65218,084

Manager's incentive fee-6,600

Trustee fees564569

Other operating expenses4,9224,533

Total other expenses23,13829,786

(7.b) Fees Paid To Auditor

2025

$000s

2024

$000s

Fees Paid To Auditor

Auditor's remuneration:

Audit and review of financial statements

Statutory audit of the consolidation financial statements168168

Review of the condensed consolidated interim financial statements4646

Other services

AGM scrutineering33

Total fees paid to auditor217217

ANNUAL REPORT 2025|91
Capital Structure, Financing and Risk Management

This section outlines how the Group manages its capital structure and related financing activities and presents the resultant returns delivered

to Unit Holders via distributions and earnings per unit.

8. Units on Issue

2025

$000s

2024

$000s

Balance at the beginning of the year1,204,9771,180,922

Issue of units under Distribution Reinvestment Plan6,2479,203

Issue of units to satisfy Manager's incentive fee6,60014,951

Issue costs of units(140)(99)

Balance at the end of the year1,217,6841,204,977

2025

000s

2024

000s

Reconciliation of number of units

Balance at the beginning of the year671,923661,014

Issue of units under the Distribution Reinvestment Plan3,3274,492

Units issued to satisfy Manager's incentive fee3,6466,417

Balance at the end of the year678,896671,923

Distributions for the financial year were 9.75 cents per unit (2024: 9.75 cents per unit) including the final quarter distribution of 2.4375 cents

per unit (2024: 2.4375 cents per unit) declared subsequent to the reporting date. Refer Note 21.

There have been no equity raise activities outside of the units issued under the distribution reinvestment plan, and the payment of the

manager's incentive fee in units.

Recognition and measurement

Issued capital

Issued and paid up units are recognised at the fair value of the consideration received by the Group, net of directly incurred transaction

costs. Fully paid ordinary units carry one vote per unit and the right to distributions.

Distributions are recognised as a liability in the Group’s financial statements in the period in which the distribution is declared.

92|VITAL HEALTHCARE PROPERTY TRUST
Share based payments (Managers incentive fee)

Subject to the Trust Deed, the Manager is entitled to an incentive fee that is settled in newly issued units (i.e. a share based payment). As

such, the incentive fee expense is recognised in the share based payment reserve as the services are provided until such a time as it is settled

via the issuance of new units, at which point the amount is reclassified to units on issue.

On 21 August 2024, 3,645,936 units were issued against the 2024 Manager’s incentive fee of $6.6 million (2024: 6,417,684 units were

issued against the 2023 Manager’s incentive fee of $14.9 million).

Capital risk management


The Manager's objective when managing the capital of the Group is to ensure compliance with the capital requirements under the Trust

Deed (i.e. total borrowings do not exceed 50% of the gross value of the Trust Fund), borrowings arrangements (refer note

11.a)and that

the Group will be able to continue as a going concern while maximising the return to investors through the optimisation of the Group's

cost of capital. The Manager maintains or adjusts the capital of the Group through various methods including by adjusting the quantum of

distributions paid, raising or repaying debt, issuing or buying back units, or buying or selling assets.

As at reporting date, the Group's total borrowings to the Gross Value of the Group (as defined in the Trust Deed) was 42.1% (2024: 39.1%).

The Group’s policies in respect of capital management and allocation are reviewed regularly by the Board of the Manager. There have

been no material changes in the Group’s overall capital risk management strategy during the year.

9.

 Earnings per Unit

20252024

Profit/(loss) attributable to Unit Holders of the Trust ($000s)(51,220)(107,611)

Weighted average number of units on issue (000's of units)675,899668,753

Basic and diluted earnings per unit (cents)(7.58)(16.09)

Recognition and measurement


Basic and diluted earnings per unit is calculated by dividing the profit attributable to Unit Holders of the Trust by the weighted average

number of ordinary units on issue during the year.

ANNUAL REPORT 2025|93
10. Distributable Income


Statutory profit attributable to Unit Holders is determined in accordance with NZ GAAP and includes a number of non-cash items including

fair value movements, straight line lease accounting adjustments and amortisation of borrowing and leasing costs and incentives.

The Manager uses Adjusted Funds from Operations ("AFFO") and AFFO per unit as the Group's key performance metric, representative of

the Group's underlying performance, and as a guide to informing the Group's distribution policy. AFFO adjusts statutory operating profit for

certain items that are non-cash, unrealised, capital in nature or are one-off or non-recurring (i.e. outside the Group's ordinary operations or

not reflective of its underlying performance). As AFFO is a non GAAP measure it may not be directly comparable with AFFO presented by

the Group's peers.

A reconciliation of statutory operating profit to AFFO and AFFO per unit is as follows:

2025

$000s

2024

$000s

Adjusted funds from operations

Operating profit before tax and other gains and losses77,43873,924

Add/(deduct):

Current tax expense(15,546)(19,046)

Incentive fee-6,600

Strategic transaction expenses2,848-

Current tax on translation of foreign currency funding transactions(59)(48)

Current tax on interest rate swap restructure and property disposals1,2146,536

Amortisation of borrowing costs2,0942,009

Amortisation of leasing costs & tenant inducements3,6043,423

IFRS 16 Operating lease accounting(117)(157)

Funds from operations ("FFO")71,47673,241

Add/(deduct):

Actual maintenance capex from continuing operations(1,108)(342)

Adjusted funds from operations (AFFO)70,36872,899

AFFO (cpu)10.4110.90

Distribution per unit (cpu)9.7509.750

AFFO payout ratio94%89%

Units on issue (weighted average, 000s)675,899668,753

94|VITAL HEALTHCARE PROPERTY TRUST
11. Borrowings

2025

$000s

2024

$000s

AUD denominated loans1,156,5321,145,753

NZD denominated loans211,917146,900

Borrowing costs(4,810)(5,176)

Total borrowings1,363,6391,287,477

Current liability--

Non current liability1,363,6391,287,477

Total borrowings1,363,6391,287,477

2025

$000s

2024

$000s

Total borrowings at the beginning of the year1,287,4771,239,156

Drawdowns during the year358,056316,327

Repayments during the year(264,022)(277,227)

Additional facility refinancing fee(1,640)(1,084)

Facility refinancing fee amortised during the year2,0942,009

Foreign exchange movement(18,326)8,296

Total borrowings at the end of the year1,363,6391,287,477

Recognition and measurement


Borrowings are initially measured at fair value, net of transaction costs. Subsequent to initial recognition, borrowings are measured at

amortised cost using the effective interest rate method. Gains and losses on derecognition are recognised in the consolidated statement of

comprehensive income in the period in which they arise. The carrying values of these balances are approximately equivalent to their fair

values because the loans have floating rates of interest that generally reset every 90 days.

Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the facility for at least 12

months as at year-end.

(11.a)

 Summary of Borrowing Arrangements

The Group has a club financing arrangement governed by a common terms deed and bi-lateral facility agreements. Currently there are

eight financiers (2024: 8 financiers) that provide facilities to the Group. The facilities' expiry profile and undrawn limits are as follows:

ANNUAL REPORT 2025|95
Jun-25Jun-24

A$m LimitA$m UndrawnExpiryA$m LimitA$m UndrawnExpiry

Common Terms Deed - AUD

Facility A150.015.5May-30100.042.2Oct-28

Facility A225.0-May-2850.0-Mar-27

Facility A475.030.0May-3275.075.0Mar-29

Facility D275.0-Mar-2775.0-Mar-27

Facility D350.0-Apr-2825.0-Mar-26

Facility K170.1-Mar-2870.1-Mar-28

Facility K221.0-Mar-2921.0-Mar-29

Facility K313.0-Mar-2813.0-Mar-28

Facility L75.0-Sep-2875.0-Sep-28

Facility M119.0-Mar-2919.0-Mar-29

Facility M212.0-Mar-2812.0-Mar-28

Facility O50.0-May-3050.0-Mar-28

Total AUD Facility535.145.5960.1117.2

Common Terms Deed - NZD

NZ$m LimitNZ$m UndrawnExpiryNZ$m LimitNZ$m UndrawnExpiry

Facility A50.0-May-2850.0-Mar-27

Facility B75.05.0Mar-2875.019.6Mar-28

Total NZD Facility125.05.0125.019.6

Common Terms Deed -

Multicurrency (A$/NZ$)

A$m LimitA$m UndrawnExpiryA$m LimitA$m UndrawnExpiry

Facility A5150.00.2May-2975.05.0Mar-27

Facility B150.0-May-2850.02.1Mar-27

Facility C162.5-May-2862.5-Mar-27

Facility C262.5-May-2962.5-Mar-27

Facility C3125.0-May-30125.0-Mar-29

Facility D1100.0-Apr-29125.0-Mar-27

Facility N125.06.7Mar-28125.01.7Mar-28

Total Multicurrency Facility675.06.9250.08.8

In addition to the above, the Group has available a A$5.0m (2024: A$5.0m) bank guarantee facility of which A$0.4m (2024: A$0.7m)

has been utilised at the reporting date.

The facilities provided are secured and cross collateralised over the Group's mortgaged investment properties (by first ranking real property

mortgages) and other assets (via a first ranking general 'all assets' security agreement).

The common terms deed contains both financial and non-financial covenants and undertakings that are customary for secured facilities of

this nature. The key financial covenants (being defined terms in the common terms deed) are as follows:

Covenant

2025

Actual

2024

Actual

Banking Covenants

Loan to value ratio< 55%43.6%40.4%

Interest cover> 2.00x3.023.07

Total EBITDA of Obligors v total EBITDA of GroupNot < 95%100%100%

Total assets of Obligors v total assets of GroupNot < 95%100%100%

Total value of unmortgaged properties v total assets of GroupNot > 10%0.9%0.9%

96|VITAL HEALTHCARE PROPERTY TRUST
(11.b) Finance Expense

2025

$000s

2024

$000s

Expenses

Interest expense71,77769,731

Borrowing costs capitalised(24,870)(26,480)

Total finance expenses46,90743,251

The effective interest rate on borrowings, incorporating interest rate swaps, as at the reporting date was 4.90% per annum (2024: 5.06%).

Recognition and measurement


Interest expense is recognised in the consolidated statement of comprehensive income using the effective interest rate method except where

it is incurred in relation to a qualifying asset, where it is capitalised during the period of time that is required to hold, complete and/or

prepare the asset for its intended use.

The effective interest rate method calculates the amount to be recognised over the relevant period at the rate that exactly discounts estimated

future cash payments through the expected life of the financial instrument or a shorter period where appropriate, to the net carrying amount

on initial recognition.

12.

 Lease Liabilities


The Group holds a ground lease over the car parks at the rear of Ascot Hospital and Ascot Central and the GenesisCare Integrated Cancer

Centre. The weighted average terms remaining are 13.8 and 53.7 years respectively (2024: 14.8 and 54.7 years) noting that Vital has

options to extend the ground leases (refer Note6.a).

13.

 Derivative Financial Instruments

(13.a) Interest Rate Swaps

The Group has exposure to debt facilities that are subject to floating interest rates. The Group uses derivative financial instruments, on a

portfolio basis, to manage its exposure to interest rates such as interest rate swaps (to lock-in fixed interest rates), interest rate swaptions

(interest rate swaps for a fixed period of time, which are extendable at the counterparties election for a fixed period of time at the same

interest rate) and/or interest rate caps (to limit exposure to rising interest rates). At the reporting date, 82.3% of borrowings were fixed using

derivate financial instruments (2024: 77.0%). Refer Note14.c for further information on the Group's exposure to interest rate risk.

All interest rate derivative providers receive the benefit of pari-passu security and cross collateralisation rights over the Group’s

mortgaged investment properties (via first registered real property mortgages) and other assets (via a first ranking general 'all assets'

security agreement).

Generally, interest rate contracts settle on a quarterly basis coinciding with the dates on which the interest is payable on the underlying

debt. The floating rate incurred on the debt is based on New Zealand BKBM - Bid or Australian BBSY. The difference between the

fixed and floating interest rate is generally settled on a net basis by the relevant counterparty. The interest rate contracts have not been

identified as hedging instruments and any movements in their fair value are recognised immediately in the consolidated statement of

comprehensive income.

ANNUAL REPORT 2025|97
2025

$000s

2024

$000s

Current assets

Interest rate derivative assets1,085149

Non-current assets

Interest rate derivative assets23117,704

Current liabilities

Interest rate derivative liabilities(4,870)-

Non-current liabilities

Interest rate derivative liabilities(9,066)(1,850)

Total(12,620)16,003

During the period the Group recognised a fair value loss of $28.7m (2024: $10.5m loss) on interest rate contracts. The Group's interest rate

swaps outstanding and the corresponding floating interest rates at the reporting date are as follows:

2025

$000s

2024

$000s

Notional value of interest rate swaps - AUD905,630863,630

Notional value of interest rate swaps - NZD150,00045,655

Average fixed interest rate A$3.26%3.52%

Average fixed interest rate NZ$3.73%4.63%

Floating rates based on AUD BBSY3.75%4.39%

Floating rates based on NZD BKBM3.36%5.68%

Interest rate derivatives mature over the next four years and have fixed interest rates ranging from 2.50% to 4.37% (2024: from 2.50%

to 4.63%).

At balance date the Grouphad six A$ forward start swaps with a total notional value of A$300m with fixed rates ranging from 2.89% to

3.60% (2024: one swap, A$50m notional value at 3.54%), and one $50m forward start swap with a fixed rate of 3.15% (2024: one

swap, $50m notional value at 4.63%). The start dates for these swaps range from September 2025 to March 2026 with tenors ranging

between one and three and a half years (2024: December 2024 start date and a three year tenor).

The Group also had five A$ callable swaptions (at the counterparty's option) with a notional value of A$348.5m with fixed rates ranging

from 2.89% to 3.92% (2024: three swaptions, A$200m notional value, with rates ranging from 3.54% to 3.92%), and one $50m callable

swaption with a fixed rate of 2.99% (2024: nil). The exercise dates on the callable swaptions range from March 2026 to March 2028 with

tenors ranging between one and three years (2024: exercise dates ranging from March 2026 to June 2027 with tenors between two and

three years).

During the year, the Group entered into a NZ$50m cross-currency basis swap for a 1-year term, maturing in March 2026. This transaction

settles quarterly with VHP paying BKBM and receiving BBSY which in June 2025 were 3.36% and 3.76% respectively. At 30 June 2024,

the Group had no cross-currency basis swaps.

Recognition and measurement


Interest rate derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised and

subsequently measured at fair value derived from independent 3rd party valuations, discounting the estimated future cashflows and using

market interest rates for a substitute instrument at the measurement date. The resulting gain or loss is recognised immediately in profit or loss in

the consolidated statement of comprehensive income as hedge accounting has not been applied.

98|VITAL HEALTHCARE PROPERTY TRUST
(13.b) Forward Exchange Contracts

The Group has exposure to foreign currency risk arising from owning investment property in Australia. Derivative financial instruments, such

as forward exchange contracts, may be used to reduce the exposure to foreign exchange risk by locking in the conversion of Australian

dollar denominated income (transaction hedging) or net assets (translation hedging) to New Zealand dollars. Refer Note14.c for further

details on the Group's exposure to foreign exchange risk.

Transaction hedging arrangements generally settle on a quarterly basis while translation hedging arrangements settle on a periodic basis

depending on the term of the contract. At reporting date forward exchange contracts have not been designated as hedging instruments and

any movements in the fair value are recognised immediately in profit or loss in the consolidated statement of comprehensive income.

2025

$000s

2024

$000s

Current assets

Foreign exchange derivative assets37434

Non-current assets

Foreign exchange derivative assets6316

Current liabilities

Foreign exchange derivative liabilities-(94)

Non-current liabilities

Foreign exchange derivative liabilities-(6)

Total437(50)

During the period the Group recognised a fair value gain of $0.49m (2024: $0.28m loss) on forward exchange contracts. The Group's

forward exchange contracts outstanding at the reporting date are as follows:

2025

$000s

2024

$000s

Nominal value of foreign exchange contracts - AUD20,00122,750

Average foreign exchange rate0.91210.9110

Recognition and measurement


Foreign exchange derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised

and subsequently measured at fair value derived from counterparty bank valuations. Counterparty bank valuations are tested for

reasonableness by using a valuation model based on the applicable forward price curves derived from observable forward prices.

As hedge accounting has not been applied any resulting gain or loss is recognised immediately in profit or loss in the consolidated

statement of comprehensive income.

(13.c)

 Fair value hierarchy

The Group has determined that interest rate swaps and foreign exchange contract derivatives are valued using Level 2 inputs (observable

prices of similar instruments). There have been no reclassifications between levels in the current year (2024: nil).

14.

 Financial and Risk Management


The Group’s activities expose it primarily to credit risk, market risk (interest rate risk and foreign exchange risk) and liquidity risk. The Group’s

overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on

the Group’s financial performance. The Group uses financial derivatives to manage market risks. The use of financial derivatives is governed

ANNUAL REPORT 2025|99
by the Group’s policies approved by the Board of the Manager, which provide written principles that are consistent with the Group’s risk

management strategy and appetite. The Group does not use derivative financial instruments for speculative purposes.

(14.a) Financial Instruments

The Group has the following financial instruments:

•cash and cash equivalents;

•receivables (including loans);

•payables;

•borrowings; and

•derivative financial instruments.

Transactions in these instruments expose the Group to a variety of financial risks including market risk (which includes interest rate risk, foreign

exchange risk and other price risks), credit risk and liquidity risks.

Categories of

financial instruments


The Group’s financial instruments are classified as:

Financial assets

at amortised

cost

$000s

Financial

liabilities at

amortised cost

$000s

Financial

assets at fair

value through

profit or loss

$000s

Financial

liabilities at fair

value through

profit or loss

$000s

30 June 202533,198(1,403,080)1,753(13,936)

30 June 202442,995(1,329,752)17,903(1,950)

Cash, cash equivalents, trade and other receivables (including loans), trade and other payables and borrowings


The carrying values of these financial instruments approximate their fair values because of their short terms to maturity, frequency of interest

rate reset dates and/or pricing based on counterparty credit ratings.

(14.b)

 Credit Risk

The Group is subject to credit risk (the risk that a counterparty will default on its contractual obligations resulting in financial loss to the

Group) predominately through its trade and other receivables (including loans), derivatives and cash exposures. The maximum exposure to

credit risk at a reporting date is the carrying value of each financial asset as disclosed in the applicable note to the financial statements.

Credit risk is managed by:

•ensuring that at the time of entering into a contractual arrangement or acquiring a property, counterparties or tenants are of appropriate

credit worthiness, provide appropriate security or other collateral and/or do not show a history of default;

•seeking to optimise tenant diversity by actively managing the property portfolio composition and leasing arrangements; and

•only entering into derivative financial instruments and placing cash and deposits with high credit quality financial institutions.

The Group applies an expected credit losses (ECL's) model (simplified approach) that uses historical experience, external indicators and

forward looking information to calculate the expected lifetime credit loss for financial assets carried at amortised cost.

The expected lifetime credit loss of trade receivables is assessed on a collective basis (grouped based on days past due), reflecting shared

credit characteristics, and is determined based on the forecast shortfalls in contractual cash flows considering the potential for default at any

point during the life of the financial instrument. Details of the expected credit loss recognised in relation to trade receivables is disclosed

in Note17.a.

100|VITAL HEALTHCARE PROPERTY TRUST
(14.c) Market Risk

The Group is subject to market risk (the risk that borrowings or derivatives are repriced to different interest rate margins on refinance or

renewal arising from changes in the debt markets), interest rate risk (the risk of a change in interest rates may impact the Group’s profitability,

cashflows and/or financial position) and foreign exchange risk (the risk of a change in foreign exchange rates on translation of foreign

currency denominated assets, liabilities, revenue and expenses) predominantly through its investment property, borrowings, derivatives and

cash exposures.

The interest rates applicable to each category of financial instrument are disclosed in the relevant note to the financial statements.

Interest rate risk


Loans have floating rates of interest that are generally reset every 90 days. The risk is managed by the Group by maintaining an appropriate

mix between fixed and floating rates by the use of interest rate swaps. The following table indicates the effective interest rates and the

earliest period in which financial instruments reprice.

Weighted

effective

interest rate

%

Less than

1 year

$000s

1-2 years

$000s

2-3 years

$000s

3+ years

$000s

Total

$000s

30 June 2025

Cash and cash equivalents

(floating rates)

3.70%15,642---15,642

Borrowings (floating rates)5.18%(242,029)---(242,029)

Borrowings (fixed rates)

1

4.80%(508,361)(357,951)(160,108)(100,000)(1,126,420)

(734,748)(357,951)(160,108)(100,000)(1,352,807)

30 June 2024

Cash and cash equivalents

(floating rates)

4.54%18,934---18,934

Borrowings (floating rates)5.47%(296,831)---(296,831)

Borrowings (fixed rates)

1

4.22%(10,952)(573,464)(306,648)(104,759)(995,823)

(288,849)(573,464)(306,648)(104,759)(1,273,720)

1Fixed rate balances are presented with the effect of hedging derivatives.

Interest rate sensitivity

The Group’s sensitivity to interest rate risk can be expressed in two ways:

Fair value sensitivity

A change in interest rates impacts the fair value of the Group’s fixed rate financial instruments. Fair value changes impact profit or loss or

equity only where the instruments are carried at fair value. Accordingly, the fair value sensitivity to a 100 bps movement in interest rates

(based on the financial instruments held at reporting date) is:

Impact on

profit/(loss)

2025

$000s

Impact on

Unit Holders'

funds

2025

$000s

Impact on

profit/(loss)

2024

$000s

Impact on

Unit Holders'

funds

2024

$000s

If interest rates had been 100 bps higher:23,50423,50418,01318,013

If interest rates had been 100 bps lower:(27,375)(27,375)(19,807)(19,807)

ANNUAL REPORT 2025|101
Instruments included in the fair value sensitivity are the Group's interest rate swaps.

Cash flow sensitivity analysis

A change in interest rates impacts interest income and expense on the Group’s interest bearing floating rate financial instruments.

Accordingly, the one-year cash flow sensitivity to a 100 bps movement in interest rates (based on the financial instruments held at reporting

date) is:

Impact on

profit/(loss)

2025

$000s

Impact on

unit holders'

funds

2025

$000s

Impact on

profit/(loss)

2024

$000s

Impact on

unit holders'

funds

2024

$000s

If interest rates had been 100 bps higher:(2,420)(2,420)(2,968)(2,968)

If interest rates had been 100 bps lower:2,4202,4202,9682,968

Instruments included in the cash flow sensitivity are the Group's interest rate swaps and its borrowings.

Foreign exchange risk


The following table presents the foreign currency risk that the Group is exposed to arising from Australian dollar (AUD) denominated assets

and liabilities:

2025

$000s

2024

$000s

Non-financial instrument assets and liabilities denominated in Australian dollars

Investment properties2,106,3592,213,762

Other assets50,40128,848

Deferred tax(139,858)(148,160)

Total non-financial instrument assets and liabilities2,016,9022,094,450

Non-derivative financial instruments

Cash and cash equivalents7,78012,764

Trade and other receivables2,97012,805

Trade and other payables(19,238)(22,430)

Borrowings(1,156,532)(1,107,630)

Lease liabilities(6,349)(6,381)

Total exposure from non-derivative financial instruments(1,171,369)(1,110,872)

Derivative financial instruments

Foreign exchange derivatives437(50)

Interest rate swaps(12,620)16,003

Total exposure from derivative instruments(12,183)15,953

Net exposure to currency risk833,350999,531

Foreign currency sensitivity

A change in the New Zealand dollar (NZD) / AUD exchange rate impacts profit after tax and equity on the conversion of AUD

denominated assets, liabilities, revenue and expenses. A 10% change in the exchange rate (2024:10%), based on year end exposures, has

the following effect:

102|VITAL HEALTHCARE PROPERTY TRUST
2025

$000s

2024

$000s

If the New Zealand Dollar versus the Australian Dollar was 10% higher for the year:

Profit and loss5,9572,742

Other comprehensive income(80,161)(91,783)

Unit Holders' funds(74,204)(89,041)

If the New Zealand Dollar versus the Australian Dollar was 10% lower for the year:

Profit and loss(7,280)(3,352)

Other comprehensive income97,974112,179

Unit Holders' funds90,694108,827

(14.d) Liquidity Risk

The Group is subject to liquidity risk (the risk that the Group will not be able to meet its contractual or other operating obligations).

Liquidity risk is managed by continuously monitoring forecast and actual cash flows, maintaining appropriate head room under debt

facilities and matching the maturity profiles of financial assets and liabilities. To help reduce liquidity risks the Group:

•has readily accessible unutilised credit facilities and other funding arrangements;

•seeks a debt maturity profile that limits the total debt maturing in any one 12-month period; and

•seeks to maintain sufficient loan covenant headroom to ensure that the Group can withstand downward movements in investment

property valuations, a reduction in revenue and/or an increase in interest rates without breaching loan facility covenants.

Liquidity risk exposure

The following table details the Group’s exposure to liquidity risk based on the contractual undiscounted cash flows relating to financial

liabilities, foreign exchange contracts and interest rate derivatives:

Carrying

value

$000s

Contractual

cash flows

$000s

Less than 1

year

$000s

1-2 years

$000s

2-3 years

$000s

3+ years

$000s

30 June 2025

Non-derivative financial instruments

Borrowings (excluding borrowing costs)(1,368,449)(1,624,773)(66,438)(142,592)(485,168)(930,575)

Trade and other payables(29,553)(29,553)(29,553)---

Lease liability - ground lease(9,888)(28,254)(620)(626)(631)(26,377)

(1,407,890)(1,682,580)(96,611)(143,218)(485,799)(956,952)

Derivative financial instruments

Interest rate swaps(12,620)(8,628)(3,598)(3,675)(1,058)(297)

Foreign exchange derivatives437437437---

(12,183)(8,191)(3,161)(3,675)(1,058)(297)

30 June 2024

Non-derivative financial instruments

Borrowings (excluding borrowing costs)(1,292,653)(1,295,831)(259,487)(226,706)(372,821)(436,817)

Trade and other payables(32,171)(32,171)(32,171)---

Lease liability - ground lease(10,105)(9,389)(123)29(143)(9,151)

(1,334,929)(1,337,390)(291,780)(226,677)(372,964)(445,969)

Derivative financial instruments

Interest rate swaps16,00319,15112,5205,0351,406190

Foreign exchange derivatives(50)(50)(50)---

15,95319,10112,4705,0351,406190

ANNUAL REPORT 2025|103
(14.e) Hedge Accounting

The Group is exposed to foreign exchange risk on its net investment in its AUD functional currency subsidiaries and seeks to hedge this risk

using AUD-denominated borrowings and foreign exchange derivatives (net investment hedges).

Recognition and measurement


For a financial instrument to be classified and accounted for as an effective hedge there must be:

•an economic relationship between the hedged item and the financial instrument;

•the effect of credit risk does not dominate the value changes that result from that economic relationship; and

•the hedge ratio of the hedging relationship is the same as that resulting from the quantity of the hedged item that the Group actually

hedges and the quantity of the

financial instrument that the Group actually uses to hedge that quantity of hedged item.

The Group documents its hedging relationships at their inception in accordance with the requirements of NZ IFRS 9 and the Board

approved risk management strategy.

Hedge effectiveness is determined by the Group at the inception of the hedge relationship, and through semi-annual prospective

effectiveness assessments, to ensure that an economic relationship exists between the hedged item and the financial instrument. That portion

of the foreign exchange differences arising on the financial instruments determined to be an effective hedge is recognised directly in other

comprehensive income. Any ineffective portion is recognised in profit or loss.

On disposal of the foreign operation, the cumulative value of such gains or losses recognised in other comprehensive income is reclassified

to the profit and loss in the statement of comprehensive income.

No foreign exchange derivatives currently held are designated as hedging instruments (2024: Nil).

15.

 Commitments and Contingencies


Other than the contractual obligations disclosed in Note 6.e and Note15.a, there are no other commitments and contingencies in effect at

the reporting date (2024: nil).

(15.a)

 NZX Bank Bond

As a condition of listing on the New Zealand Stock Exchange (NZX), NZX requires all issuers to provide a bank bond to NZX under

NZX/DX Listing Rule 1.23.2. The bank bond required by the Group for listing on the NZX is $75,000.

104|VITAL HEALTHCARE PROPERTY TRUST
Efficiency of Operations

This section presents the Group's working capital position and the efficiency in which it converts operating profits into cash available for Unit

Holders or reinvestment back into the operations of the Group.

16. Statement of Cash Flows Reconciliation from Operating Activities

2025

$000s

2024

$000s

Cash and cash equivalents

Australian financial institutions7,78012,764

New Zealand financial institutions7,8626,170

Cash at bank15,64218,934

Reconciliation of profit after income tax to net cash flows from operating activities

Profit after tax for the year(51,220)(107,611)

Adjustments for non-cash items

Change in fair value of investment properties96,722165,244

Fair value (gain)/loss on derivative financial instruments28,19410,824

Unrealised foreign exchange (gain)/loss(2,072)270

Deferred taxation(12,119)(19,638)

Income in advance135127

Strategic transaction costs2,872-

Manager's incentive fee-6,600

Other2,1792,224

Operating cash flow before changes in working capital64,69158,040

Change in trade and other payables3,557(1,136)

Change in taxation payable(2,333)(1,174)

Change in trade and other receivables11713

Items classified as investing activities2,3765,702

Net cash from operating activities68,40861,445

Excluded from investing and financing activities are distributions paid during the year of $6.2m (2024: $9.2m) that have been reinvested

under the Distribution Reinvestment Plan (DRP).

Recognition and measurement


Cash and cash equivalents comprise cash at bank and call deposits, net of outstanding bank overdrafts.

The statement of cash flows is prepared on a GST exclusive basis. The GST component of cash flows arising from investing and financing,

which is recoverable from/payable to, the taxation authority, is classified as part of operating cash flows.

ANNUAL REPORT 2025|105
17. Trade and Other Receivables

2025

$000s

2024

$000s

Trade receivables1,2325,615

Loss allowance(473)(552)

7595,063

Other receivables2,5594,075

Tenant fitout loans-943

Total trade and other receivables3,31810,081

(17.a) Ageing of receivables Past Due

2025

$000s

2024

$000s

0-30 days past due4654,735

31-60 days past due67307

61-90 days past due40177

beyond 90 days past due660396

1,2325,615

2025

$000s

2024

$000s

Movement in the loss allowance

Balance at the beginning of the year552388

(Decrease)/increase in allowance recognised in profit or loss(79)164

Balance at the end of the year473552

During the year the Group recognised bad debt write offs of $9,000 (2024: $18,000) in the statement of comprehensive income.

The Group holds $0.8m security or other collateral (2024: $0.2m) in respect of rent receivables past due. The Group does not have

significant credit risk exposure to any single counterparty or counterparties having similar characteristics in respect of rent receivables

past due (2024: nil). There are no significant financial assets that have had renegotiated terms that would otherwise have been past due

(2024: nil).

Recognition and measurement

Rent receivables

Rent receivables are recorded initially at fair value (including GST) and subsequently at amortised cost.

Loan receivables

Loan receivables are initially measured at fair value and subsequent at amortised cost using the effective interest rate method.

Impairment of financial assets

Loss allowances for financial assets (other than those measured at fair value through profit and loss) are measured using the simplified

approach based on a lifetime expected loss allowance. Refer Note14.b for further details.

106|VITAL HEALTHCARE PROPERTY TRUST
18. Other Assets

2025

$000s

2024

$000s

Current

GST refundable178197

Tenant fitout loans6,141-

Other1,1033,691

Total Current7,4223,888

Non-Current

Tenant fitout loans and other receivables8,09713,980

Total Non-current8,09713,980

The Group has provided unsecured amortising fitout loans to two tenants totaling $8.4m and $5.9m. These loans amortise over 10 and 15

years from inception and are currently subject to interest at 8.00% and 6.45% respectively.

Recognition and measurement

Rent receivables

Other assets are recorded initially at fair value (including GST) and subsequently at amortised cost.

Loan receivables

Loan receivables are initially measured at fair value and subsequent at amortised cost using the effective interest rate method.

Impairment of financial assets

Loss allowances for financial assets (other than those measured at fair value through profit and loss) are measured using the simplified

approach based on a lifetime expected loss allowance. Refer Note14.b for further details.

19.

 Trade and Other Payables

2025

$000s

2024

$000s

Current liabilities

Interest accrued on borrowings5,0073,952

Other creditors and accruals24,54628,219

Total trade and other payables29,55332,171

Recognition and measurement


Trade and other payables are recognised initially at fair value (inclusive of GST) and subsequently measured at amortised cost using the

effective interest method. The average credit term on purchases is generally 30 days and they are non-interest bearing. The Group has

management policies in place to ensure that all amounts are paid within the applicable credit terms.

ANNUAL REPORT 2025|107
Other Notes

20. Investment in Subsidiaries


The Trust has control over the following subsidiaries.

Holding

Name of subsidiaryPrincipal activity

Place

of incorporation

and operation20252024

Vital Healthcare Australian Property TrustProperty investmentAustralia100%100%

Vital Healthcare Investment TrustProperty investmentAustralia100%100%

Vital Healthcare Property LimitedProperty investmentNew Zealand100%100%

Colma Services LimitedHolding companyNew Zealand100%100%

All subsidiaries have the same reporting date as the Trust.

21.

 Subsequent Events


On 13 August 2025 a final cash distribution of 2.4375 cents per unit was announced. The Record Date for the final distribution is

4 September 2025 and is payable to Unit Holders on 18 September 2025. Imputation credits of 0.6327 cents per unit will be attached to

the distribution.

22.

 Related Party Transactions

The Manager

Vital is managed by Northwest Healthcare Properties Management Limited (the "Manager"), a wholly owned subsidiary of NWI

Healthcare Properties LP (NWI LP).

The ultimate parent of NWI LP is Toronto listed Northwest Healthcare Properties Real Estate Investment Trust (NWH REIT) that, as at

reporting date, holds a 28.2% (2024: 28.4%) interest in Vital. NWH REIT and its controlled entities (including the Manager) are considered

related parties to Vital and its controlled entities by virtue of common ownership and/or directorships.

Other related parties by virtue of common ownership and/or directorship to the Manager of Vital include Australian Properties Limited and

Northwest Healthcare Australian Properties Limited.

Remuneration of the Manager

Vital pays fees to the Manager in accordance with the Trust Deed. The aggregate of Base Fees, Incentive Fees and Activity Fees is capped

at 1.75% per annum of Vital's Gross Asset Value (GAV) as at the end of a financial year.

Current fee arrangements

Base Fee

The Base Fee structure is as follows:

•65 bps per annum up to $1bn of GAV:

•55 bps per annum from $1bn to $2bn of GAV;

•45 bps per annum from $2bn to $3bn of GAV; and

•40 bps per annum over $3bn of GAV.

108|VITAL HEALTHCARE PROPERTY TRUST
Incentive Fee

The Incentive Fee is determined as 10% of the average annual increase in Vital’s Net Tangible Assets ("NTA") (being a defined term in the

Trust Deed) over the respective financial year and the two preceding financial years, with payment being made by way of subscribing

for new units. The incentive fee calculations are also subject to a "three year High Watermark Net Tangible Asset” requirement (being a

defined term in the Trust Deed), such that for the purpose of determining the increase in NTA for a Financial Year, the annual NTA increase

for that Financial Year will reduce to zero if the actual NTA does not exceed the High Watermark Net Tangible Asset requirement.

Activity Fees

a. Leases or licences

Vital pays the Manager leasing or licence fees where the Manager has negotiated leases or licences. The fees are charged at 11% of the

aggregate annual rental for terms less than 3 years, 12% of the aggregate annual rental for terms of 3 years, and 12% plus an additional 1%

for each full year (pro rata for part years) for terms greater than three years (to a maximum of 20%), subject to a minimum fee of $2,500.

Lease or licence renewals are charged at 50% of a new lease or licence fee.

Leasing or licence fees are capitalised to the respective investment or property in the consolidated statement of financial position and

amortised over the term of the lease.

b. Property management

Vital pays the Manager property management fees where the Manager acts as the property manager. These fees are charged at 1%

- 2% of gross income depending on the number of tenants at the property and may be recovered from tenants if permitted under

lease agreements.

Property management fees, net of recoveries from tenants, are expensed through the consolidated statement of comprehensive income in the

year in which they arise.

c. Facilities management

Vital pays the Manager a facilities management fee where the Manager acts as a property facilities manager based on the market rate

(referenced to a reputable and high-quality third party service provider) for similar services at similar properties. This fee may be recovered

from tenants if permitted under lease agreements.

Facilities management fees are expensed, net of recoveries from tenants, through the consolidated statement of comprehensive income in the

year in which they arise.

d. Project management

Vital pays project management fees to the Manager for managing capital expenditure projects where the purpose of the project is to

upgrade, repair or otherwise extend the life of the property, including via the replacement or repair of major plant and equipment, structural

items and building envelope.

Project management fees for projects with a budget of between $0.2m and $2.5m are 2% of the committed spend where the Manager is

the project lead and 1% of committed spend where the Manager has an oversight role, increasing to 4% and 2% respectively for projects

with a budget greater than $2.5m.

Project management fees are capitalised to the respective property in the consolidated statement of financial position.

Additional Costs

a. Acquisitions

Vital pays fees to the Manager for managing the due diligence, financing, legal aspects and settlement of the purchase of an investment or

property instead of, or alongside, a third party agent. These fees are charged at 1.5% of the capitalised cost of the relevant investment or

property, being the contracted price payable, excluding any deductions netted off the settlement price (such as rates), together with other

related capitalised acquisition costs.

ANNUAL REPORT 2025|109
Acquisition fees are capitalised to the respective investment or property in the consolidated statement of financial position.

b. Disposals

Vital pays fees to the Manager for managing the due diligence, legal aspects and settlement of the sale of an investment or property

instead of, or alongside, a third party agent. These fees are charged at 1% of the contracted sale price of the relevant investment or property

actually received, provided that, if a third party agent has been engaged to provide services for the disposal, then the fee payable to the

Manager will be net of the third party agent’s costs and commissions.

Disposal fees are expensed through the consolidated statement of comprehensive income in the year in which they arise.

c. Development Management

Vital pays fees where the Manager acts as a development manager on Vital developments. These fees are charged at 4% of the committed

spend (excluding land) approved by the Board of the Manager provided that, if a third party agent has been engaged to provide

development management services, then the fee payable to the Manager will be reduced by the non-rentalisable third party costs paid.

Development management fees are capitalised to the respective property in the consolidated statement of financial position.

Other Services

Vital has entered into an agreement with Northwest Healthcare Australian Properties Limited to receive Level 2 energy audit and climate risk

assessment services for its Australian and New Zealand properties under clause 24.4 of the Trust Deed. The fees for these services do not

exceed prevailing market rates.

Other Related Parties


On 30 December 2022 the Group entered into an agreement with Northwest Healthcare Australia RE Limited as trustee for Northwest

Healthcare Australia Lumina Trust ("Lumina") under which Vital purchased the land at 15 Nexus Way, Southport, Queensland Australia

(Land) to facilitate the development of a new state of the art, 6-Star Green Star health, research and innovation building to be known as

“RDX”. Consideration paid, based on an independent valuation by Jones Lang LaSalle of the Land, totalled A$6.9m, including A$4.3m

payable to Lumina.

In conjunction with the purchase of the Land:

•Lumina has agreed to guarantee the net operating income of RDX will not be less than A$3.712m for the 12 months from practical

completion of RDX; and

•the Group has agreed to pay Lumina 50% of the actual net operating income in excess of A$3.712m plus 50% of any outperformance

against the leasing assumptions, capped at A$2.0m.

Other than the above there have been no transactions that occurred during the reporting period or remain outstanding at the reporting date

with other related parties.

110|VITAL HEALTHCARE PROPERTY TRUST
Transactions with related parties


Amounts charged by the Manager and related parties and owing are as follows:

30 June 2025

$000s

30 June 2024

$000s

Statement of

Comprehensive

Income

Statement of

Financial

PositionTotal

Amounts

Owing/

(Receivable)

Statement of

Comprehensive

Income

Statement of

Financial

PositionTotal

Amounts

Owing/

(Receivable)

Base fee17,652-17,652-18,084-18,084-

Incentive Fee

1

----6,600-6,6006,600

Activity Fees:----

Leasing/licensing

2

1462,6052,7512462472,5442,791238

Property management

3

2,444-2,4443492,299-2,299320

Facilities management

3

--------

Project management

4

-----5555-

Other services

5

-126126125----

AFSL fee1,284-1,284-1,341-1,341-

21,5262,73124,25772028,5712,59931,1707,158

Additional Costs:

Acquisitions

6

-1515--(180)(180)274

Disposals

7

86-86-789-789485

Development management

8

-1,4001,4001,213-3,7453,7451,543

861,4151,5011,2137893,5654,3542,302

Other Amounts:

Reimbursement of third

party expenses:

Other expenses104-104-120-120-

Amounts paid to directors:

9

Graham Stuart117-117-65-65-

Angela Bull44-44-100-100-

Michael Stanford121-121-76-76-

386-386-361-361-

21,9984,14626,1441,93329,7216,16435,8859,460

1Manager's incentive fee outstanding at 30 June 2025 of nil (Jun 24: $6.6m) is payable to Northwest Healthcare Properties Management Limited

2Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24:$0.2m); Northwest Healthcare Australian Property Limited $0.2m (Jun

24: $0.1m)

3Property Management and Facilities Management fees, exclusive of recoveries from tenants, incurred by the Trust totalled $2.4m and nil respectively for the 30 June 2025 year (Jun 24:

$2.3m and nil respectively).

Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited $0.1m (Jun 24: $0.1m); Northwest Healthcare Australian Property Limited $0.2m

(Jun 24:$0.2m)

4Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24: $0.1m) Northwest Healthcare Australian Property Limited Nil (Jun 24: Nil)

5Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Pty Ltd $0.1m (2024: Nil)

6Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24: Nil); Northwest Healthcare Australian Property Limited Nil (Jun 24: $0.3m)

7Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited Nil (Jun 24: $0.2m); Northwest Healthcare Australian Property Limited Nil (Jun

24: $0.3m)

8Amounts outstanding at 30 June 2025 are: Northwest Healthcare Properties Management Limited $0.5m (Jun 24: $0.9m); Northwest Healthcare Australian Property Limited $0.7m (Jun

24: $0.7m)

9Directors' fees for Graham Stuart are currently paid by the Manager



Independent Auditor’s Report

To the Unitholders of Vital Healthcare Property Trust

Opinion

We have audited the consolidated financial statements of Vital Healthcare Property Trust and its

subsidiaries (the ‘Group’), which comprise the consolidated statement of financial position as at 30

June 2025, and the consolidated statement of comprehensive income, statement of changes in

equity and statement of cash flows for the year then ended, and notes to the consolidated financial

statements, including material accounting policy information.

In our opinion, the accompanying consolidated financial statements, on pages 70 to 110, present

fairly, in all material respects, the consolidated financial position of the Group as at 30 June 2025,

and its consolidated financial performance and cash flows for the year then ended in accordance

with New Zealand Equivalents to IFRS Accounting Standards (‘NZ IFRS’) as issued by the External

Reporting Board and IFRS Accounting Standards (‘IFRS’) as issued by the International Accounting

Standards Board.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (‘ISAs’) and

International Standards on Auditing (New Zealand) (‘ISAs (NZ)’). Our responsibilities under those

standards are further described in the Auditor’s Responsibilities for the Audit of the Consolidated

Financial Statements section of our report.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis

for our opinion.

We are independent of the Group in accordance with Professional and Ethical Standard 1

International Code of Ethics for Assurance Practitioners (including International Independence

Standards) (New Zealand) issued by the New Zealand Auditing and Assurance Standards Board and

the International Ethics Standards Board for Accountants’ International Code of Ethics for

Professional Accountants (including International Independence Standards), and we have fulfilled

our other ethical responsibilities in accordance with these requirements.

Other than our capacity as auditor, we perform other assurance services in relation to the Group’s

quarterly reporting pack to the Group’s Parent. We also carry out other assignments for the Group

as independent AGM vote scutineer. These services have not impaired our independence as auditor

of the Group. The firm has no other relationships with, or interests in, the Group.

Audit materiality



We consider materiality primarily in terms of the magnitude of misstatement in the financial

statements of the Group that in our judgement would make it probable that the economic decisions

of a reasonably knowledgeable person would be changed or influenced (the ‘quantitative’

materiality). In addition, we also assess whether other matters that come to our attention during

the audit would in our judgement change or influence the decisions of such a person (the

‘qualitative’ materiality). We use materiality both in planning the scope of our audit work and in

evaluating the results of our work.

We determined materiality for the Group financial statements as a whole to be $3.87 million.

Key audit matters Key audit matters are those matters that, in our professional judgement, were of most significance

in our audit of the consolidated financial statements of the current period. These matters were

addressed in the context of our audit of the consolidated financial statements as a whole, and in

forming our opinion thereon, and we do not provide a separate opinion on these matters.








Key audit matter How our audit addressed the key audit matter

Valuation of Investment Properties

The Group’s investment properties (including those held for sale)

consist of health sector properties totalling $3,212 million as at 30

June 2025. Valuation losses on the Group’s investment properties

for the year ended 30 June 2025 totalled $97 million, which

includes a $20 million carrying value adjustment relating to

investment property under development. Further details on the

Group’s property portfolio and valuation are provided in Note 6.

Investment properties are carried at fair value. Where

development is in progress at a property, this is carried at cost,

until either its fair value becomes reliably measurable or the

development reaches practical completion.

The valuation of investment property is highly dependent on

forecasts and estimates including a number of unobservable inputs

to take into account property-specific attributes.

Independent registered valuers determined the fair value of

approximately 64 percent of the investment properties at 30 June

2025, and the Manager determined the fair value of the remaining

properties.

The valuation methods used for assessing the fair value include a

combination of direct comparison, discounted cash flow,

capitalisation of contract and market income approaches.

The external valuers and the Manager, amongst other matters,

take into consideration occupancy rates, weighted average lease

term to expiry (‘WALE’) and capitalisation rates.

The valuation of investment properties is a key audit matter due to

the subjective judgements and assumptions in the valuation

models.

We have evaluated the appropriateness of the valuation of

investment property by performing the following:

• Reviewing the external valuers’ valuation reports and the

valuation reports prepared by the Manager.

• We evaluated the key metrics, including

capitalisation rate, market rent and contract rent on

a property and portfolio basis for year on year

movements and assessed whether, in our

judgement, the movements represented outliers to

investigate.

• We held discussions, on a sample basis, with the

valuers and separately, with representatives of the

Manager and challenged assumptions, including the

possible outliers identified.

• We agreed property specific information supplied

to the external valuer and used in the Manager’s

valuations, including occupancy data, current

rentals, and lease terms, to the underlying records

held by the Group, on a sample basis.

• We involved our valuation specialists to consider

and challenge, on a sample basis, the

reasonableness of the assumptions and valuation

methodology applied, including comparing

assumptions to market data where available.


• Evaluating the objectivity, independence and expertise of

the external valuers.

• Evaluating the expertise of the Manager.

• With respect to significant property developments:

• Where the Group has determined the development

has reached practical completion, obtaining

evidence supporting the Group’s estimates of the

expected future rental cash flows that will apply

upon completion and the costs to complete the

development.

• Where property developments are carried at cost,

testing the cost incurred to date on a sample basis.

• Where the Group has recorded a carrying value

adjustment to property under development, we

reviewed management’s assessment of the carrying

value of the property by evaluating the assumptions

and estimates made as at 30 June 2025 (including

forecast costs to complete estimates, and leasing

considerations), as well as the independent advice

received by management.


Other information


The Board of Directors of the Manager is responsible on behalf of the Group for the other

information. The other information comprises the information in the Annual Report that

accompanies the consolidated financial statements and the audit report, and the Climate Statement.

The Climate Statement is expected to be made available to us after the date of the audit report.

Our opinion on the consolidated financial statements does not cover the other information and we

do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and consider whether it is materially inconsistent

with the consolidated financial statements or our knowledge obtained in the audit or otherwise

appears to be materially misstated. If so, we are required to report that fact. We have nothing to

report in this regard.





When we read the Climate Statement, if we conclude that there is a material misstatement therein,

we are required to communicate the matter to the Board of Directors of the Manager and consider

further appropriate actions.

Board of Directors’ responsibilities

for the consolidated financial

statements

The Board of Directors of the Manager is responsible on behalf of the Group for the preparation and

fair presentation of the consolidated financial statements in accordance with NZ IFRS and IFRS, and

for such internal control as the directors determine is necessary to enable the preparation of

consolidated financial statements that are free from material misstatement, whether due to fraud

or error.

In preparing the consolidated financial statements, the Board of Directors of the Manager is

responsible on behalf of the Group for assessing the Group’s ability to continue as a going concern,

disclosing, as applicable, matters related to going concern and using the going concern basis of

accounting unless the directors either intend to liquidate the Group or to cease operations, or have

no realistic alternative but to do so.

Auditor’s responsibilities for the

audit of the consolidated financial

statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial

statements as a whole are free from material misstatement, whether due to fraud or error, and to

issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of

assurance, but is not a guarantee that an audit conducted in accordance with ISAs and ISAs (NZ) will

always detect a material misstatement when it exists. Misstatements can arise from fraud or error

and are considered material if, individually or in the aggregate, they could reasonably be expected

to influence the economic decisions of users taken on the basis of these consolidated financial

statements.

A further description of our responsibilities for the audit of the consolidated financial statements is

located on the External Reporting Board’s website at:

https://www.xrb.govt.nz/standards/assurance-standards/auditors-responsibilities/audit-report-1-1/

This description forms part of our auditor’s report.

Restriction on use


This report is made solely to the Group’s unitholders, as a body. Our audit has been undertaken so

that we might state to the Group’s unitholders those matters we are required to state to them in an

auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept

or assume responsibility to anyone other than the Group’s unitholders as a body, for our audit work,

for this report, or for the opinions we have formed.






Andrew Boivin, Partner

for Deloitte Limited

Auckland, New Zealand

13 August 2025



114|VITAL HEALTHCARE PROPERTY TRUST
Unit Holder statistics

Analysis of unit holders as at 30 June 2025

Holding Range

Number of

Unit HoldersTotal units% of total units issued

1 - 49923943,5460.01

500 - 9999062,6340.01

1,000 - 1,999202284,9420.04

2,000 - 4,9997402,535,4070.37

5,000 - 9,9999156,469,0510.95

10,000 - 49,9991,82640,361,2595.95

50,000 - 99,99927218,200,5772.68

100,000 - 499,99914325,712,7173.79

500,000 - 999,999118,202,8711.21

1,000,000 Over28577,023,03984.99

Total4,466678,896,043100

Substantial unit holders as at 30 June 2025

Unit HoldersDate of noticeNumber of units

% of total units

issued

1

FORSYTH BARR INVESTMENT MANAGEMENT LIMITED13-May-2579,641,34711.76

ACCIDENT COMPENSATION CORPORATION30-Apr-2546,778,3096.91

NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST6-Sep-24191,708,03628.38

ANZ NEW ZEALAND INVESTMENTS LTD21-Mar-2226,304,8415.06

1On date notice filed

ANNUAL REPORT 2025|115
Twenty largest unit holders as at 30 June 2025

Unit holdersTotal% of units

NZGT SECURITY TRUSTEE LIMITED191,481,80428.20

FORSYTH BARR CUSTODIANS LIMITED <1-CUSTODY>94,542,01013.93

CUSTODIAL SERVICES LIMITED <A/C 4>50,930,7917.50

ACCIDENT COMPENSATION CORPORATION - NZCSD <ACCI40>44,127,4106.50

BNP PARIBAS NOMINEES (NZ) LIMITED - NZCSD <BPSS40>30,194,9744.45

HSBC NOMINEES (NEW ZEALAND) LIMITED - NZCSD <HKBN90>25,436,6093.75

TEA CUSTODIANS LIMITED CLIENT PROPERTY TRUST ACCOUNT - NZCSD <TEAC40>19,680,0622.90

NEW ZEALAND DEPOSITORY NOMINEE LIMITED <A/C 1 CASH ACCOUNT>16,473,0352.43

ANZ WHOLESALE TRANS-TASMAN PROPERTY SECURITIES FUND - NZCSD <PNTT90>15,807,1712.33

FNZ CUSTODIANS LIMITED11,050,8811.63

JBWERE (NZ) NOMINEES LIMITED <NZ RESIDENT A/C>9,872,0661.45

ADMINIS CUSTODIAL NOMINEES LIMITED9,626,5841.42

FORSYTH BARR CUSTODIANS LIMITED <ACCOUNT 1 E>8,060,1231.19

INVESTMENT CUSTODIAL SERVICES LIMITED <A/C C>7,502,2391.11

CITIBANK NOMINEES (NEW ZEALAND) LIMITED - NZCSD <CNOM90>7,302,7531.08

SIMPLICITY NOMINEES LIMITED - NZCSD6,045,4370.89

MFL MUTUAL FUND LIMITED - NZCSD <MFLA90>4,519,0010.67

HSBC NOMINEES (NEW ZEALAND) LIMITED A/C STATE STREET -NZCSD <HKBN45>4,073,3000.60

NZX WT NOMINEES LIMITED <CASH ACCOUNT>3,263,2450.48

PT (BOOSTER INVESTMENTS) NOMINEES LIMITED3,250,0000.48

Top 20 holders of Units563,239,49582.96

Total Remaining Holders Balance115,656,54817.04

Vital’s structure
About Vital

Vital Healthcare Property Trust (Vital, the Trust) is an NZX-

listed investment fund (NZX:VHP) that invests in high-

quality healthcare properties in New Zealand and

Australia. The Trust is externally managed by Northwest

Healthcare Properties Management Limited.

Vital's portfolio of 34 properties is valued at

~$3.2b with 67.0% (by value) located in Australia

and the balance in New Zealand. The portfolio

has over 143 tenants and over 2,100 beds.

Vital’s tenants include hospital operators and healthcare

providers who deliver a wide range of services

across the full spectrum of health services.

Further information is available at vhpt.co.nz

About the Manager

Northwest Healthcare Properties Management Limited

(NWHPM, the Manager) is an external manager that

provides management services to Vital and its Unit Holders.

The Manager’s primary responsibilities include the day-to-

day administration of Vital, portfolio management, sourcing

new opportunities and conducting due diligence on potential

acquisitions. The Manager is also responsible for providing

specialist property management, project management,

development management and leasing services to the Trust.

The Manager’s Board of five comprises three independent

directors and two Northwest appointees. Refer to page 54

for more details.

Vital’s leadership team is led by Chris Adams (Co-Head,

A/NZ Region), and draws on the skills and experience

of over 50 real estate professionals across New Zealand

and Australia with offices in Auckland, Melbourne

and Sydney. Refer to page 56 for more details.

OUR STRUCTURE – A UNIT TRUST

Vital Unit Holders

New Zealand’s largest specialist and

only listed owner of healthcare real estate

~$10.3b7

assets under

management

number of countries

Northwest

operates in

Vital’s Manager and largest Unit Holder

Management of Vital in accordance with the Trust Deed

Majority NZ based institutions and retail investors

~$3.2b portfolio healthcare

real estate in Australia and New Zealand

~28.0%

~72.0%

>240

healthcare

real estate

professionals

Vital benefits from being managed by a global

healthcare property owner and manger.

11 6

|

VITAL HEALTHCARE PROPERTY TRUST

Vital is the only
NZX listed specialist

landlord of healthcare

property and the fourth

largest NZX listed

property vehicle.

Ormiston Hospital Stage 1 Expansion, Auckland

In Australia and New

Zealand, Northwest has

a 50+ team of healthcare

property professionals.

Northwest

The Manager is a subsidiary of Toronto Stock

Exchange-listed Northwest Healthcare Properties

REIT (Northwest REIT). Northwest REIT operates

across seven countries in four continents.

Northwest REIT has ~$10.3b of assets

under management globally and over

240 real estate professionals.

ANNUAL REPORT 2025

|

11 7

GenesisCare Integrated Cancer and Health Centre, Sydney
Driving operational

performance

MANAGER

Northwest Healthcare Properties Management Limited

Level 17, HSBC Tower

188 Quay Street

Auckland 1010

Telephone: 0800 225 264 (NZ freephone);

+64 9 973 7300

Email: enquiry@vhpt.co.nz

Northwest Healthcare Properties Management – Australia

Level 45, Rialto South Tower

525 Collins Street

Melbourne 3000

Sydney Office

Northwest Healthcare Properties REIT

Level 2, 285 George Street

Sydney, NSW 2000, Australia


BOARD AND OFFICERS OF THE MANAGER

Graham Stuart – Independent Chair

Mike Brady - Non-Independent Director

Angela Bull – Independent Director

Craig Mitchell – Non-Executive Director (resigned 12 August 2025)

Dr Michael Stanford – Independent Director

Zachary Vaughan - Non-Independent Director (appointed 12 August 2025)

Chris Adams - Co-Head, A/NZ Region

Michael Groth – Chief Financial Officer

Vanessa Flax – Regional General Counsel and Company Secretary

Directory

11 8

|

VITAL HEALTHCARE PROPERTY TRUST

AUDITOR
Deloitte Limited

Deloitte Centre

1 Queen Street

Auckland 1010

Private Bag 115-033

Auckland 1140

Telephone: +64 9 303 0700

Facsimile: +64 9 303 0701


LEGAL ADVISERS TO THE

TRUST AND THE MANAGER

Bell Gully

Deloitte Centre

Level 14, 1 Queen Street

PO Box 4199

Auckland 1140

Telephone: +64 9 916 8800

Facsimile: +64 9 916 8801

Ashurst Australia

Level 16, 80 Collins Street

South Tower,

GPO Box 4958

Melbourne, Victoria 3001

Telephone: +61 3 9679 3000

SUPERVISOR

Trustees Executors Limited

Level 9, Spark Central

42-52 Willis Street

Wellington 6011

PO Box 4197

Auckland 1140

Telephone: +64 9 308 7100

BANKERS TO THE TRUST

ANZ Bank New Zealand Limited

ANZ Centre

23–29 Albert Street

Auckland 1010

Australia and New Zealand

Banking Group Limited

ANZ Centre Melbourne, Level 9

833 Collins Street, Docklands

Victoria 3008, Australia

Bank of New Zealand

80 Queen Street

Auckland 1010

Westpac Banking Corporation

Westpac Place

275 Kent St

Sydney NSW 2000

Australia

The Hongkong and Shanghai

Banking Corporation Limited

International Towers

100 Barangaroo Avenue

Sydney NSW 2000

Australia

The Hongkong and Shanghai

Banking Corporation, incorporated

in the Hong Kong SAR, acting

through its New Zealand Branch

HSBC Tower

188 Quay Street

Auckland 1010

New Zealand

Industrial and Commercial Bank

of China Limited – Australia

International Towers

100 Barangaroo Avenue

Sydney NSW 2000

Australia

Industrial and Commercial Bank of

China Limited – New Zealand

2 Queen Street

Auckland CBD

Auckland 1010

New Zealand

Credit Agricole CIB Australia Limited

Aurora Place

88 Phillip Street

Sydney NSW 2000

Australia

Bank of China Limited

140 Sussex Street

Sydney NSW 2000

Australia

Commonwealth Bank of Australia Limited

Tower One, Collins Square

727 Collins Street

Docklands VIC 3008

Australia

UNIT REGISTRAR

Computershare Investor Services Limited

159 Hustmere Road

Takapuna, Auckland 0622

Private Bag 92119

Auckland 1142

New Zealand

vital@computershare.co.nz

Telephone: +64 9 488 8777

Facsimile: +64 9 488 8787

This document is printed on an environmentally responsible

paper, produced using Elemental Chlorine Free (ECF),

FSC(R) certified, Mixed Source pulp from Responsible

Sources, and manufactured under the strict ISO14001

Environmental Management System.

ANNUAL REPORT 2025

|

11 9

DISCLAIMER:
This document has been prepared by Northwest Healthcare Properties Management

Limited (the Manager) as manager of the Vital Healthcare Property Trust (the Trust).

This document provides general information only and is not intended as investment,

legal, tax, financial product or financial advice or recommendation to any per-

son and must not be relied on as such. You should obtain independent professional

advice prior to making any decision relating to your investment or financial needs.

All references to $ are to New Zealand dollars unless otherwise indicated.

This document may contain forward-looking statements. Forward-looking statements

can include words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar

words in connection with discussions of future operating or financial performance or

conditions. Any indications of, or guidance or outlook on, future earnings or financial

position or performance and future distributions are also forward-looking statements. The

forward-looking statements are based on management’s and directors’ current expectations

and assumptions regarding the Trust’s business, assets and performance and other future

conditions, circumstances and results. As with any projection or forecast, forward-looking

statements are inherently susceptible to uncertainty and to any changes in circumstanc-

es. The Trust’s actual results may vary materially from those expressed or implied in the

forward-looking statements. The Manager, the Trust, and its or their directors, employees

and/or shareholders have no liability whatsoever to any person for any loss arising from

this document or any information supplied in connection with it. The Manager and the

Trust are under no obligation to update this document or the information contained in it

after it has been released. Past performance is no indication of future performance.

The information in this document is of general background and does not purport to

be complete. It should be read in conjunction with Vital’s market announcements

lodged with NZX, which are available at www.nzx.com/companies/VHP.

---

FY25 Annual
Results

Presentation

Driving operational performance

13 AUGUST 2025

Contents
Presenters

Richard Roos

CO-HEAD,

ANZ REGION

Michael Groth

CHIEF FINANCIAL

OFFICER

Chris Adams

CO-HEAD,

ANZ REGION

Investing in Healthcare Property

across Australia and New Zealand 3

FY25 Highlights 6

Financial Results and Capital Management 11

Property and Sector Update 17

Development Activity 21

Outlook 26

Appendices 28

All amounts are in NZD unless otherwise shown

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

2

Investing in Healthcare Property across Australia and New Zealand
*Excludes strategic land held for development

1

Inclusive of landlord options

2

On a constant currency basis

VITAL IS THE ONLY SPECIALIST HEALTHCARE LANDLORD LISTED ON THE NZX

Active property management with both occupancy and

WALE enhanced

Two value enhancing developments delivered

$11.5m accretive capacity expansion at Wakefield initiated

$1.1b debt refinance secured on improved terms and flexibility

DELIVERING ON STRATEGY

~$2 .1b

20* PROPERTIES;

5.5% WACR

~$1.1b

14* PROPERTIES;

5.6% WACR

Further enhanced over the past two years through

non-core asset sales

Predominantly located in health precincts

Diversified by geography and tenants

HIGH-QUALITY PORTFOLIO

Strategic land holdings and brownfield expansions potential

over time

Unmatched healthcare property development team

EMBEDDED VALUE

Hospital operator profitability improvements emerging

Attractive tenant demand dynamic and sector fundamentals

MEDIUM-TERM OUTLOOK

~$3.2b

34* PROPERTIES;

5.5% WACR

3.7%

LIKE-FOR-LIKE, NET

PROPERTY INCOME

GROWTH

2

18. 5 years

WALE

1

AustraliaNew Zealand

NZ 9.75cpu

DISTRIBUTION PAID IN FY25 AND

GUIDANCE MAINTAINED FOR FY26

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

3

Why healthcare real estate?
Vital focuses on the cure parts of the healthcare

real estate spectrum; a defensive asset class that

provides attractive risk-adjusted returns, driven

by an ageing and growing population

Shift to

ambulatory care

Increasing number

of procedures being

performed outside

of hospitals

Sustained

population

migration

Shift of population creating

outsized need for medical

facilities in local markets

Growing need

for health and life

sciences space

Health and life science

growing rapidly, driven

by increased funding and

emerging technologies

Growing demand

for healthcare

Ageing population and

growth (including chronic

disease) supported by

recent and proposed

government policy /

funding

Transition towards

healthcare

precincts

Demand for precincts

that combine educational

and clinical facilities with

other amenities

Increased

M&A activity

Consolidation and

transaction activity

increasing number of

sophisticated players

at scale

Ormiston Hospital Stage 1 Expansion, Auckland

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

4

Sector tailwinds
underpinned by robust

consumer demand

Embedded value in

strategic land for shovel

ready developments

Defensive, diversified

and long duration

cash flows

7.3% gross yield

1

High-quality portfolio

Majority independent

board and experienced

management team

Unit Price trading at

a 19.8% discount to

NTA of $2.47 per unit

Why invest in Vital?

1

3

5

7

2

4

6

RDX, Gold Coast (Artist's Impression)

1

Based on 12 August closing price of $1.98 per unit assuming NZ domiciled investor with a 33% tax rate.

Cash yield before tax benefit is ~4.9%.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

5

FY25
Highlights

Wakefield Hospital Stage 2, Wellington (Development now completed)

Ormiston Hospital Stage 1 Expansion, Auckland
FY25 Highlights

1

On a constant currency basis

$49. 7m

realised from FY25 asset

sales at a 7.0% discount

to book value

18 . 5 years

WALE versus 18.1 years in

FY20 despite passage of time

3.7%

increase in like-for-like

net property income

1

1s t

place globally in GRESB

for listed healthcare in

developments

completed developments

for total cost of $108.8m

2

DPU maintained, 93.6%

AFFO payout ratio

9. 75c pu

3.8

years

weighted average debt

duration – no maturity

before March 2027

98.6%

Occupancy,

up 0.6% versus FY24

OPERATIONAL PERFORMANCE FOCUS DELIVERED STRONG LEASING OUTCOMES,

COMPLETION OF HIGH-QUALITY DEVELOPMENTS AND AN ENHANCED BALANCE SHEET

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

7

98.6%
OCCUPANCY

Portfolio further strengthened

Over 51,000sqm of space were leased, extended or renewed during FY25, including over 9,400sqm of

new leasing. Represents 22% of Vital’s total income and 20% of the portfolio's lettable area.

The strong leasing success and early extensions increased Vital's WALE to 18.5 years, up from 18.3 years

at 30 June 2024.

Leasing momentum continuing in FY26 across vacancies at 68 Saint Asaph Street, Ascot and Ascot Central,

Playford Health Hub and 120 Thames Street to further increase Vital's occupancy post balance date.

Vital's income security continues to be enhanced by early lease renewals with no material lease expiries

scheduled for the next 18 months.

BUILDING A RESILIENT PORTFOLIO

Leasing highlights

18.5 years

WALE

51,000 sqm

NEW LEASING & EXTENSIONS

Playford Health Hub, Adelaide

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

8

2025
Sustainability achievements

MBA NSW 2024 AWARDS - EXCELLENCE IN SUSTAINABILITY

– COMMERCIAL CATEGORY | MACARTHUR HEALTH PRECINCT

STAGE 1 (GENESISCARE, CAMPBELLTOWN)

DEVELOPMENT EXCELLENCE AWARDS 2025 – WINNER – HIGHLY

COMMENDED HEALTH SOCIAL INFRASTRUCTURE | MACARTHUR

HEALTH PRECINCT STAGE 1 (GENESISCARE, CAMPBELLTOWN)

CIVIC, HEALTH AND ARTS PROPERTY AWARD

ORMISTON HOSPITAL - STAGE 1 EXPANSION

2025 NEW ZEALAND COMMERCIAL PROJECT AWARDS –

GOLD | ORMISTON HOSPITAL – STAGE 1 EXPANSION

GOLD AWARD FOR VITAL’S ANNUAL REPORT

GRESB SECTOR LEADER IN DEVELOPMENTS

FOR LISTED HEALTHCARE GLOBALLY

Vital achieved sector leader status (first place) for listed

healthcare globally in developments by GRESB

1

. In

addition, Vital was ranked second place across healthcare

listed entities globally. These results and awards below

are a reflection of our commitment to sustainability and

responsible investment practices.

Sustainability performance is a key driver in:

seeking to advance the long-term resilience and value of our property

portfolio by future-proofing against regulatory and climate-related risks

seeking to enhance Unit Holder returns by lowering borrowing costs

and improving access to capital markets

Playford Health Hub, Adelaide

1

The Global Real Estate Sustainability Benchmark (GRESB) is an international and independent standards organisation which reviews over 2,200 entities in 80 markets representing over US$7.0 trillion in investments.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

9

GenesisCare Integrated Cancer
and Health Centre, Sydney

RDX, Queensland -

6 Star Green Star Design

certification achieved

Endoscopy Auckland -

Targeting 5 Star

Green Star

Playford Health Hub, Adelaide

Two 6 Star Green Star 'Design & As Built' developments completed

in FY24 achieved 6 Star Green Star certification in FY25

Sustainability

17 %

BETTER ENERGY

PERFORMANCE

13%

BETTER WATER

PERFORMANCE

45%

LOWER EMBODIED

EMISSIONS

10 0%

ENERGY FROM

RENE WABLE SOURCES

34%

BETTER ENERGY

PERFORMANCE

25%

BETTER WATER

PERFORMANCE

32%

LOWER EMBODIED

EMISSIONS

10 0%

ENERGY FROM

RENE WABLE SOURCES

Artist's impression

RDX, Gold Coast (Artist's Impression)

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

10

Financial Results
and Capital

Management

Ormiston Hospital Stage 1 Expansion, Auckland

Financial performance
INCREASED OPERATING PROFIT BEFORE TAX

ACTUAL

FY25

ACTUAL

FY24

(%)

CHANGE

Net property income148,83414 4 , 533 3.0%

Corporate expenses(5,854) (5,798)(1. 0 %)

Management fees( 1 7, 6 5 2 )(24,684)28.5%

Realised transaction gains / (losses)151 479 (68.4%)

Strategic transaction costs(2,872)--

Net finance expenses(45,169)(40,606)(11 . 2 % )

Operating profit before tax and other income77,43873,924 4.8%

Property revaluations and other losses(12 5 , 231)(182,127)31. 2 %

Profit (loss) before income tax( 4 7, 7 9 3 )(108, 203)55.8%

Adjusted funds from operations (AFFO)70,36972,899 (3.5%)

Adjusted funds from operations (cpu)10. 4110.90 (4.5%)

Distributions per unit (cpu)9. 75 9. 75 -

All values shown as $000

Average NZD/AUD exchange rate in the period0 .91210.9249

3.7%

LIKE-FOR-LIKE NET PROPERTY

INCOME GROWTH

10.41cpu

AFFO

9.75cpu

DPU

Net property income up 3.0%

Rent reviews and development rent

partially offset by impact of asset disposals

Higher interest expense as

developments complete

Management fees down substantially

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

12

144.5
9.6

4.9(11.0)

(0.5)

1.4148.8

100

105

110

115

120

125

130

135

140

145

150

155

160

FY24Development

income

Rent reviews and

leasing activity

Disposals

(1)

Amortisation

and other

(2)

Foreign

exchange

FY25

Net property income

RENT REVIEWS AND DEVELOPMENTS UNDERPIN 3.0% NET PROPERTY INCOME GROWTH

NET PROPERTY INCOME DRIVERS

($M)

1

Disposals of non-core assets; Epworth Brighton (VIC), Alverna Grove (VIC), Hurstville Houses (NSW) and Hirondelle Private (NSW)

2

Amortisation, non-recurring R&M and abatements

~82.5% of Vital's leases (by income)

are CPI linked

Positive leasing momentum and results achieved:

+$9.6m additional development income

+$4.9m income from rent reviews and increased occupancy

Partially offset by current and prior year property disposals

+3.0%

NET PROPERTY INCOME (NPI)

+3.7%

LIKE-FOR-LIKE NPI

+0.6%

OCCUPANCY IMPROVEMENT TO 98.6%

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

13

Balance sheet
1

Including property held for sale

2

Calculated in accordance with Vital's Trust Deed

STRONG BALANCE SHEET AND CAPITAL POSITION

30 J U N E

2025

30 J U N E

2024

(%)

CHANGE

Investment properties

1

3,211,8603,239,973 (0.9 %)

Other assets36,23264,786 (4 4 .1%)

Bank debt1,368, 4 491,292,653 5.5%

Other liabilities2 0 0 ,12820 6,979 (3.3%)

Debt to gross assets

2

42.1%3 9.1 %3.0%

Unit Holder funds1, 679, 5151,805,126 ( 7. 0 % )

Units on issue (000s)678,896671,923 1.0%

Net tangible assets ($/unit)2.472.69 (7.9%)

All values shown as $000s

Period end NZD/AUD exchange rate0.92750 .9131

5.54%

WEIGHTED AVERAGE

PORTFOLIO CAP RATE

$2.47

NET TANGIBLE ASSETS

PER UNIT

DOWN 22 CENTS TOSOFTENED BY 23BPS TO

$6.2m

NEW EQUITY RAISED

VIA DRP

Strong balance sheet:

Property values stabilising

$133m investment in developments

and value-adding capex

Proceeds from asset sales, debt liquidity

and DRP funded development spend

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

14

Capital management
MAJOR DEBT REFINANCE COMPLETED – IMPROVED TERMS AND DURATION

1

Trust Deed debt ratio is based on total borrowings to gross asset value of the Trust

2

Bank LVR is based on total indebtedness to secured property value as determined by external valuers

DEBT MATURITY PROFILE – 30 JUNE 2025 (A$M)

BANK FACILITIES30 JUNE 202530 JUNE 2024

Debt to gross assets (Trust Deed)

1

42.1%39.1%

Bank loan to value ratio – actual

2

43.6%40.4%

Bank loan to value ratio – covenant55.0%55.0%

Weighted average duration to maturity3.8 yrs3.5 yrs

Undrawn facility limit (A$)$56.8m$14 4 . 0 m

FY25 proactive capital management focus:

$1.1b debt facilities refinanced

Strong banking partner support and appetite

Improved terms, multi-currency flexibility and pricing

No debt maturing until March 2027

Headroom sufficient to cover committed development spend

42.1%

GEARING – TRUST DEED

3.0x

INTEREST COVER

3.8 years~$728m

WEIGHTED AVERAGE

DEBT MATURITY

TOTAL DEBT ABLE TO BE DRAWN

IN MULTI-CURRENCY

ANZBOCBNZCA CIBCBAHSBCICBCWBC

$0

$50

$100

$150

$200

$250

$300

$350

$400

$450

$500

FY32FY31FY26FY27FY28FY29FY30

Defensive, diversified and long-dated cash flows, together with

disciplined capital management support current gearing levels.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

15

FY25
3.32%

3.55%

3.57%

3.56%

3.68%

FY26FY27FY28FY29

Contracted hedging based on drawn debtAdditional potential hedging exercisable at counterparty election

82%

Hedged

72%

Hedged

42%

Hedged

19%

Hedged

4%

Hedged

Interest rate hedging

1

INTEREST RATE RISK EXPOSURE SUBSTANTIALLY MITIGATED

1

Excluding borrowing margins and costs

Interest rate risk management milestones:

$684m interest rate hedging completed

Interest rate risk protection increased

and duration extended

82% at 3.32%

HEDGED AT 30 JUNE 2025

72% at 3.55%

HEDGED AT 30 JUNE 2026

3.2 years

WEIGHTED AVERAGE INTEREST RATE HEDGE DURATION

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

16

Property and
Sector Update

Ormiston Hospital Stage 1 Expansion, Auckland

Market dynamics
MEDIUM-TERM PROSPECTS FOR PRIVATE HEALTHCARE IN THE INTEGRATED AUSTRALIAN AND NEW ZEALAND HEALTHCARE SECTORS

REMAIN STRONG

Maitland Private Hospital, Maitland

Focal areas for operators

Prioritising activities which support margin growth

and improve operating efficiency

Continued focus on efficiency, case mix

management and technology investment

Focus on maximising use of existing assets

and select brownfield capacity expansions to

drive operating performance

Increased focus on advocacy and engagement

with policy makers, prioritising actions which improve

the long-term sustainability of private healthcare

What this means for Vital

High-quality, well-located assets will

continue to perform

High barriers to entry; replacement costs

well in excess of Vital's portfolio value and

other barriers protect existing investments

Performance of Australian operators is

improving, following a period in which

cost inflation outpaced revenue growth

Performance of Vital’s operators continue to improve, demonstrated through improving Rent/EBITDAR (51% vs 57% pcp

1

)

NZ operators continue to trade strongly,

with potential to support Te Whatu Ora

health targets

1

Last twelve months performance to 31 March 2025

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

18

30%
3%

Portfolio overview

AUSTRALASIA'S HIGHEST QUALITY INVESTABLE HEALTHCARE PORTFOLIO

$3.2B PORTFOLIO DIVERSIFIED

ACROSS AUSTRALIA AND NZ

(BY VALUE)

DIVERSIFIED TENANT AND INCOME BASE

% OF RENT

FY26 income growth underpinned by CPI linked (~61%), market linked (~26%) and fixed (13%) rent reviews

with no exposure to Healthscope

occupancy

98.6%

NPI growth (like-for-like,

constant currency basis)

3.7%

WACR

(5.5% AUS; 5.6% NZ)

5.5%

of rental increases

linked to CPI

82.5%

hospitals

78%

ambulatory care

18%

life sciences

4%

Epworth HealthCare 13. 7%

Allevia 3.0%

Evolution Healthcare 13.9%

Healthe Care 16 . 4%

Southern Cross 4.2%

GenesisCare 2.3%

Burnside 3.0%

Boulcott Hospital 1.7%

Endoscopy Auckland

1

1. 5%

Other 21.9 %

Aurora Healthcare 18. 4%

WA

NT

SA

NSW

TAS

VIC

QLD

4%

8%

22%

12 %

21 %

NORTH

ISLAND

SOUTH

ISLAND

1

Joint venture between Evolution Healthcare and AlleviaVITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

19

FY35FY26FY27FY28FY29FY30FY31FY32FY33FY34
Total expiry

Largest single rent expiring10 Year average

0.0%

2.5%

5.0%

7.5%

Lease expiry profile

LOW-RISK EXPIRY PROFILE SUPPORTS SUSTAINABLE, PREDICTABLE AND DEFENSIVE CASH FLOWS

10-year average annual lease

expiry of only 1.7%

(as % of total portfolio income)

Vital's market-leading WALE increased to 18.5 years, up from 18.3

years in FY24 after a year passing, reflecting asset management

initiatives, the strength of Vital's portfolio and tenant demand

Lease expiries over the next three years are below the

10-year average, with no major single tenant exposure

Renewal confidence supported by historical renewal rates

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

20

Development
Activity

GenesisCare Integrated Cancer and Health Centre, Sydney

$108.8m of developments completed in FY25
Run-off of existing committed development

program with $36.9m left to be spent

$11.5m Wakefield Hospital Level 5 capacity

expansion initiated

~$530.0m of projects completed in the last

five years enhancing the quality and resilience of

Vital's portfolio

Development update

Maitland Private Hospital, Maitland

Development activity is focused on new high-

quality facilities, capacity expansion and portfolio

renewal to support operators and drive future Unit

Holder earnings and value growth

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

22

Wakefield Hospital - Stage 2
COMPLETED DEVELOPMENTS


Staged redevelopment of Wellington's largest private hospital


$49.9m Stage 1 completed in 2021, $91.5m Stage 2 acute

services building operational from January 2025


100% leased to Evolution Healthcare


Seismically resilient facility with base isolators and services

movement joints


State-of-the-art operating theatres and catheterisation

laboratories


Hospital operations, including surgery, continued throughout

this major transformation


Early activation of built space with commencement of

$11.5m capacity expansion project on Level 5

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

23

Maitland Private Hospital
COMPLETED DEVELOPMENTS

A$16.0m mental health and oncology expansion

completed in September 2024

100% leased to Healthe Care

Stage 1 included a new level constructed above

the existing mental health ward supporting an

increase in the mental health service capacity by

24 beds, including high-quality consulting suites,

communal areas, group rooms and gymnasium

Stage 2 relocated the day oncology unit,

providing an increase of 5 chairs to 12, added an

additional 67 car parks and improvements to the

hospital entry

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

24

COMMITTED DEVELOPMENTS
Boulcott Hospital - Refurbishment and Expansion

A$134 . 2m$36. 7m

$32.2m$11. 5 m~6.0%

~5.6%~5.5%

~5.4%~ 7. 0 %Mid-25

Early-26Mid-26

Mid-late-25Late-25

RDX

Endoscopy AucklandWakefield Hospital – Level 5 Expansion

Grace Hospital - Expansion

$24.8m

estimated

development cost

estimated

development cost

estimated

development cost

estimated

development cost

estimated

development cost

yield on cost

forecast yield on

cost (blended)

yield on cost

yield on costyield on cost

(blended)

forecast

completion

forecast completion

(delayed from Mid-25)

forecast

completion

forecast

completion

forecast

completion

Strategically focused on precincts and

growing ambulatory care exposure

All developments are 100% pre-leased

with the exception of RDX which is

subject to a 57% 12-month net property

income guarantee from practical

completion. Signed Agreements for

Lease and Heads of Terms are currently

below this level at 30 June 2025.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

25

Outlook
Kapa Haka Group from South Wellington Intermediate

School performing during the Wakefield Hospital

Stage 2 redevelopment official opening

Whāia te iti kahurangi ki te tūohu koe me

he maunga teitei.

Seek the treasure you value most dearly.

If you bow your head, let it be to a lofty

mountain.

Whakataukī

Māori proverb

Outlook and guidance
A FOCUS ON FUNDAMENTALS TO DRIVE OPERATIONAL PERFORMANCE AND UNIT HOLDER VALUE

Sector tailwinds

Development upside from

shovel ready projects and

brownfield expansions

AFFO and distribution

growth

Medium term

Core of everything we do

Positive long-term commercial

and community outcome focus

Sustainability

Vital is a 'best in class' investment platform.

9.75cpu distribution guidance

Continued enhancement and

optimisation of portfolio

Disciplined capital

deployment aligned with

long-term value creation

FY26 focus

Playford Health Hub, Adelaide

An attractive risk-adjusted

income return, opportunities to

leverage embedded portfolio

value and underlying demand

for health services offer long-

term Unit Holder value.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

27

Appendices
Board and Management

Maitland Private Hospital, Maitland

Experienced management team
Grace Hospital, Tauranga

Alex Belcastro

SENIOR VICE PRESIDENT

- DEVELOPMENTS AND

PRECINCTS

Kirsty Bowyer

VICE PRESIDENT -

DEVELOPMENT

Chris Adams jointly leads the Northwest business in Australia

and New Zealand, and manages Northwest’s NZX-listed

Vital Healthcare Property Trust, which he has been part of the

leadership team since 2017.

He has extensive experience in the property industry in

Australia, New Zealand and the United Kingdom, including

over 25 years’ direct experience in health property.

Chris was one of the founding Executives at ASX-listed

Generation Healthcare REIT which was acquired by Northwest

in 2017. Prior to that he established Vital Healthcare Property

Trust’s presence in Australia in 1999 following various roles

with the group in New Zealand.

Chris holds a Bachelor of Property from the University

of Auckland.

Alex Belcastro, formerly the Chief Business Development Officer

at Ramsay Health Care managing a multi-billion-dollar hospital

asset portfolio, joined our team in 2021.

Alex leads precinct transactions, leasing and developments.

She also provides strategic leadership to the development and

leasing divisions and heads our Strategy and Research function.

With over 18 years of specialised experience in social

infrastructure, she has facilitated large-scale transactions and

developments across public and private sectors.

Her diverse background spans advisory, operational, and

ownership roles, adding valuable real estate expertise to

our platform.

Holding a Master of Construction Management and a Bachelor

of Planning and Design from the University of Melbourne, Alex

has also honed her skills through executive education at Harvard

Business School.

Kirsty Bowyer joined the team in New Zealand in 2023 and is

responsible for overseeing the planning, design and construction of

Vital’s development projects across New Zealand. With more than 15

years of experience in the construction and property industry including

major healthcare infrastructure projects, Kirsty brings a deep and

practical understanding of the complexities of healthcare development,

combining technical expertise with strategic leadership.

Before joining Northwest, Kirsty spent 13 years at Johnstaff, one of

Australia’s leading property and construction consultancies. During her

time there, she held various senior roles, leading the end to end delivery

of capital works programmes across both Australia and New Zealand.

Over the course of her career, Kirsty has delivered more than

$2.5 billion worth of healthcare real estate. Her leadership is

characterised by a strong commitment to clinical user engagement,

operational efficiency and design excellence.

Kirsty is also a committee member of the New Zealand Health

Design Council, where she contributes to national discourse on health

infrastructure innovation.

Chris Adams

CO-HEAD, A/NZ REGION

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

29

Experienced management team
Michael Groth

CHIEF FINANCIAL OFFICER

Richard Roos

CO-HEAD, A/NZ REGION

Michael Groth has over 18 years’ experience as a senior

finance executive in the listed and unlisted property funds and

funds management industry. Prior to joining the team in 2019,

Michael’s most recent position was as Group Chief Financial

Officer of the Melbourne based and ASX-listed real estate

fund manager, APN Property Group Limited.

Michael has extensive experience in financial management

and reporting, taxation, treasury and capital management,

corporate structuring, acquisitions, disposals and equity

raisings in the listed and unlisted property and funds

management industry.

Michael holds a Bachelor of Commerce and Bachelor of

Science and has been a member of the Chartered Accountants

Australia and New Zealand since 2000.

Richard Roos jointly leads the Northwest business in Australia

and New Zealand. He has over 25 years’ experience in

commercial real estate financing, acquisitions and property

management, of which the last 17 years have been in healthcare

real estate in senior roles for Northwest in Canada and Australia.

Richard is responsible for asset management, transactions,

people and culture, and ESG. He is also focused on building

and expanding strong relationships with Northwest’s

operator partners.

Playford Health Hub, Adelaide

Vanessa Flax

VICE PRESIDENT, REGIONAL

GENERAL COUNSEL

AND COMPANY SECRETARY

Vanessa Flax joined the team in 2019, prior to which she was a

special counsel at Ashurst Australia.

Vanessa has 25 years of deep and broad ranging property

law experience in Australia and New Zealand, including acting

as primary legal adviser (for approximately 15 years) for Vital

and Northwest.

Vanessa’s legal experience covers all aspects of real estate

property transactions, including acquisitions, divestments and

sales, leasing and Crown leasing, development transactions and

due diligence.

Vanessa has a Bachelor of Arts and Bachelor of Laws from the

University of Witwatersrand, South Africa.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

30

Majority independent board
Graham Stuart

INDEPENDENT CHAIR AND

MEMBER OF THE AUDIT

COMMITTEE

Mike Brady

NON-INDEPENDENT

DIRECTOR

Angela Bull

INDEPENDENT DIRECTOR

AND MEMBER OF THE AUDIT

COMMITTEE

Graham Stuart is an experienced corporate director with

an established track record of performance in governance

and in prior executive roles. He is currently a Director of

Ravensdown Limited and Director of Dairy Goat Co-operative

(N.Z.) Limited.

He was previously the CEO of Sealord Group from 2007 to

2014 and Director, Strategy and Growth and CFO of Fonterra

Co-operative Group from 2001 to 2007, Independent Chair

of EROAD Limited and an Independent Director and Chair of

the Audit Committee at Tower Limited.

Graham is a Fellow of Chartered Accountants Australia &

New Zealand (CAANZ) and has a Master of Science degree

from Massachusetts Institute of Technology and a Bachelor of

Commerce with first class honours from the University of Otago.

Mike Brady was appointed global President of Northwest

Healthcare Properties REIT (TSX: NWH.UN) in 2023 after

serving as global Executive Vice President, General Counsel and

Board Secretary since joining the REIT in 2006. He has extensive

experience in real estate investments and finance, transaction

management, global leadership, governance and legal matters.

Mike has played a significant commercial and legal role in the

strategic direction and growth of the REIT, most recently leading

the team to complete a €2 billion pan-European joint venture

fund, a $435 million UK hospital portfolio, and a $2 billion joint

venture fund and acquisition of a $1.25 billion hospital portfolio

in Australia.

Prior to joining the corporate real estate world, Mike was a

corporate law partner at two Toronto-based law firms, where

he developed his real estate practice. He has a Bachelor of Arts

(Economics) and a joint LL.B./Masters of Business Administration

from Dalhousie University, Halifax.

Angela Bull is an independent director of Channel Infrastructure

Ltd (NZX: CHI), Property For Industry Limited (NZX:PFI),

Foodstuffs South Island Ltd and Foodstuffs NZ Ltd. She is also

on the Trust Board of St Cuthbert’s College and an independent

director of Bayleys Corporation Board (NZ) and recently joined

the Board of Fulton Hogan as an independent director.

Angela is a former Chief Executive of Tramco Group, a large

New Zealand owned property investment company which

specialises in large scale land holdings, notably the Viaduct

Harbour precinct in Auckland and Wairakei Estate in the

Waikato; a former Board member of the Property Council of

New Zealand; and a former independent director of the Real

Estate Institute of New Zealand and realestate.co.nz.

She holds a Bachelor of Laws and a Bachelor of Arts (Political

Science) and practised property and environmental law prior

to her executive career. Previously, Angela held a number of

senior positions over a 10-year period with Foodstuffs Auckland

and Foodstuffs North Island Ltd, most recently being General

Manager Property Development for Foodstuffs North Island.

RDX, Gold Coast (Artist's Impression)

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

31

Majority independent board
Craig Mitchell

NON-EXECUTIVE DIRECTOR AND

MEMBER OF THE AUDIT COMMITTEE

(ZACHARY VAUGHAN REPLACED CRAIG MITCHELL ON THE

BOARD EFFECTIVE 12 AUGUST 2025)

Zachary Vaughan

NON-INDEPENDENT DIRECTOR

(APPOINTED 12 AUGUST 2025)

Dr Michael Stanford AM

INDEPENDENT DIRECTOR AND CHAIR

OF THE AUDIT COMMITTEE

Craig Mitchell is a professional manager with an inclusive

leadership style, Craig has more than 20 years of experience

specialising in the property industry. His previous roles include

Northwest CEO (ceased 30 June 2025) and Executive Director

and Chief Operating Officer of Dexus, an ASX top 50 listed REIT.

Craig has a Master of Business Administration (Executive) from

the Australian Graduate School of Management, a Bachelor

of Commerce and a Fellow of CPA Australia. He has also

completed the Advanced Management Program at Harvard

University, Boston.

Zachary Vaughan was appointed Chief Executive Officer of

Northwest Healthcare Properties REIT in July 2025. He brings

over 20 years of experience in real estate investment and asset

management, with a strong track record of leadership across

global markets.

Prior to joining Northwest, Zachary served as Global Head

and Chief Investment Officer of Real Estate at Arrow Global,

where he led the firm’s real estate strategy. He remains a Non-

Executive Director at Arrow. Before Arrow, he held several senior

roles at Brookfield Asset Management, including Managing

Partner and Head of European Real Estate, Head of Multifamily

Investments, and CEO of Brookfield REIT.

Earlier in his career, Zachary was a Director in the Real Estate

Investment team at the Canada Pension Plan Investment Board

(CPPIB), and Director of Acquisitions at International Property

Corporation/Reichmann International.

Zachary holds an Honours Bachelor of Economics from

Western University. He is now based in Toronto, where he leads

Northwest’s global healthcare real estate platform spanning

North America, Brazil, Europe, and Australasia.

Zachary was appointed as a Non-Independent Director to the

board of the Manager on 12 August 2025.

RDX, Gold Coast (Artist's Impression)

Dr Michael Stanford has more than 30 years’ experience in the health sector in

either Group CEO or Board roles. Michael’s current Board roles include Chair

of Nexus Hospitals, a leading provider of specialist day and short stay private

hospital based care; and Board member of the Royal Australian College

of General Practitioners as well as Board member of Healius (ASX:HLS).

Other Board roles in the last three years have included Australian Clinical

Labs (ASX: ACL), Australia’s third largest private pathology provider; Nucleus

Networks, one of the world’s largest Phase one clinical research organisations;

Virtus Health (ASX: VRT), one of the world’s top five providers of Assisted

Reproductive Services; as Chair of disability, aged, employment and training

services provider GenU; and as President and Board Chair of Diabetes

Australia, a significant Not-for-Profit organisation.

Michael was the Group CEO of St John of God Healthcare, Australasia’s third

largest private hospital provider, for 16 years during which time the company

increased revenue fivefold through organic and M&A growth plus more

than A$1 billion greenfield and brownfield developments. Michael’s other

Managing Director roles included the ASX listed Australian Hospital Care

and two public hospital networks in Victoria. Michael holds an MBA from

Macquarie University and Bachelor of Medicine and Bachelor of Surgery

from UNSW. He is a Fellow of the Australian Institute of Company Directors.

In 2018 Michael was awarded a Member of the Order of Australia for

significant service to the health sector through executive roles, to tertiary

education and the WA community, in 2010 he received the WA Citizen of the

Year Award – Industry and Commerce category.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

32

Appendices
Additional financial information

Playford Health Hub, Adelaide

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

33

Adjusted funds from operations (AFFO)
DISTRIBUTIONS CASH COVERED

FY2025FY2024(%) CHANGE

Operating profit before tax and other income7 7, 4 3 8 73,924 4.8%

Add/(deduct):

Current tax expense(15, 5 4 6)(19,0 4 6) 18. 4%

Incentive fee- 6,600 (10 0 . 0 %)

Strategic transaction costs 2,848-10 0.0%

Realised and unrealised fx on borrowings (net of tax)(59)(48) (22.9%)

Amortisation of borrowing costs2,094 2,009 4.2%

Amortisation of leasing costs and tenant inducements3,604 3,423 5.3%

Current tax expense on interest rate swap restructure and asset disposals1, 214 6,536 (81. 4 %)

IFRS 16 operating lease accounting(117 )(157 ) 25.5%

Funds from operations (FFO)71,477 73,241 (2.4%)

Add/(deduct): -

Actual repairs and maintenance from continuing operations(1,10 8) (342) (224.0%)

Adjusted funds from operations (AFFO)70,369 72,899 (3.5%)

AFFO (cpu)10. 41c 10.90c(4.5%)

Distribution per unit (cpu)9. 75c9. 75c -

AFFO payout ratio93.6%89. 4%

All values shown in $000's

Units on issue (weighted average, 000s)675,89 96 68, 753

+4.8%

OPERATING PROFIT BEFORE TAX

93.6%

AFFO PAYOUT RATIO

10.41cpu

AFFO

Higher interest and tax expense, and

reduced income from asset disposals only

partially offset by income growth and from

completed developments:

1.1% increase in weighted average units

Repairs and maintenance spend up $0.8m

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

34

Net tangible assets (NTA)
NTA PER UNIT BRIDGE (FY25)

NTA PER UNIT IMPACTED PRIMARILY BY UNREALISED PROPERTY REVALUATION LOSSES

$2.69

($0.13)

($0.02)

$2.0

$2.2

$2.4

$2.6

$2.8

$2.1

$2.3

$2.5

$2.7

$2.9

$3.0

FY24Property

revaluations

Currency

translation

$2.47

($0.01)

($0.04)

($0.02)

New units

issued

Interest

rate swaps

OtherFY25

$2.47

NET TANGIBLE ASSETS

PER UNIT

DOWN 22 CENTS TO

NTA per unit impacted by:

$96.7m unrealised

property revaluation loss

$28.7m unrealised

mark-to-market loss

on interest rate swaps

Weaker exchange rate

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

35

Movement in investment property
STRONG CPI-LINKED HEALTHCARE PORTFOLIO OFFSETS CAP RATE SOFTENING

TOTAL PORTFOLIO VALUE BRIDGE (FY25)

($M)

1

$1.2m of acquisitions for strategic / development sites. All values shown in $, pre costs

2

Includes development expenditure and capitalised interest costs

3

Book value of properties disposed

4

Period end NZD/AUD exchange rate moved from 0.9131 at 30 June 2024 to 0.9275 at 30 June 2025

3,240

$2,240m

1

(97)

(46)

(36)

3,212

$0

$500

$1,000

$1,500

$2,000

$2,500

$3,000

$3,500

$4,000

FY24Acquisitions (1)Capital

additions (2)

Property

revaluations

Disposals (3)Foreign

exchange (4)

FY25

$1,000m

$2,148m

$1,064m

150

5.54%

5.49%

5.63%

WACR - PORTFOLIO

WACR - AUSTRALIA

WACR - NEW ZEALAND

SOFTENED 23BPS TO

SOFTENED 31BPS TO

SOFTENED 3BPS TO

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

36

Comparative returns
VITAL MAINTAINS LONG-TERM OUTPERFORMANCE VS BENCHMARK ON A TOTAL RETURN

1

BASIS

TOTAL RETURN

1

TO 30 JUNE 20251YR5YR (P.A.)10YR (P.A.)SINCE 2004 (P.A.)

2

Vital12. 6%(1. 2 %)5.8%9. 4%

S&P/NZX All Real Estate Index8.7%0.6%4.7%6.6%

Vital’s performance vs NZX REIT3.9%(1. 8%)1.0%2.8%

1

Total returns measured by change in unit price plus post-tax distributions to 30 June 2025Source: Forsyth Barr

VHP VS S&P NZX REAL ESTATE INDEX

2

S&P/NZX All Real Estate Index data from 31 December 2004, being the inception date of the NZX All Real Estate Index

0

100

200

300

400

500

600

700

800

900

1,000

Jun-05

Dec-05

Jun-06

Dec-06

Jun-07

Dec-07

Jun-08

Dec-08

Jun-09

Dec-09

Jun-10

Dec-10

Jun-11

Dec-11

Jun-12

Dec-12

Jun-13

Dec-13

Jun-14

Dec-14

Jun-15

Dec-15

Jun-16

Dec-16

Jun-17

Dec-17

Jun-18

Dec-18

Jun-19

Dec-19

Jun-20

Dec-20

Jun-21

Dec-21

Jun-22

Dec-22

Jun-23

Dec-23

Jun-24Dec-24Jun-25

VitalS&P/NZX All Real Estate Index

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

37

Appendices
Additional property information

Playford Health Hub, Adelaide

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

38

WESTERN
AUSTRALIA

NORTHERN


TERRITORY

SOUTH


AUSTRALIA

NEW SOUTH

WALES

TASMANIA

VICTORIA

QUEENSLAND

2

3

6

2

7

Investment properties

~$3.2B PORTFOLIO OF HEALTHCARE REAL ESTATE COMPRISING 34 INVESTMENT PROPERTIES

AS AT 30 JUNE 2025

South Australia (3)


Burnside Hospital - Stepney


Playford Health Hub – MOB, Retail and Carpark


Tennyson Centre

Victoria (6)


120 Thames Street


Avive Clinic, Mornington Peninsula


Ekera Medical Centre


Epworth Camberwell


Epworth Eastern Hospital


South Eastern Private Hospital

Wellington (4)


Boulcott Hospital


Bowen Hospital


Hutt Valley Health Hub


Wakefield Hospital

Northland (1)


Kensington Hospital

Bay of Plenty (1)


Grace Hospital

Christchurch (1)


68 Saint Asaph Street

Hawke's Bay (1)


Royston Hospital

Queenstown (1)

Kawarau Park

Health Hub

2

12

Click on one of the underlined properties

to see a fly-through of that property

Western Australia (2)


Abbotsford Private Hospital


Marian Centre

Auckland (5)


Ascot


Ascot Carpark (Right of Use)


Ascot Central


Endoscopy Auckland


Ormiston Hospital

Queensland (2)


Belmont Private Hospital


Currumbin Clinic

New South Wales (7)


GenesisCare Integrated Cancer

and Health Centre


Hurstville Private Hospital


Kellyville Private Hospital


Lingard Day Centre


Lingard Private Hospital


Maitland Private Hospital


Toronto Private Hospital

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

39

PRIVATE HOSPITALS
14 hospitals (acute and specialty

– mental health, rehabilitation)

Five hospital operators

83.0% of AUS portfolio value;

86.0% of AUS portfolio rent

WALE: 20.7 years

Six assets, multiple tenants

17.0% of AUS portfolio value;

14.0% of AUS portfolio rent

WALE: 9.5 years

AMBULATORY CARE

~$2.1b Australian portfolio overview

PRECINCT FOCUSED PORTFOLIO WITH A DIVERSE TENANT BASE

SUBSECTOR DIVERSITY (BY VALUE)

49. 8%

33.2%

17. 0 %

H

O

S

P

I

T

A

L


8

3

.

0

%

O

T

H

E

R


1

7

.

0

%

AMBULATORY

CARE

SPECIALTY

HOSPITAL

19.0 years

WALE

1

1

Inclusive of landlord options

ACUTE

HOSPITAL

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

40

H
O

S

P

I

T

A

L


8

4

.

1

%

O

T

H

E

R


1

5

.

9

%

~$1.1b New Zealand portfolio overview

STRONG GROWTH IN NZ PORTFOLIO OVER LAST FIVE YEARS

REFLECTING POSITIVE CONDITIONS FOR PRIVATE OPERATORS

PRIVATE HOSPITALS

Nine hospitals (all acute)

Six hospital operators

84.1% of NZ portfolio value;

84.3% of NZ portfolio rent

WALE: 19.2 years

Five assets, multiple tenants

15.9% of NZ portfolio value;

15.7% of NZ portfolio rent

WALE: 10.2 years

AMBULATORY CARE

17. 8 years

WALE

SUBSECTOR DIVERSITY (BY VALUE)

15.9 %

8 4 .1%

AMBULATORY

CARE

ACUTE

HOSPITAL

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

41

Rent reviews undertaken in FY25
HIGH PERCENTAGE OF TOTAL RENT IS REVIEWED ANNUALLY WITH STRUCTURED

1

REVIEW MECHANISMS

1

Includes fixed percentage and CPI reviews

Rent reviews have been

completed for 172 leases

in FY25

Structured reviews

represented 96.1%

1


of leases by income

Positive uplift via CPI and

fixed rent reviews

FY25


#

June 24 Rent p.a.

(NZD)

June 25 Rent p.a.

(NZD)

Increase

(NZD)

Annualised Growth

(Stable currency)

AustraliaAUS9499,212,005102,025,1082 , 813 ,10 22.8%

New ZealandNZ7850,537,85752,589,5632,051, 7074 .1%

Total172149,749,862154,614,6714,864,8093.2%


#

June 24 Rent p.a.

(NZD)

June 25 Rent p.a.

(NZD)

Increase

(NZD)

Annualised Growth

(Stable currency)

CPICPI108125,340,238129,368,3004,028,0623.2%

FixedFixed4618,542,5391 9 , 1 7 7, 8 9 2635,3523.4%

MarketMarket174,645,4714,772,4901 2 7, 0 1 92.7%

TurnoverTurnover11,221, 6141,295,98974 , 3 766 .1%

Total172149,749,862154,614,6714,864,8093.2%

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

42

No Review
(1.0%)

Turnover

(0.8%)

Fixed <3%

(1.7%)

Fixed 3%+

(10.2%)

Market Review

Rent Review Breakdown

(3.8%)

Other Reviews

CPI Linked Reviews

(82.5%)

(17.5%)

Rent review profile

BREAKDOWN OF PORTFOLIO CPI REVIEWS

FOR THE YEAR ENDED 30 JUNE 2025

TYPE%

CPI - Un-Capped 20.8%

CPI - 2.5% Cap1.3%

CPI - 3% Cap5.4%

CPI - 3.5% Cap1. 7%

CPI - 4% Cap42.3%

CPI - 5% Cap0.6%

CPI x 1.5 - 2.5% Cap4.8%

CPI x 1.5 - 3% Cap15. 7 %

CPI x 1.75 - 5% Cap2.2%

Lesser of CPI and 3%5.1%

FY26 rent review profile:

13% Fixed

26% market linked

61% CPI linked

RENT REVIEW BREAKDOWN

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

43

Core portfolio metrics
FIVE YEAR TRENDS HIGHLIGHT PORTFOLIO STRENGTH AND UNDERPIN LONG-TERM PERFORMANCE

OCCUPANCY

AVERAGE 10 YR LEASE EXPIRY

1

WALE

TOTAL INCOME SUBJECT TO

STRUCTURED RENT REVIEWS

>98.0%

Occupancy

Long-term track record of maintaining

High degree of confidence that

future expiries will be renewed

or replaced with new tenants in

advance of expiry

0.0%

1.0%

2.0%

3.0%

4.0%

5.0%

6.0%

PERCENTAGE OF INCOME

1.6%1.7%

1.8%

1.8%

1.7%

2 0 212022202320242025

0.0%

20.0%

40.0%

60.0%

80.0%

100.0%

2 0 212022202320242025

PERCENTAGE OF INCOME

95.0%

92.3%

94.2%

96.0%96.4%

15

16

17

18

19

20

18.7

17.6

17.8

18.3

18.5

2 0 212022202320242025

95.0%

96.0%

97.0%

98.0%

99.0%

100.0%

2 0 212022202320242025

99.2%

98.7%98.8%

98.0%

98.6%

1

Reflects the average % of total portfolio income that expires over the next 10 years

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

44

Appendices
Additional development information

Playford Health Hub, Adelaide

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

45

Committed developments – Australia and New Zealand
DEVELOPMENTS ENHANCE EARNINGS GROWTH AND IMPROVE ASSET QUALITY

ALL VALUES SHOWN IN $MDESCRIPTION OF WORKSDEVELOPMENT

COST

1

LAND

VALUE

SPEND

TO DATE

COST TO

COMPLETE

FORECAST

NET RETURN

FORECAST

COMPLETION DATE

STATUS

Australia

RDX (QLD)9 level research and development centre of excellence

and 3 level, 181 bay basement car parking.

134.27. 2119 . 215 . 05.6%

2

Early-26Façade complete. Internal services fit off and finishes continue to all

levels. Completion delayed to early-26 due to inclement weather

(Cyclone Alfred) and to accommodate rework of atrium.

Total Australian Developments A$134.27. 211 9 . 215.05.6%

Total Australian Developments NZ$144.77. 7128.516.25.6%

New Zealand

Grace Hospital (NZ TRG)Fitout of 2 theatres, endoscopy and 10 beds.36.7 - 26.610 .15.5%Mid-26Same day admissions unit, OT8/9, on-grade car park and

Oropi Day Unit works are complete. Western Wing IPU construction

is on program.

Endoscopy Auckland (NZ AKL)New endoscopy clinic.32.2 - 29.92.35.4%Mid-late-25Main works construction currently on program.

Boulcott Hospital (NZ LH)2 theatres, post-anaesthesia care unit (PACU)

expansion and conversion.

24.8 - 23.31.56.0%Mid-25Construction works are forecast to be completed on program.

Wakefield Hospital Level 5

Expansion (NZ WGN)

34 bed ward expansion of Level 5 shell space.11 . 5 - 4.76.87.0%Late-25Fitout works are underway and progressing towards the midpoint

of construction.

Total New Zealand Developments A$105.20.084.520.75.7%

Total Developments in NZ$

3

249.97. 7213.036.95.6%

1

Excluding Land

2

Fully leased initial yield

3

A$ converted at 30 June 25 spot rate 0.9275

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

46

Glossary
AFFO

Adjusted Funds from Operations is an alternate measure used for assessing distributable income. Essentially adjusts net profit after tax for non-cash/non-recurring items (i.e. NDI) then makes adjustments for items such as

maintenance capex

CAGR

Compound Annual Growth Rate

Cap Rate

Capitalisation Rate. Generally calculated as net operating income / current market value of investment property

CPI

Consumer Price Index. An index that measures the change in the cost of a ‘basket’ of basic goods and services, showing how the cost-of-living changes over time. The most widely accepted indicator of inflation

DPU

Distribution per unit

DRP

Distribution Reinvestment Plan

EBITDAR

Earnings Before Interest, Tax, Depreciation, Amortisation, Rent

FX

An abbreviation for ‘foreign exchange’ used where there is a transaction in a currency other than the local currency

IFRS

International Financial Reporting Standards

M&A

Mergers and acquisitions

NPI

Net Property Income

NTA

Net Tangible Assets. The total assets of the Trust less total liabilities. NTA is normally divided by the number of units on issue and expressed as an annual amount per unit

NZX

New Zealand Stock Exchange

S&P

Standard & Poors, a credit rating agency

WAC R

Weighted Average Capitalisation Rate

WALE

Weighted Average Lease term to Expiry. The weighted average lease term remaining to expire across a portfolio, sometimes also referred to as WALT

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

47

Disclaimer
This document has been prepared by Northwest Healthcare Properties Management Limited (the Manager) as manager of the Vital

Healthcare Property Trust (the Trust). This document provides general information only and is not intended as investment, legal, tax, financial

product or financial advice or recommendation to any person and must not be relied on as such. You should obtain independent professional

advice prior to making any decision relating to your investment or financial needs.

All references to $ are to New Zealand dollars unless otherwise indicated.

This document may contain forward-looking statements. Forward-looking statements can include words such as “expect”, “intend”, “plan”,

“believe”, “continue” or similar words in connection with discussions of future operating or financial performance or conditions. Any indications

of, or guidance or outlook on, future earnings or financial position or performance and future distributions are also forward-looking

statements. The forward-looking statements are based on management's and directors’ current expectations and assumptions regarding the

Trust’s business, assets and performance and other future conditions, circumstances and results. As with any projection or forecast, forward-

looking statements are inherently susceptible to uncertainty and to any changes in circumstances. The Trust’s actual results may vary materially

from those expressed or implied in the forward-looking statements. The Manager, the Trust, and its or their directors, employees and/or

shareholders have no liability whatsoever to any person for any loss arising from this document or any information supplied in connection with

it. The Manager and the Trust are under no obligation to update this document or the information contained in it after it has been released.

Past performance is no indication of future performance.

The information in this document is of general background and does not purport to be complete. It should be read in conjunction with Vital’s

market announcements lodged with NZX, which are available at www.nzx.com/companies/VHP.

13 August 2025

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2025

|

48

Thank you
www.vhpt.co.nz

Wakefield Hospital, Wellington

---

Driving operational performance
Annual Report

Summary 2025

DISTRIBUTIONS PAID

TO UNIT HOLDERS

9. 75cpu

OCCUPANCY

98.6%

$2.47

NTA PER UNIT

Vital is pleased to report that distributions of 9.75cpu were paid to Unit

Holders in FY25, funded from an AFFO result of 10.41cpu. Good progress

was made on driving operational performance. New and renewal leasing

success lifted occupancy to 98.6% and the profitability of our diverse

underlying hospital tenants continued to improve. Vital’s strong balance sheet

was further enhanced during the final quarter of the year as improved terms

and pricing from a major $1.1b debt refinance were secured. Vital’s next debt

maturity is now not until March 2027.

Delivery of Vital’s major development projects continued the Stage 2

($91.5m) Wakefield Hospital (WGN) and the A$16.0m Maitland Private

Hospital (NSW) operationalised during the year. New opportunities

are being considered on a selective value adding basis and include the

commencement of a new $11.5m capacity expansion project at Wakefield

Hospital to meet demand. These initiatives, together with the continued focus

on actively curating the portfolio including its ESG resilience, position Vital to

offer enhanced Unit Holder returns over the medium term.

As part of our sustainability efforts, hard copy Annual Reports will no longer be mailed unless specifically requested by Unit Holders. Instead, this summary document

provides an overview of Vital’s key results for FY25. As with previous results, the full Annual Report will be emailed to Unit Holders and will be available on the NZX and

be posted on Vital’s website: https://www.vitalhealthcareproperty.co.nz/financial-results/. This initiative will save approximately 252,000 pages of printing per annum

and reduce our greenhouse gas emissions both through reducing printing and mailing.

Investors who would like to receive a printed Annual Report can request one by calling +64 9 488 8777, emailing enquiry@computershare.co.nz or mailing a request

to: Computershare Investor Services Limited, Private Bag 92119, Auckland 1142.

All values in this report are in NZ dollars unless stated otherwise.

$4.9m

LIKE-FOR-LIKE

NPI GROWTH

VITAL HEALTHCARE PROPERTY TRUST, MANAGED BY NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LTD | ANNUAL REPORT SUMMARY 2025 | 1

Financial results
Cash from operations measured by AFFO decreased by 3.5%

reflecting a higher tax expense and interest rate environment

partially offset by increased net property income.

Importantly, Vital was able to achieve distribution guidance

of 9.75cpu on a 93.6% payout ratio.

$148.8m

NET PROPERTY INCOME

Sustainability

Vital continues to prioritise sustainability throughout

its operations in line with Northwest’s global

sustainability strategy and framework.

PLACE GLOBALLY IN GRESB

FOR LISTED HEALTHCARE IN

DEVELOPMENTS

1s t

DEVELOPMENTS REGISTERED

TARGETING AT LEAST 5 STAR

GREEN STAR

Outlook

We believe the Vital business is well placed for FY26 and

beyond as we begin to see many of the headwinds that have

impacted healthcare property and the real estate sector

more generally begin to abate, including higher interest rates,

operator challenges in Australia and a risk off position from

investors. The recovery in New Zealand is further advanced

than Australia, with continued strong operator performance

and a stabilisation of property valuations and moderation in

construction costs observed. The continuation of this trend will

allow the fundamentals of the Vital business to again emerge,

Development update

Portfolio

overview

During FY25 two developments totalling $108.8m were

successfully operationalised, reducing the remaining committed

development spend to $36.9m.

Over 51,000sqm of space were leased, extended

or renewed during FY25, representing 22% of Vital’s

total income and 20% of the portfolios lettable area.

These strong leasing outcomes, including over

9,400sqm of new leasing, lifted portfolio occupancy

from 98.0% to 98.6% and increased weighted

average lease expiry (WALE) by 0.2 years to 18.5

years, despite the passage of time.

PORTFOLIO ($2.1B AUSTRALIA

& $1.1B NEW ZEALAND)

$3.2b

OCCUPANCY

98.6%

PIPELINE DEVELOPMENTS BEING

CONSIDERED FOR ACTIVATION

~$147.0m

SPENT ON CAPITAL WORKS IN

FY25 INCLUDING DEVELOPMENTS

$133.4m

COMMITTED DEVELOPMENT

SPEND REMAINING

$36.9m

WALE

18.5 year

DISTRIBUTION 10-YEAR CAGR

FY15 - FY25

2.0%

including strong demand for health services, an attractive

income return from a diversified tenant base and opportunities

to leverage the embedded value in the Vital portfolio. The Board

and management remain confident around Vital’s strategy

for delivering medium-long term returns for our Unit Holders.

Distributions totalling 9.75cpu (payable quarterly) are expected

to be paid for FY26.

We encourage you to join us and look forward to welcoming

you to our Annual General Meeting being held on

6 November 2025.

Ormiston Hospital Stage 1 Expansion, Auckland

Kawarau Park, Queenstown

Maitland Private Hospital, Maitland

AMBULATORY CARE

22%

SPECIALTY HOSPITALS

20%

ACUTE HOSPITALS

58%

TENANT DIVERSIFICATION

% OF RENT

Healthe Care 16.4%

Allevia 3.0%

Epworth HealthCare 13.7%

Evolution Healthcare 13.9%

Burnside 3.0%

Southern Cross 4.2%

GenesisCare 2.3%

Endoscopy Auckland

1

1.5%

Boulcott Hospital 1.7%

Other 21.9%

Aurora Healthcare 18.4%

BALANCE SHEET GEARING

42.1%

LIKE-FOR-LIKE NET PROPERTY INCOME GROWTH

3.7%

FY26 DISTRIBUTION

GUIDANCE

9.75cpu

9

WEIGHTED AVERAGE DEBT MATURITY

- NO MATURITY BEFORE MARCH 2027

3.8 years

1

Joint venture between Evolution Healthcare and Allevia

The recovery in New Zealand is further

advanced than Australia, with continued strong

operator performance and a stabilisation

of property valuations and moderation in

construction costs observed.

VITAL HEALTHCARE PROPERTY TRUST, MANAGED BY NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LTD | ANNUAL REPORT SUMMARY 2025 | 3VITAL HEALTHCARE PROPERTY TRUST, MANAGED BY NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LTD | ANNUAL REPORT SUMMARY 2025 | 2

Our
Board

Majority independent

board; directors

located in Auckland

(x2), Melbourne,

Sydney

*

& Toronto

vhpt.co.nz

Bios available at www.vitalhealthcareproperty.co.nz/board-management/

Disclaimer:

This document has been prepared by Northwest Healthcare Properties Management Limited (the Manager) as manager of the Vital Healthcare Property Trust (the Trust) and provides

high-level summary information only.

This document does not contain all the information in the Trust’s Annual Report which is available on www.nzx.com/companies/VHP and https://www.vitalhealthcareproperty.co.nz/

announcements/ and is not intended to replace the Annual Report.

This document is not intended as investment, legal, tax, financial product or financial advice or recommendation to any person and must not be relied on as such. You should obtain

independent professional advice prior to making any decision relating to your investment or financial needs.

All references to $ are to New Zealand dollars unless otherwise indicated.

This document may contain forward-looking statements. Forward-looking statements can include words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar words

in connection with discussions of future operating or financial performance or conditions. Any indications of, or guidance or outlook on, future earnings or financial position or

performance and future distributions are also forward-looking statements. The forward-looking statements are based on management’s and directors’ current expectations and

assumptions regarding the Trust’s business, assets and performance and other future conditions, circumstances and results. As with any projection or forecast, forward-looking

statements are inherently susceptible to uncertainty and to any changes in circumstances. The Trust’s actual results may vary materially from those expressed or implied in the forward-

looking statements. The Manager, the Trust, and its or their directors, employees and/or shareholders have no liability whatsoever to any person for any loss arising from this document

or any information supplied in connection with it. The Manager and the Trust are under no obligation to update this document or the information contained in it after it has been

released. Past performance is no indication of future performance.

The information in this document is of general background and does not purport to be complete. It should be read in conjunction with Vital’s market announcements lodged with NZX,

which are available at www.nzx.com/companies/VHP.

Craig Mitchell

Non-Executive Director

and Member of the Audit

Committee (Zachary

Vaughan replaced Craig

Mitchell on the Board

effective 12 August 2025)

Dr Michael

Stanford AM

Independent Director

and Chair of the Audit

Committee

Zachary Vaughan

Non-Independent

Director (Appointed

12 August 2025)

Graham Stuart

Independent Chair and

Member of the Audit

Committee

Angela Bull

Independent Director

and Member of the Audit

Committee

Mike Brady

Non-Independent

Director

Kirsty Bowyer

VP - Development

Chris Adams

Co-Head,

A/NZ Region

Alex Belcastro

SVP - Developments

and Precincts

Vanessa Flax

VP, Regional General

Counsel and Company

Secretary

Michael Groth

Chief Financial Officer

Richard Roos

Co-Head,

A/NZ Region

* As of 12 August 2025, with the

replacement of Craig Mitchell by

Zachary Vaughan, two directors

are based in Toronto and no

directors are based in Sydney

Executive

Team

Located across

New Zealand

and Australia

---

VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by Northwest Healthcare

Properties Management Limited

Page 1 of 1





13 August 2025


Results for announcement to the market

Name of issuerVital Healthcare Property Trust

Reporting Period12 months to 30 June 2025

Previous Reporting Period12 months to 30 June 2024

CurrencyNZD

Amount (000s)Percentage change

Revenue from continuing operations$148,8343.0%

Total revenue$148,8343.0%

Net profit/(loss) from continuing

operations($51,220)52.4%

Total net profit/(loss)($51,220)52.4%

Interim/Final Dividend

Amount per Quoted Equity Security$0.02437500

Imputed amount per Quoted Equity

Security$0.00632664

Record Date4 September 2025

Distribution Payment Date18 September 2025

Current periodPrior comparable period

Net tangible assets per Quoted

Equity Security$2.47$2.69

A brief explanation of any of the

figures above necessary to enable

the figures to be understoodRefer announcement

Authority for this announcement

Name of person authorised to make

this announcementMichael Groth

Contact person for this

announcementMichael Groth

Contact phone number+61 409 936 104

Contact email addressMichael.Groth@nwhreit.com

Date of release through MAP13 August 2025

The Annual Report accompanies this announcement

RESULTS ANNOUNCEMENT

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.